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ABSTRACT 
Mammalian	 cell-fate	 transitions	 are	 fundamentally	 important	 processes	 shaping	 evolution	 and	development.	 In	 vitro	 differentiation	 and	 reprogramming	 of	 pluripotent	 stem	 cells	 are	 valuable	models	 to	 study	 these	 processes.	 Until	 recently,	 interrogating	 the	 protein	 regulatory	 networks	involved	 in	 cell-fate	 transitions	 was	 hampered	 by	 technological	 limitations.	 Using	 the	 latest	 mass-spectrometry-based	 technologies	 available	 to	 date,	 combined	 with	 innovative	 biochemistry,	 this	thesis	presents	three	projects	exploring	the	proteome	rearrangements	which	occur	during	neuronal	differentiation	and	reprogramming.		First,	we	characterized	 the	global	proteome	dynamics	during	neuronal	differentiation	of	embryonic	stem	cells	 (ESCs)	and	 identified	a	co-expression	protein	cluster	with	high	 functional	enrichment	 for	neurogenic	processes.	A	predictive	bioinformatic	analysis	pointed	out	Sox2	as	a	top	regulator	of	this	protein	 group.	 Like	 most	 transcription	 factors,	 Sox2	 forms	 complexes	 with	 other	 proteins	 which	influence	its	target	selection.	We	interrogated	the	chromatin-associated	protein	interactome	of	Sox2	at	the	beginning	and	the	end	of	differentiation	and	found	that	it	undergoes	a	remarkable	stem	cell-	to	neuronal	transition.	Integrative	multi-omic	analysis	of	our	interactome	data	with	transcriptomic	and	chromatin	 accessibility	 assays	 suggest	 that	 the	 joint	 genome	 association	 of	 Sox2	 and	 selected	interactors	 has	 a	 regulatory	 effect	 on	 hundreds	 of	 genes	 involved	 in	 embryonic	 development.	Interestingly,	this	effect	can	be	activating	or	repressing	dependent	on	the	differentiation	stage.		The	second	study	explores	the	potential	of	epigenetic	memory	and	its	proteomic	manifestation	in	the	context	 of	 induced	 pluripotency.	 We	 demonstrate	 that	 unlike	 primary	 neurons,	 neuronal	 cultures	derived	 from	 induced	 pluripotent	 stem	 cells	 (iPSCs)	 retain	 the	 capacity	 to	 reprogram	 back	 to	 a	pluripotent	 state.	 To	 interrogate	 the	 potential	 proteomic	 manifestation	 of	 epigenetic	 memory,	 we	compared	the	 initial	 iPSCs	to	the	neuron-derived	iPSCs	and	found	that	while	their	overall	proteome	composition	is	highly	similar,	the	neuron-derived	iPSCs	retain	distinct	neuronal	signatures	in	addition	to	 the	 pluripotent	 ones.	 We	 further	 investigated	 the	 spatio-temporal	 progression	 of	 neuronal	differentiation	within	embryoid	bodies.	As	expected,	we	found	that	many	more	proteins	change	in	the	embryoid	body	rim,	which	is	exposed	to	differentiation-inducing	signals	compared	to	the	core,	which	is	 protected	 and	 retains	 pluripotent	 proteomic	 characteristics	 until	 the	 late	 differentiation	 stages.	Surprisingly,	 however,	 we	 found	 that	 key	 epigenetic	 and	 developmental	 switches	 involved	 in	pluripotency	exit	are	initiated	very	early	in	the	embryoid	body	core,	suggesting	very	fast	and	efficient	cross-communication	between	the	cells	layers	in	these	spheroid	structures.		Finally,	we	examined	the	protein	regulatory	network	associated	with	 the	promoter	of	c-Myc,	a	gene	critically	 involved	 with	 differentiation,	 development,	 pluripotency	 establishment	 and	maintenance.	Using	a	novel	technique	developed	in	our	lab,	we	successfully	isolated	the	c-Myc	promoter	on	a	single-locus	level	and	were	able	to	characterize	the	proteins	associated	with	it.	These	include	known	c-Myc	regulators,	as	well	as	many	novel	candidates.	Our	study	provides	a	unique	and	valuable	foundation	for	functional	analysis	of	potential	new	c-Myc	regulators.			In	sum,	we	employed	novel	biochemical	and	mass-spectrometry	based	techniques	in	different	cellular	context	 and	 successfully	 expanded	 the	 protein	 regulatory	 networks	 driving	 differentiation	 and	reprogramming.		

	ZUSAMMENFASSUNG 
Entscheidungen	 über	 das	 Zellschicksal	 sind	 von	 fundamentaler	 Bedeutung	 für	 die	 Evolution	 und	Entwicklung	 der	 Säugetiere.	 Die	 in	 vitro	 Differenzierung	 und	 Reprogrammierung	 pluripotenter	Stammzellen	 sind	 wertvolle	 biologische	 Modelle	 zum	 Erforschen	 dieser	 Vorgänge.	 Technologische	Mängel	haben	bis	vor	Kurzem	die	Forschung	an	die	Protein-gesteuerten	regulatorischen	Mechanismen,	welche	 in	 diesen	 zellulären	 Umwandlungen	 involviert	 sind,	 gehindert.	 Diese	 Doktorarbeit	 profitiert	von	 den	 neusten	 Entwicklungen	 der	 Massenspektrometrie	 und	 Biochemie	 und	 wendet	 sie	 in	 drei	Projekte	 an,	 welche	 es	 sich	 zum	 Ziel	 machen,	 die	 Umstrukturierung	 des	 Proteoms	 während	 der	neuronalen	Differenzierung	und	Reprogrammierung	zu	erforschen.			Wir	 haben	 das	 globale	 Proteom	während	 der	 neuronalen	Differenzierung	 embryonaler	 Stammzellen	untersucht	und	einen	co-exprimierten	Protein-Cluster	 identifiziert,	bei	dem	neuronale	Prozesse	stark	angereichert	waren.	Voraussagende	bioinformatische	Analyse	wies	auf	Sox2	als	 top	Regulator	dieser	Proteingruppe	 hin.	 Wie	 die	 meisten	 Transkriptionsfaktoren,	 bildet	 Sox2	 Komplexe	 mit	 anderen	Proteinen,	 welche	 die	 Selektion	 seiner	 Zielgene	 beeinflussen.	 Wir	 untersuchten	 das	 interaktive	Proteinnetzwerk	 von	 Sox2	 am	 Anfang	 und	 am	 Emde	 der	 Differenzierung	 und	 stellten	 einen	bemerkenswerten	Übergang	von	Stamzell-	zu	neuronalen	Proteinen	fest.	Eine	integrative	multi-omics	Analyse	 unseres	 Interaktionsdatensatzes	 zusammen	mit	 RNA-seq	 und	 ATAC-seq	 Daten	 deuteten	 an,	dass	 das	 gemeinsame	Binden	 von	 Sox2	 und	 bestimmten	 Interaktionspartnern	 einen	 regulatorischen	Effekt	 auf	 hunderten	 von	 Genen	 hat,	 welche	 in	 der	 embryonalen	 Entwicklung	 involviert	 sind.	Interessanterweise	 kann	 dieser	 Effekt	 aktivierend	 oder	 hemmend	 sein,	 abhängig	 vom	Differenzierungsstadium.		In	 der	 zweiten	 Studie	 wurde	 das	 Potenzial	 der	 epigenetischen	 Erinnerung	 und	 ihr	 Effekt	 auf	 das	Proteom	 im	 Kontext	 der	 induzierten	 Pluripotenz	 untersucht.	 Wir	 zeigen	 dass	 im	 Unterschied	 zu	primären	 Neuronen,	 iPSC-induzierten	 neuronalen	 Kulturen	 die	 Kapazität	 behalten,	 zurück	 zu	pluripotenten	 Zellen	 umgewandelt	 zu	 werden.	 Um	 das	 Potenzial	 der	 epigenetischen	 Erinnerung	 zu	untersuchen	 haben	wir	 die	 anfänglichen	mit	 den	 aus	 Neuronen	 reprogrammierten	 iPSCs	 verglichen	und	 stellten	 fast,	 dass	 ihre	 Proteome	 insgesamt	 zwar	 sehr	 ähnlich	 sind,	 jedoch	 die	 aus	 Neuronen	reprogrammierten	 iPSCs	 klare	 neuronale	 Merkmale	 beibehalten,	 zusätzlich	 zu	 ihren	 pluripotenten	Zeichen.	Weiterhin	wurde	der	raumzeitliche	Ausdruck	der	neuronalen	Differenzierung	 innerhalb	von	Embryoid	bodies.untersucht.	Als	erwartet	stellten	wir	 fest,	dass	sich	die	Exprimierung	von	viel	mehr	Proteinen	 am	 äußeren	 Rand	 verändern,	 als	 im	 Inneren	 Teil,	 welcher	 von	 der	 Zellkultur-Umgebung	geschützt	 ist	 und	 bis	 in	 den	 späten	 Differenzierungsphasen	 pluripotente	 Eigenschaften	 beibehält.	Überraschenderweise	 stellten	 wir	 aber	 fest,	 dass	 wesentliche	 Entwicklungs-	 und	 Epigenetikschalter	sehr	 früh	 und	 im	 Kern	 der	 Embryoid	 bodies	 eingeschaltet	 werden,	 was	 auf	 äußerst	 effiziente	Kommunikation	zwischen	den	unterschiedlichen	Zellschichten	hindeutet.			Schließlich	untersuchten	wir	das	regulatorische	Netwerk,	assoziiert	mit	dem	Promoter	von	c-Myc	–	ein	Gen	kritisch	involviert	 in	Differenzierung,	Entwicklung,	Pluripotenzentstehen	und	-aufrechterhaltung.	Wir	 wandten	 eine	 innovative	 Technik	 an	 um	 den	 einzelnen	 Genort	 (der	 Promoter	 von	 c-Myc)	 zu	isolieren	 und	 die	 Proteine	 zu	 bestimmen,	 welche	 daran	 gebunden	 waren.	 Darunter	 waren	 viele	bekannte	 Regulatoren	 von	 c-Myc,	 aber	 auch	 viele	 neue	 Kandidaten.	 Unsere	 Studie	 bietet	 eine	einzigartige	und	wertvolle	Basis	für	funktionelle	Analyse	potenzieller	neuer	c-Myc	Regulatoren.		Zusammengefasst	 setzten	 wir	 innovative	 biochemische	 und	 auf	 Massenspektrometire-basierten	Techniken	 an,	 in	 unterschiedlichen	 zellulären	 Kontexten,	 und	 erweiterten	 das	 proteomische	regulatorische	Netwerk,	welches	die	Differenzierung	und	Reprogrammierung	vorantreibt.	
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1. Introduction 
 
1.1 Cellular differentiation in evolution and development 	When	 the	 primary	 forms	 of	 life	 emerged	 on	 Earth	 around	 3.7	 billion	 years	 ago,	they	resembled	little	more	than	an	isolating	compartment,	made	of	phospholipids,	and	a	 self-replicating	molecule	 inside,	RNA	(Cooper	2000).	From	 this	basic	 stage	onwards,	 living	 matter	 took	 on	 a	 long	 journey	 guided	 by	 the	 core	 principles	 of	evolution	and	development,	thereby	reshaping	the	surface	and	atmosphere	of	the	planet	and	creating	a	biosphere	of	vast	complexity	and	variety.			This	 evolutionary	 road	 is	marked	 by	 several	 key	milestones.	 It	 took	 about	 1-1.5	billion	 years	 for	 living	 cells	 to	 develop	 a	 nucleus	 (as	 well	 as	 other	 cellular	compartments)	 and	 another	 billion	 years	 for	 multicellular	 structures,	 initially	cellular	 aggregates,	 to	 form	 (Cooper	 2000).	 At	 last,	 the	 mechanism	 of	 cellular	specialization	-	or	differentiation	-	emerged.	This	was	the	fuel	that	finally	drove	the	development	 of	 manifold	 organisms	 of	 unprecedented	 complexity.	 By	 taking	 on	highly	 specialized	 functions,	 cells	 could	 form	 different	 tissues	 which	 together	assemble	into	entities	with	a	wide	spectrum	of	biological	capacities.	The	number	of	cell	types	within	an	organism	is	often	used	as	a	proxy	for	its	complexity		and	in	the	present	day	biosphere,	mammals	sit	on	top	of	this	evolutionary	hierarchy	(Arendt	2008;	Hall	&	Olson	2006).			Several	 key	 aspects	 of	 the	 evolutionary	 milestones	 ultimately	 leading	 to	 the	formation	 of	 higher-order	 organisms	 like	 mammals	 are	 undergone	 during	 their	embryonic	development*.	 It	 is	 initiated	with	the	 formation	of	a	single	diploid	cell	(zygote),	 which	 then	 forms	 an	 aggregate	 of	 identical	 cells	 (morula),	 which	proceeds	 to	undergo	 series	 of	 differentiation	 steps	 to	 form	a	 complete	organism																																																									*	not	to	be	confused	with	the	largely	discredited	XIX	century	Recapitulation	theory,	which	 postulates	 that	 during	 development,	 animals	 go	 through	 phases	representing	the	evolutionary	stages	of	their	remote	ancestors.	
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with	 hundreds	 of	 highly	 specialized	 cell	 types.	 Clearly,	 the	 process	 of	 cellular	differentiation	runs	like	a	thread	through	the	fundamental	forces	shaping	biology	and	 studying	 it	 is	 therefore	 paramount	 to	 understanding	 how	 life	 works	 and	evolves.		
1.2 Cell-fate transitions in nature and research 	Mammalian	 embryonic	 development,	 much	 like	 evolution,	 is	 a	 unidirectional	process	 (Hochedlinger	&	Plath	2009).	 It	 involves	 transition	 through	a	number	of	cell-fate	 decisions,	 during	 which	 the	 cellular	 developmental	 and	 differentiation	potential	 progressively	 decreases	 (Hochedlinger	 &	 Plath	 2009).	 The	 highest	potential	bare	the	so	called	totipotent	cells	(from	Latin:	totus	–	whole	and	potens	–	power),	 which	 are	 the	 zygote	 and	 the	 blastomeres	 of	 the	 early	 morula	 (Kelly	1977).	They	can	give	rise	to	an	entire	organism.	The	second-highest	potential	have	the	 so	 called	 pluripotent	 cells	 (from	 Latin:	 pluri-	 very,	 many).	 Those	 are	 the	embryonic	stem	cells	(ESCs)	derived	from	the	inner	cell	mass	(ICM)	of	a	blastocyst.	They	have	 the	potential	 to	differentiate	 into	 any	 cell	 type,	 but	 cannot	 alone	 give	rise	to	an	organism.	Down	the	process	of	cellular	specialization,	the	differentiation	potential	of	the	stem	cells	gets	more	restricted	to	multipotency	(multipotent	stem	cells	can	give	rise	only	to	cell	types	within	their	lineage;	from	Latin:	multi-	many)	and	unipotency	(from	Latin:	unus	–	one)	(Mitalipov	&	Wolf	2009).		The	 fact	 that	 the	 genetic	 information	 is	 preserved	 during	 development	 and	remains	 identical	 in	 all	 adult	 cell	 types	 explains	 the	 necessity	 of	 "outer-genetic"	mechanisms	which	 account	 for	 the	 vast	 differences	 in	 gene	 expression	 patterns	and	subsequent	morphology	and	functionality	of	the	different	cell	types.	The	term	"epigenetic"	(from	Greek	ἐπι-	outer,	above)	was	first	coined	in	the	mid	XX	century	by	 the	British	 developmental	 biologist	 Conrad	Hal	Waddington,	who	 established	the	very	 foundations	of	 evolutionary	developmental	biology.	Originally,	 the	 term	"epigenetic"	used	to	describe	the	poorly	understood	regulatory	processes	related	to	the	formation	of	an	adult	organism	from	a	fertilized	zygote	(Waddington	1953).	This	 definition	 has	 evolved	 along	 with	 the	 significant	 increase	 in	 our	
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understanding	 of	 the	 mechanisms	 behind	 gene	 expression	 regulation	 and	 is	currently	 used	 to	 describe	 the	 heritable	 modifications	 which	 impact	 gene	expression	 and	 are	 not	 based	 on	 changes	 in	 the	 DNA	 sequence	 (Riggs	 &	 Porter	1996).	However,	 the	 history	 of	 epigenetics	 has	 always	 been	 intimately	 linked	 to	the	 study	 of	 evolution	 and	 development;	 as	 the	 famous	molecular	 biologist	 and	epigenetics	 expert	Gary	 Felsenfeld	 described	 it,	 "Although	 the	 definition	 that	we	choose	for	epigenetics	has	changed	to	accommodate	our	increasing	knowledge,	it	is	 important	 to	 remember	 that	 the	 original	 problem	 was:	 How	 can	 a	 single	fertilized	 egg	 give	 rise	 to	 a	 complex	 organism	with	 cells	 of	 varied	 phenotypes?"	(Felsenfeld	2014).		C.H.	Waddington	famously	depicted	the	relationship	between	gene	regulation	and	development	in	his	"epigenetic	landscape	model"	(Fig.	1.1)	(Waddington	1957).		In	it,	 developmental	 restrictions	 are	 depicted	 as	 marbles	 (cells)	 rolling	 down	 a	landslide	 into	 one	 of	 several	 valleys	 (cell	 fates).	 At	 the	 earliest	 developmental	stages,	cells	start	with	the	highest	developmental	potential	and	end	"down	on	the	bottom"	with	their	fully	differentiated	state,	which	bares	no	further	potential.			
	
Figure 1.1 Epigenetic landscape at different stages of development. Adaptation of C. H. 
Waddington’s epigenetic landscape model (Waddington 1957) by K. Hochedlinger and K. Plath 
(Hochedlinger & Plath 2009) showing cell populations with different developmental potentials (left) and 
their respective epigenetic states (right). Developmental restrictions are depicted as marbles (cells) rolling 
down a landslide into one of several valleys (cell fates). Colored marbles correspond to different 
differentiation states. Examples of reprogramming are shown by dashed arrows.  	
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The	 past	 70	 years	 of	 bioresearch	 have	 provided	 the	 insight	 that	 the	 progressive	loss	 of	 cellular	 developmental	 potential	 is	 neither	 unidirectional,	 as	 previously	thought,	 nor	 irreversible.	 The	developmental	 program	of	 the	 cells	 can	be	 turned	backwards	 towards	 pluripotency	 or	 totipotency	 under	 certain	 experimental	conditions	-	a	process	known	as	reprogramming	(Stadtfeld	&	Hochedlinger	2010).	There	 are	 several	methods	 to	 achieve	 this,	 such	 as	 somatic-cell	 nuclear	 transfer	(Briggs	&	King	1952;	Wilmut	et	al.	1997;	Hochedlinger	&	Jaenisch	2002;	Liu	et	al.	2018),	 cell	 fusion	 (Tada	et	al.	1997)	and	overexpression	of	defined	 transcription	factors	 (Takahashi	 &	 Yamanaka	 2006).	 All	 these	 methods	 ensure	 that	 the	epigenetic	 landscape	 of	 the	 somatic	 cell	 nucleus	 is	 reset	 back	 to	 a	 state	 which	largely	 resembles	 a	 pluripotent	 or	 totipotent	 state	 (Fig.	 1.1)	 (Apostolou	 &	Hochedlinger	2013).		This	 remarkable	 cellular	 plasticity	 has	 vast	 implications,	 both	 for	 fundamental	science	 and	 for	 medical	 research.	 In	 the	 context	 of	 the	 former,	 it	 provides	 an	invaluable	 insight	 into	the	developmental	processes	that	 lead	to	the	 formation	of	complex	 organisms.	 By	 studying	 the	 molecular	 changes	 which	 occur	 during	cellular	 differentiation	 and	 reprogramming,	 we	 gain	 understanding	 in	 how	biological	complexity	emerges.				In	the	context	of	medical	research,	stem	cells	bare	a	tremendous	therapeutic	and	diagnostic	 potential	 (Watt	 &	 Driskell	 2010).	 Different	 stem	 cell	 therapies	 are	already	 a	 common	 medical	 practice	 –	 most	 notably	 hematopoietic	 stem	 cell	transplantations	 (Watt	&	Driskell	 2010).	 Owing	 to	 their	 capacity	 to	 differentiate	into	 any	 cell	 type,	 pluripotent	 stem	 cells	 hold	 a	 great	 potential	 in	 replacement	therapies	 and	 offer	 the	 advantage	 that	 they	 can	 be	 differentiated	 into	 various	lineages	under	strictly	controlled	conditions	in	vitro.	Furthermore,	Takahashi	and	Yamanaka's	establishment	of	 the	so	called	 induced	pluripotent	stem	cells	(iPSCs)	(Takahashi	 &	 Yamanaka	 2006),	which	 ultimately	 led	 to	 Yamanaka's	 Nobel	 Prize	award	only	6	years	later,	offers	the	significant	advantages	that	(1)	the	cells	can	be	generated	 from	 patient-own	 material,	 thereby	 omitting	 the	 need	 for	immunosuppression	 and	 (2)	 omit	 the	 necessity	 of	 destroying	 human	 embryos,	which	poses	a	 significant	 ethical	 issue	 for	a	 large	number	of	people	 (Inoue	et	 al.	
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2014;	Wu	&	Hochedlinger	2011).	Another	important	medical	 implication	is	owed	to	the	fact	that	pluripotency	emergence	and	cancer	formation	are	processes	which	share	 a	multitude	 of	molecular	 properties	 (Meissner	 et	 al.	 2008),	 explaining	 the	stem	cells'	relevance	to	cancer	research.	Last	but	not	least,	pluripotent	stem	cells	can	be	used	as	personalized	diagnostic	 tools,	due	 to	 their	capacity	 to	 indefinitely	renew	themselves	(Egashira	et	al.	2013).		Taken	 together,	 these	 factors	explain	 the	 immense	scientific	 interest	 in	 stem	cell	biology	 in	 general	 and	 the	 processes	 of	 differentiation	 and	 reprogramming	 in	particular.	While	significant	progress	has	been	made	in	uncovering	the	molecular	mechanisms	behind	these	processes,	there	are	still	a	lot	of	unknowns,	particularly	in	the	cases	where	the	necessary	technologies	have	either	not	existed	or	not	been	sufficiently	effective	in	unraveling	the	remaining	open	questions.	Addressing	them	is	paramount	for	overcoming	the	hurdles	hampering	the	way	of	this	technology	to	the	 clinic	 and	 for	 advancing	 our	 understanding	 in	 how	 cell-fate	 transitions	 and	complexity	emergence	work.		
1.3 Proteomics of differentiation and reprogramming 	In	 the	past	decades,	major	 technological	 and	bioinformatic	 advances	have	 turned	large-scale	studies	into	indispensible	components	of	bioresearch.	The	reduced	cost	and	increased	efficiency	of	sequencing,	for	example,	has	given	the	study	of	genomes	and	 transcriptomes	 a	 new	 position	 of	 importance	which	 spans	 through	 virtually	every	 aspect	 of	 biology.	 Methods	 which	 combine	 biochemical	 assays	 and	sequencing,	 such	 as	 chromatin	 immunoprecipitation	 combined	 with	 sequencing	(ChIP-seq),	 have	 also	 greatly	 increased	 our	 understanding	 of	 the	 regulatory	mechanisms	behind	a	multitude	of	cellular	functions	and	transformations.	Stem	cell	research	makes	 no	 exception	when	 it	 comes	 to	 benefitting	 from	 these	 advances.	Our	 current	 understanding	 of	 reprogramming,	 for	 example,	 is	 to	 a	 large	 extent	based	 on	 'global'	 studies	 of	 the	 dynamic	 changes	 in	 the	 transcriptome,	 genome	methylation	 patterns	 and	 chromatin	 conformation,	 occurring	 during	reprogramming	of	somatic	cells	to	iPSCs	(Polo	et	al.	2012;	Meissner	et	al.	2008).	
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	While	 the	 importance	 of	 transcriptome	 studies	 is	 undeniable,	 ultimately	 the	 key	functional	 entities	 in	 the	 cells	 are	 proteins.	 Based	 on	 the	 "central	 dogma	 of	molecular	 biology",	 it	 had	 been	 long	 assumed	 that	 there	 is	 a	 high	 correlation	between	transcriptomic	and	proteomic	changes	(Haider	&	Pal	2013).	However,	we	now	know	that	different	factors,	such	as	post-transcriptional	regulations	or	varying	protein	 half-lives,	 can	 lead	 to	 a	 discrepancy	 between	 the	 transcriptome	 and	proteome	(Haider	&	Pal	2013),	underlying	the	importance	of	integrated	studies.			Compared	to	genomics	and	transcriptomics,	proteomics	was	slower	to	enter	the	big	arena	of	big	data.	This	was	due	to	specific	technological	challenges	(put	bluntly	and	in	oversimplified	fashion,	nucleic	acids	can	be	amplified,	proteins	can	not,	resulting	in	much	lower	coverage).	That	being	said,	the	tremendous	recent	advances	in	mass	spectrometry-based	 technologies,	 as	 well	 as	 the	 invention	 of	 novel	 biochemical	methods	 and	 tailor-made	 bioinformatic	 solutions	 have	moved	 proteomics	 to	 the	forefront	of	stem	cell	research	(Abazova	&	Krijgsveld	2017).	The	increasing	impact	in	 the	 field	now	spans	both	global	proteome	analysis	 and	 sub-proteomes	 such	as	membrane	 proteins	 (enabling	 the	 novel	 discovery	 of	 cell	 surface	 markers),	phosphoproteomics	 (essential	 for	 signal	 transduction	 studies),	 and	 protein	interaction	networks	(allowing	the	elucidation	of	protein	complexes	and	regulatory	networks)	(Fig.	1.2)	(Abazova	&	Krijgsveld	2017).	
	
Figure 1.2 Usage of different proteomic technologies to study stem cell biology. Adapted from 
(Abazova & Krijgsveld 2017).	
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	There	have	been	a	number	of	mass	 spectrometry-based	applications	 focusing	on	the	 molecular	 transformations	 during	 cell	 fate	 transitions.	 Prominent	 examples	include	 the	 proteome	 analysis	 of	 some	 of	 neuronal	 differentiation	 paths	(Shoemaker	&	Kornblum	2016),	as	well	as	lineage-specification	studies	such	as	the	transition	 to	 the	 extraembryonic	 endoderm	 (Mulvey	 et	 al.	 2015).	 Induced	pluripotency	 has	 also	 been	 explored	 from	 a	 proteomic	 perspective.	 Our	 lab	performed	 the	 first	 deep,	 dynamic	 proteome	 profiling	 of	 fibroblasts	reprogramming	 to	 iPSCs	 and	 showed	 that	 most	 proteome	 expression	 changes	occur	 in	 the	early	and	 late	phases	of	 this	 transition	 (Hansson	et	al.	2012).	These	findings	were	 later	mirrored	 in	 the	groups	of	Nagy	and	Heck	 in	a	similar	system	(Benevento	et	 al.	 2014).	 Several	 studies	have	 focused	on	 the	earliest	pluripotent	cell-fate	transitions	by	comparing	the	proteome	composition	of	the	early	("naïve")	and	 late	 ("primed")	 states	 of	 pluripotency,	 which	 resemble	 the	 pre-	 and	 post-implantation	 epiblast.	 They	 identified	 differences	 in	 glycolysis	 (Taleahmad	 et	 al.	2015)	and	chromatin	regulation	(Song	et	al.	2012;	Taleahmad	et	al.	2015),	which	supports	the	notion	that	pluripotency	is	controlled	epigenetically	(Jia	et	al.	2012).			Rather	 than	 solely	 focusing	 on	 expression	 changes,	 proteomics	 has	 also	 been	employed	 to	 study	 (regulatory)	 interaction	 networks	 in	 stem	 cells.	 The	 core	pluripotency	 factors	 Oct4,	 Sox2	 and	 Nanog	 (OSN)	 have	 been	 the	 subject	 of	particular	attention	and	plentitude	of	interaction	studies	(Do	et	al.	2014;	Pardo	et	al.	2010;	van	den	Berg	et	al.	2010;	Mallanna	et	al.	2010;	Lai	et	al.	2012;	Costa	et	al.	2013;	 Gagliardi	 et	 al.	 2013).	 Based	 on	 them,	 interaction	 partners	 with	 key	regulatory	functions	have	been	identified,	such	as	TET1	and	TET2,	which	rely	on	Nanog	for	their	role	in	pluripotency	establishment	(Costa	et	al.	2013).	Our	lab	has	further	expanded	the	circuitry	of	pluripotency	by	examining	the	chromatin-bound	OSN	interaction	network	and	how	it	changes	between	the	naïve	and	ground	states	of	pluripotency	(Rafiee	et	al.	2016).		In	 sum,	 proteomics	 is	 making	 an	 increasing	 impact	 in	 stem	 cell	 research	 and	continues	 to	 shape	 our	 understanding	 of	 how	 the	 molecular	 architecture	transforms	during	cell-fate	transitions.	
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1.4 Objectives 	This	thesis	aims	to	harness	the	power	of	some	of	the	major	technological	advances	in	 mass	 spectrometry-based	 proteomics	 and	 apply	 them	 to	 expand	 the	 current	knowledge	and	understanding	of	differentiation	and	reprogramming.			In	Chapter	2,	we	present	a	 large-scale	analysis	of	 the	dynamic	proteome	changes	taking	 place	 during	 neuronal	 differentiation	 of	 pluripotent	 stem	 cells.	 We	identified	 Sox2	 as	 a	 top	 regulator	 of	 a	 cluster	 of	 proteins	with	 similar	 temporal	expression	 profile	 and	 high	 enrichment	 for	 neurogenesis-related	 processes	 and	characterized	the	chromatin-associated	Sox2	interactome	at	the	beginning	and	end	of	neuronal	differentiation.	Finally,	we	used	multi-omics	integrative	analysis	with	transcriptomic	and	chromatin	accessibility	datasets	to	explore	the	transcriptional	regulatory	 effects	 of	 the	 associated	 binding	 of	 Sox2	 and	 its	 newly	 identified	interaction	partners	during	differentiation.			Chapter	 3	 explores	 the	 potential	 and	 proteomic	 manifestation	 of	 the	 so	 called	"epigenetic	 memory"	 in	 the	 context	 of	 neuronal	 differentiation	 and	reprogramming.	We	demonstrate	 that	unlike	primary	neurons,	neuronal	cultures	generated	 from	 pluripotent	 stem	 cells	 retain	 sufficient	 epigenetic	 traits	 which	allow	 them	 to	 be	 transformed	 back	 to	 a	 pluripotent	 state	 using	 only	overexpression	 of	 the	 four	 "Yamanaka	 factors"	 (Oct4,	 Sox2,	Klf4	 and	 c-Myc).	We	characterized	 the	 proteomes	 of	 the	 initial	 and	 final	 pluripotent	 stem	 cells	 and	found	that	while	they	are	overall	highly	similar	in	both	morphology	and	expression	patterns,	 the	 final	 culture	 has	 a	 dual	 pluripotent/neuronal	 proteomic	 signature,	possibly	 owing	 to	 epigenetic	 memory	 retention.	 Finally,	 we	 interrogated	 the	spatio-temporal	 resolution	 of	 the	 proteomic	 shifts	 driving	 the	 transition	 from	pluripotent	 stem	 cells	 to	 neural	 progenitors	 within	 embryoid	 bodies	 and	 found	that,	surprisingly,	 important	epigenetic	and	expression	switches	driving	neuronal	differentiation	become	activated	very	early	inside	the	embryoid	body	core,	which	expresses	 high	 levels	 of	many	 pluripotency	markers	 like	Oct4	 and	Nanog	 and	 is	largely	isolated	from	the	signal-inducing	cell	culture	environment.		
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In	 Chapter	 4,	 we	 expand	 the	 transcriptional	 regulatory	 network	 in	 pluripotent	stem	 cells	 by	 presenting	 the	 first	 unbiased	 characterization	 of	 the	 proteome	associated	with	the	c-Myc	promoter	in	ESCs.	Using	a	novel	technique	developed	in	our	 lab,	we	 successfully	 isolated	 the	c-Myc	promoter	 region	 at	 single-locus	 level,	along	with	 the	proteins	bound	 to	 it.	We	employed	mass	spectrometry	 to	analyze	them	 and	 identified	 over	 250	 proteins	 associated	 with	 the	 promoter	 c-Myc,	 the	majority	of	which	are	novel,	thus	warranting	further	exploration	of	their	potential	regulatory	function	in	future.			Each	chapter	is	introduced	and	discussed	individually.									
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2. Proteome characterization and dynamic 
Sox2 interaction network during neuronal 
differentiation of ESCs  
	
2.1 Introduction 	From	all	differentiation	lineages	which	pluripotent	cells	can	assume,	the	neuronal	is	 among	 the	 most	 intriguing	 ones,	 for	 basic	 and	 clinical	 research	 alike.	 The	conversion	 of	 pluripotent	 cells	 to	 terminally	 differentiated	 neurons	 represents	 a	dramatic	 cellular	 transformation	 in	 terms	 of	 morphology	 (highly	 proliferative	round	 cells	 compacted	 in	 colonies	 transform	 into	 an	 intricate	 network	 of	 post-mitotic	 cells	 connected	 with	 axons	 and	 dendrites)	 and	 functionality	 (loss	 of	pluripotency	 and	 gain	 of	 the	 capacity	 to	 transmit	 electrical	 signals	 via	neurotransmitters).	 It	 requires	 drastic	 chromatin	 conformation	 and	modification	changes,	ultimately	leading	to	the	gene	expression	switch	associated	with	this	far-reaching	cell	fate	transition.			In	 the	 context	 of	medical	 research,	 generation	 of	 neurons	 from	pluripotent	 cells	has	 been	 widely	 seen	 as	 a	 potential	 promising	 treatment	 option	 for	 patients	suffering	 from	 neurodegenerative	 diseases,	 such	 as	 Alzheimer's	 and	 Parkinson's	disease.	 Since	 neurons	 do	 not	 divide,	 stem-cell-based	 replacement	 therapy	remains	 the	 most	 likely	 and	 hopeful	 solution.	 Indeed,	 studies	 in	 animal	 models	have	already	demonstrated	the	power	of	stem	cell	transplantation	therapy,	where	ESC-	and	iPSC-derived	neuron	progenitors	and	neurons	have	improved	the	clinical	outcome	and	life	expectancy	of	diseased	animals	(Kim	et	al.	2013).	It	is	thus	clear	that	 understanding	 the	 molecular	 underpinnings	 of	 this	 cellular	 transition	 –	 in	addition	 to	being	 scientifically	 interesting	–	 is	of	utmost	 importance	 for	bringing	the	therapy	safely	to	the	clinic.			
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There	are	various	systems	for	neuronal	differentiation	which	span	a	multitude	of		neural	cell	types	(cortical	neurons,	astrocytes,	motor	neurons,	to	name	but	a	few)	and	 time	 segments	 of	 the	 process	 (e.g.	 pluripotent	 cells	 to	 neural	 progenitors;	neural	 progenitors	 to	 neurons).	 The	 vast	 majority	 of	 studies	 focus	 only	 on	 a	segment	of	the	differentiation	process	(either	until	or	from	the	neural	progenitor	stage),	 	 rather	 than	 the	 full	 timeline	 from	pluripotent	 cells	 to	 fully	differentiated	neurons.	 Proteomics	 in	 particular	 has	 been	 rarely	 implied	 for	 studying	 a	 full	neuronal	 differentiation	 transition	 owing	 to	 technical	 challenges	 and	 the	 until	recently	insufficient	depth	of	proteome	coverage.	The	last	time-course	study	of	full	neuronal	 differentiation	 of	 ESCs	 using	 a	 similar	 differentiation	 system	 was	performed	 in	 2009	 and	 the	 authors	 identified	 only	 1200	 proteins	 -	 a	 depth	 far	below	 the	 demands	 of	 an	 integrated	 multi-omics	 analysis	 (Chaerkady	 &	 Kerr	2009).	 This	 "proteomics	 gap"	 has	 resulted	 in	 a	 lack	 of	 complete,	 multi-level	molecular	characterization	of	the	neuronal	differentiation	process.	To	address	this	knowledge	 gap,	 we	 used	 the	 latest	 mass-spectrometry-based	 technologies	 to	generate	 a	 dataset	 of	 much	 deeper	 coverage	 (470%),	 thereby	 obtaining	 a	more	comprehensive	 overview	 of	 the	 dynamic	 transition	 of	 pluripotent	 ESCs	 to	 fully	differentiated	 neurons.	 To	 study	 the	 level	 at	 which	 the	 protein	 expression	regulation	 occurs	 (tanscriptional,	 post-transcriptional,	 translational),	 a	transcriptome	 dataset	 (RNA-seq)	 was	 generated	 in	 the	 same	 neuronal	differentiation	 system	and	 compared	 the	 expression	 changes	on	both	 levels.	Our	integrative	 analysis	 showed	 that	 the	 protein	 expression	 changes	 are	 nearly	perfectly	 mirrored	 in	 the	 RNA-seq	 data,	 indicating	 that	 they	 are	 regulated	 on	transcriptional	level.		A	detailed	bioinformatic	analysis	of	 the	 factors	which	change	significantly	during	neuronal	differentiation	revealed	a	co-expression	cluster	of	98	proteins	which	are	highly	 enriched	 for	 neurological	 processes.	 A	motif-recognition-based	 predictive	analysis	 identified	 Sox2	 (Sex	 determining	 region	 Y-box	 2)	 as	 one	 of	 the	 top	regulators	 of	 this	 protein	 cluster.	 We	 therefore	 focused	 our	 further	 analysis	 on	Sox2.		
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Sox2	 is	a	 transcription	 factor	 fulfilling	key	regulatory	roles	 in	different	biological	contexts.	 It	 is	 most	 well-known	 as	 one	 of	 the	 three	 'core	 pluripotency	 factors':	together	with	 Oct4	 and	 Nanog	 it	 constitutes	 the	 center	 of	 a	 complex	 regulatory	network	involved	in	pluripotency	maintenance	and	induction	(Zhang	&	Cui	2014;	Takahashi	 &	 Yamanaka	 2006).	 Its	 expression	 is	 detected	 already	 in	 the	 early	morula	 stage	of	 embryonic	development	and	 is	 afterwards	 localized	 to	 the	 inner	cell	mass	(ICM)	of	the	blastocyst,	from	which	ESCs	are	derived	(Avilion	et	al.	2003).	The	 indispensible	 role	 of	 Sox2	 during	 early	 embryonic	 development	 is	demonstrated	 by	 the	 fact	 that	 its	 zygotic	 deletion	 causes	 failure	 to	 form	pluripotent	 epiblast	 and	 is	 therefore	 embryonically	 lethal	 (Avilion	 et	 al.	 2003).	Moreover,	 Sox2	 was	 a	 part	 of	 the	 first	 set	 of	 genes	 used	 to	 generate	 induced	pluripotent	stem	cells	 from	somatic	cells,	 further	showcasing	 its	essential	 role	 in	the	pluripotency	network	(Takahashi	&	Yamanaka	2006).			Interestingly,	the	core	pluripotency	factors	Sox2	and	Oct4	have	also	been	shown	to	play	 important	 roles	 in	 cell	 lineage	 specification	 (Wang	et	 al.	2012).	Rather	 than	being	principal	 repressors	of	differentiation,	 they	are	also	 involved	 in	a	 complex	dose-,	 context-,	 and	 co-factor-dependent	 regulatory	 system	 which	 controls	 the	cellular	specification	into	different	developmental	fates	(Wang	et	al.	2012).	While	Oct4	 promotes	 the	 mesendoderm	 lineage,	 Sox2	 represses	 it	 and	 induces	 a	neuroectoderm	 fate	 instead	 (Zhao	 et	 al.	 2004;	 Thomson	 et	 al.	 2011;	Wang	 et	 al.	2012).	 Indeed,	 while	 the	 expression	 of	 Sox2	 declines	 during	 embryogenesis,	 it	continues	 to	 be	 expressed	 throughout	 mouse	 nervous	 system	 development	 and	into	 adulthood,	 even	 in	 some	mature	 neurons	 (Ferri	 et	 al.	 2004;	 Cavallaro	 et	 al.	2008).	When	the	expression	of	Sox2	is	reduced	to	30%	in	adult	mice,	the	mutants	display	 severe	 neural	 stem	 cell	 proliferative	 defects	 as	 well	 as	 dead	 neurons	 in	different	 regions	 of	 the	 brain	 (Ferri	 et	 al.	 2004).	 Remarkably,	 it	 has	 also	 been	shown	 that	 ectopic	 expression	 of	 Sox2	 alone	 is	 sufficient	 to	 directly	 reprogram	human	 fibroblasts	 to	 induced	neural	 stem	cells	 (iNSCs)	 (Ring	et	al.	2012).	Taken	together,	 this	 underlies	 the	 critical	 role	 of	 Sox2	 in	 neuronal	 differentiation	 and	development.	This	notion	is	also	supported	by	our	data,	which	points	to	Sox2	as	a	top	regulator	of	neural	differentiation.		
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Sox2	 has	 the	 particular	 property	 that	 it	 is	 present	 and	 active	 both	 in	 ESCs	 and	neurons,	 where	 it	 fulfills	 different	 functions.	 During	 neuronal	 differentiation,	 it	begins	 to	 target	 different	 genes	 and	while	 not	 all	 mechanisms	 behind	 this	 have	been	elucidated,	 it	 is	clear	that	Sox2	relies	on	its	varying	interaction	partners	for	target	 selection	 (Kondoh	&	 Kamachi	 2010;	 Zhang	&	 Cui	 2014).	 The	 cooperation	with	a	different	binding	partner	alters	the	Sox2	target	gene	specificity	(Kondoh	&	Kamachi	 2010).	 The	 best	 studied	 interaction	 is	 between	 Sox2	 and	 Oct4	 in	pluripotent	 cells.	 Together,	 they	 form	a	dimer	which	 regulates	 the	 expression	of	thousands	 of	 genes	 genome-wide	 –	 activating	 genes	 involved	 in	 pluripotency	maintenance	 and	 repressing	 genes	 inducing	 lineage	 specification	 (Boyer	 et	 al.	2005).	 In	 neural	 development,	 Sox2	 cooperates	 with	 various	 other	 binding	partners,	such	as	the	brain-specific	Brn2	in	neural	progenitors	and	Pax6	in	visual	system	 primordia	 during	 lens	 development	 (Tanaka	 et	 al.	 2004;	 Kamachi	 et	 al.	2001).	 Understanding	 how	 Sox2	 fulfills	 its	 varying	 regulatory	 functions	 during	neuronal	development	requires	identification	of	 its	changing	interaction	partners	during	 the	 process.	 Albeit	 significant	 progress	 in	 the	 expansion	 of	 the	 Sox2	interactome	 (Gao	 et	 al.	 2012;	 Huang	 &	 Wang	 2014;	 Rafiee	 et	 al.	 2016),	 a	comparative	 analysis	 between	 its	 binding	 partners	 at	 the	 beginning	 and	 end	 of	neuronal	 differentiation	 is	 still	 lacking.	 An	 important	 reason	 is	 that	 while	 Sox2	continues	 to	 be	 highly	 expressed	 in	 neural	 progenitors,	 its	 expression	 strongly	decreases	or	completely	disappears	in	most	mature	neurons.	In	our	differentiation	system,	however,	we	were	able	to	detect	sufficient	Sox2	expression	in	the	terminal	neurons	 (Suppl.	 Fig.	 2),	 making	 it	 a	 suitable	 model	 to	 study	 the	 changing	 Sox2	interactome	at	the	beginning	and	end	of	neuronal	differentiation.			With	 the	 rapid	 improvement	 of	 mass-spectrometry-based	 technologies,	 the	protein	 interactomes	 can	 be	 studied	 with	 much	 more	 depth	 and	 in	 a	 more	comprehensive	 way	 than	 ever	 before.	 A	 milestone	 in	 this	 regard	 was	 the	development	 of	 chromatin	 immunoprecipitation	 coupled	 to	 mass	 spectrometry,	termed	 ChIP-MS,	 whereby	 proteins	 (and	 nucleic	 acids)	 are	 first	 crosslinked	 and	then	 an	 antibody	 is	 used	 to	 pull	 down	 the	 protein	 of	 interest	 along	 with	 its	interaction	partners	 (Wang	et	 al.	 2013;	Won	et	 al.	 2015).	More	 recently,	 our	 lab	developed	a	novel	version	of	this	technique	termed	ChIP-SICAP	(Selective	Isolation	
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of	 Chromatin-Associated	 Proteins)	 allowing	 for	 the	 specific	 isolation	 of	 DNA-bound	 proteins	 from	 soluble	 protein	 complexes	 (Rafiee	 et	 al.	 2016)	 (Fig.	 2.8).	Based	 on	 our	 data	 which	 pointed	 out	 Sox2	 as	 an	 important	 regulator	 of	 neural	differentiation,	as	well	as	on	previous	knowledge	which	indicated	that	its	changing	function	in	different	cellular	states	relies	on	different	interaction	partners,	we	used	ChIP-SICAP	to	establish	the	first-ever	Sox2	chromatin-associated	interactome	both	in	 ESCs	 and	 terminally	 differentiated	 neurons.	 Our	 results	 demonstrate	 a	remarkable	transition	from	stem-cell	to	neuronal	interaction	partners	of	Sox2	(Fig.	2.10).	 Furthermore,	 we	 found	 that	 Sox2	 is	 associated	 with	 several	 epigenetic	factors,	 some	 of	 which	 are	 common	 between	 the	 beginning	 and	 end	 of	differentiation,	some	unique	(Fig.	2.10).			Finally,	we	investigated	the	effects	of	the	joint	DNA	binding	of	Sox2	and	its	newly	identified	interactors	on	target	gene	expression,	as	well	as	the	biological	processes	in	 which	 these	 targets	 are	 involved.	 To	 this	 end,	 an	 Assay	 for	 Transposase-
Accessible	 Chromatin	 using	 sequencing	 (ATAC-seq)	 dataset	 was	 generated	 for	different	time	points	during	neuronal	differentiation.	We	find	that	for	some	of	the	key	 Sox2	 interactors	 we	 identified,	 the	 level	 of	 chromatin	 accessibility	 on	 their	common	 binding	 sites	 with	 Sox2	 correlates	 with	 the	 transcription	 levels	 of	 the	most	proximate	genes,	suggesting	a	possible	gene	expression	regulatory	 function	of	 the	Sox2+interactor	 complex	 (Fig.	2.11).	We	 further	 find	 that	 the	processes	 in	which	 the	 target	 genes	 are	 involved	 are	 highly	 dependent	 on	 the	 cellular	differentiation	 state,	 indicating	 that	 the	 Sox2+interactor	 complex	 can	 have	 an	activating	 or	 repressing	 effect	 dependent	 on	 the	 biological	 context	 (Fig.	 2.12).	Finally,	 we	 mined	 publically	 availabe	 ChIP-seq	 datasets	 for	 Sox2	 and	 the	interactors	we	identified	in	our	ChIP-SICAP	experiment.	We	identified	the	common	binding	 sites	 across	 the	 genome	 and	 investigated	 the	 correlation	 between	 the	expression	levels	of	the	Sox2-interactor	and	the	target	gene.	We	show	that	highly	correlated	 and	 highly	 anti-correlated	 target	 genes	 are	 grouped	 in	 functionally	distinct	groups,	many	of	which	are	related	to	neural	development	and	epigenetic	remodeling,	strongly	suggesting	that	the	Sox2-interactor	complex	can	have	both	an	activating	and	a	repressive	effect	on	different	genes	in	the	same	cells	(Fig.	2.13).		
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2.2. Experimental design  	We	 used	 a	 chemical-	 and	 matrix-based	 in	 vitro	 cell	 system	 protocol	 in	 which	mESCs	are	transformed	to	terminally	differentiated	cortical	glutamatergic	neurons	(Fig.2.1A,B)	(Bibel	et	al.	2007).	129X1/SvJ ESCs	were	taken	off	leukemia	inhibiting	factor	 (LIF)	 and	 brought	 into	 3D	 culture	 to	 form	 embryoid	 bodies	 (or	 "Cellular	Aggregates",	 CAs);	 those	 were	 treated	 with	 retinoic	 acid	 (RA)	 and	 finally	dissociated	 and	 plated	 out	 on	 plates	 covered	 with	 polyornithine	 (PORN)	 and	laminin,	 where	 they	 formed	 terminally	 differentiated	 neurons	 (TN)	 2	 days	 later	(Fig	2.1A,B;	detailed	protocol	description	in	"Materials	and	Methods").	The	quality	of	 the	 neuronal	 population	 was	 assessed	 by	 light	 and	 fluorescent	 microscopy,	using	a	neuron-specific	dye	(Suppl.	Fig.	1).			Cells	were	collected	every	two	days	for	proteomic	analysis	and	every	four	days	for	transcriptomic	 (RNA-seq)	 and	 chromatin	 accessibility	 (ATAC-seq)	 analysis	 (Fig	2.1A).	The	protein	interactome	of	Sox2	was	examined	at	the	first	(ESC,	day	0)	and	last	(TN,	day	10)	time	point	of	the	differentiation	process.	
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Figure	 2.1	 Multi-omics	 analysis	 of	 neuronal	 differentiation.	 (A)	 Schematic	representation	of	the	differentiation	timeline.	Cells	were	collected	every	two	days	between	day	0	and	day	10	for	proteomic	analysis	and	every	four	days	between	day	0	and	day	12	for	transcriptomic	and	ATAC-seq	analysis.	(B)	Light	microscopy	and	procedure	outline	of	neuronal	differentiation.	Scale	upper	row:	day0:	100	µm,	days	2-8:	200	µm,	day	10:	50	µm	Scale	lower	row:	50	µm,	days2-8:	100	µm,	day	10:	20	µm.	 (C)	 Schematic	 representation	 of	multi-omics	 data	 analysis.	Whole	 proteome	and	 Sox2	 interactome	 analysis	 were	 performed	 with	 mass	 spectrometry,	 the	transcriptome	changes	were	studied	via	RNA-seq	and	ATAC-seq	was	used	to	study	the	chromatin	accessibility	changes	during	neuronal	differentiation.		
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2.3 Global proteome characterization of neuronal 
differentiation 
	We	 used	 high-end	 mass	 spectrometry	 technology	 to	 study	 the	 dynamic	 protein	expression	 changes	 which	 occur	 during	 differentiation	 (Fig.	 2.2).	 Cells	 were	collected	 in	 biological	 replicates	 every	 two	 days	 during	 differentiation	 and	subjected	 to	 a	 novel	 method	 for	 super-sensitive	 proteome	 isolation	 and	 sample	preparation	 (Hughes	 et	 al.	 2014).	 After	 enzymatic	 digestion	 of	 the	 proteins,	 the	peptides	were	 labeled	 using	 a	multiplexing	 technology	 called	 Tandem	Mass	 Tag	(TMT),	 allowing	 the	 subsequent	 pool	 of	 the	 samples	 into	 a	 single	 tube,	 thereby	maximizing	the	quantification	accuracy.	The	samples	were	fractionated	using	high-pH	 liquid	 chromatography	 (HPLC)	 and	 ran	 on	 an	 Orbitrap	 FusionTM	 mass	spectrometer	using	SPS-MS3,	a	synchronous	precursor	selection	method	providing	the	 highest	 degree	 of	 sensitivity	 and	 accuracy	 available	 today	 (Fig.	 2.2A)	 (see	"Materials	and	Methods"	for	detailed	method	description).					We	 identified	 a	 total	 of	 over	5674	proteins	 in	 the	 first	 and	5695	proteins	 in	 the	second	replicate,	4510	of	which	were	common,	thereby	achieving	a	much	deeper	proteome	coverage	(over	470%)	than	any	published	data	in	a	comparable	system	(Fig.	 2.2B).	 A	 principal	 component	 analysis	 (PCA)	 of	 the	 global	 proteomic	 data	revealed	 segregation	 of	 the	 biological	 replicates	 and	 separation	 based	 on	 the	differentiation	 stage,	underlining	 the	high	 reproducibility	 and	 indicating	 that	 the	detected	 changes	 happen	 progressively	 as	 a	 result	 of	 the	 differentiation	 process	(Fig	2.2C).	The	most	distinct	 separation	between	neighboring	 time	points	occurs	between	 day	 8	 and	 day	 10	 -	 an	 observation	which	 is	 in	 line	with	 the	 biological	transformation	 taking	 place	 between	 these	 time	 points:	 on	 day	 8,	 the	 neural	progenitors	 are	 still	 packed	 in	 large	 embryoid	 bodies	 (>500	 µm/diameter;	 Fig	2.1B);	they	are	then	plated	out	as	a	monolayer	with	neuro-inducing	plate	coating	(PORN	 and	 laminin)	 and	 neuronal	 medium,	 thus	 quickly	 reaching	 a	 terminal	differentiated	state	at	day	10	(Fig.	2.1B).		
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Figure	 2.2	 Global	 proteome	 analysis	 during	 neuronal	 differentiation.	 (A)	Experimental	workflow.	Proteome	sample	preparation	 from	cells	 collected	every	two	 days,	 peptides	 were	 labeled	 using	 TMT	 multiplexed	 labeling,	 pooled	 and	fractionated	with	HPLC	and	analyzed	using	SPS-MS3.	Full	details	in	main	text	and	"Materials	 and	 Methods".	 (B)	 Number	 of	 proteins	 identified	 per	 biological	replicate.	(C)	PCA	of	global	proteome	data.			In	 order	 to	 gain	 insight	 on	 the	 proteins	 which	 are	 functionally	 relevant	 for	 the	studied	 cellular	 transition,	 the	 subset	 of	 the	proteome	which	displays	 significant	expression	 changes	 needs	 to	 be	 identified.	 	 To	 this	 end,	 we	 applied	 a	 bayesian	statistical	 analysis	 method	 called	 "limma",	 which	 is	 based	 on	 the	 use	 of	 linear	models	 for	 assessment	of	differential	 expression	and	 is	part	of	 the	Bioconductor	software	project	(full	details	in	"Materials	and	Methods").	We	find	that	compared	to	 day	 0,	 the	 proteomic	 changes	 increase	 over	 time	 and	 thus	 most	 significant	change	is	between	the	beginning	and	end	point	(Fig.	2.3A).	Our	analysis	revealed	that	 overall	 12%	 (550)	 of	 all	 proteins	 identified	 in	 both	 replicates	 display	 a	significant	expression	change	during	differentiation,	with	the	rest	of	the	proteome	remaining	mostly	stable	throughout	the	process	(Fig	2.3).			
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Figure	2.3	Differentially	expressed	proteins	during	neuronal	differentiation.	(A)	Distribution	Day10/Day0	ratios	between	biological	replicates	in	log2.	Proteins	in	 red	 have	 passed	 the	 limma	 test	 (p.adj.<0.01)	 and	 are	 thus	 considered	significantly	 changing.	 (B)	 Gradual	 expression	 change	 increase	 in	 the	 550	significantly	changing	proteins	(p.adj<0.1)	shown	as	relative	log2	fold	change	(FC)	ratio	to	day	0.			
2.4 Co-expression, co-regulation, co-functionality? 	In	 order	 to	 examine	 the	 possible	 regulatory	 and	 functional	 networks	 in	 which	proteins	 changing	 during	 neuronal	 differentiation	 are	 organized,	 we	 first	segregated	 them	 based	 on	 their	 dynamic	 expression	 patterns	 during	 the	differentiation	 time	 course.	 To	 this	 end,	we	 used	 unsupervised	 clustering	 of	 the	log2	 ratios	 of	 each	 time	 point	 to	 day	 0.	 Our	 analysis	 demonstrated	 that	 the	changing	proteins	followed	five	distinct	expression	change	patterns	(Fig.	2.4).	Two	of	 the	 co-expression	 clusters	 are	 steadily	 upregulated	 throughout	 differentiation	(Clusters	 1	 and	 5),	 two	 are	 downregulated	 (Clusters	 2	 and	 3)	 and	 one	 contains	proteins	which	are	downregulated	in	the	early	differentiation	stages,	but	return	to	their	 initial	 level	 later	 in	 reprogramming	 (Cluster	 4).	 This	 suggests	 that	 the	neuronal	 differentiation	 program	 is	 initiated	 already	 during	 the	 very	 early	differentiation	 stages	 and	 progresses	 steadily	 until	 the	 end.	 This	 is	 interesting	because	retinoic	acid,	the	prime	differentiation	agent,	is	only	added	to	the	cells	at	day	4	-	prior	to	that	time	point	the	cells	are	only	deprived	of	LIF	and	taken	in	3D	culture.				
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Figure	 2.4	 Unsupervised	 clustering	 of	 limma	 proteins.	The	relative	 log2	 fold	change	 (FC)	 ratio	 to	 day	 0	 was	 established	 for	 all	 550	 proteins	 after	 limma	analysis.	Each	line	represents	a	protein.	"n"	is	the	number	of	proteins	per	cluster.	For	inclusion	into	a	cluster,	we	used	an	upper	and	lower	limit	of	log20.5	and	log2(-0.5),	respectively.	The	"membership"	value	and	color	scheme	represents	how	well	a	protein	fits	into	the	average	cluster	profile.				Since	 the	 expression	 of	 genes	 to	 proteins	 is	 regulated	 on	 multiple	 levels	(transcriptional,	 post-transcriptional,	 translational),	 we	 then	 addressed	 the	question	of	 the	regulatory	 level	at	which	the	expression	of	 the	changing	proteins	was	 altered.	 To	 this	 end,	 we	 generated	 a	 transcriptome	 dataset	 in	 the	 same	differentiation	system	and	compared	the	proteome	and	transcriptome	expression	changes	of	the	limma	proteins	(Fig	2.5).	We	report	a	very	high	correlation	between	the	 transcriptome	and	proteome	with	both	 levels	 following	 the	 same	expression	change	patterns	over	the	time	course	(Fig	2.5).			
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Figure	 2.5	 Comparative	 analysis	 of	 proteome	 and	 transcriptome	 of	 limma	
proteins.	 	 Expression	 change	 is	 shown	 as	 relative	 fold	 change	 ratio	 to	 day	 0,	 in	log2.	 Clear	 similarity	 of	 the	 proteome	 and	 transcriptome	 expression	 change	patters	 visible	 in	 all	 five	 clusters.	 RNA-seq	 data	 by	 M.	 Gehre	 and	 D.	 Bunina,		analysis	by	D.	Bunina	and	N.	Abazova.		Based	 on	 this	 result,	 we	 concluded	 that	 the	 proteomic	 expression	 changes	observed	during	differentiation	are	primarily	regulated	at	the	transcriptional	level,	indicating	a	high	coordination	between	the	different	regulatory	systems.			To	 examine	 the	 link	 between	 co-expression	 and	 functionality,	 we	 applied	 gene	ontology	 (GO)	 enrichment	 analysis	 on	 each	 of	 the	 five	 distinct	 protein	coexpression	clusters	(Fig.	2.6).	Intriguingly,	one	of	them,	Cluster	1,	displayed	very	high	 overenrichment	 for	 processes	 involved	 with	 neurogenesis,	 neuronal	development,	 neural	 differentiation	 and	 related	 processes	 such	 as	 cytoskeleton	organization,	axonogenesis	and	regulation	of	synaptic	transmission	(Fig.	2.6).	The	dynamic	expression	pattern	that	 the	proteins	 in	 this	cluster	 follow	is	one	of	high	and	consistent	increase	from	initiation	until	the	last	time	points	of	differentiation,	
n=98	 n=92	 n=113	
n=54	 n=193	
lo
g2
	F
C	
to
	d
ay
	0
		
lo
g2
	F
C	
to
	d
ay
	0
		
lo
g2
	F
C	
to
	d
ay
	0
		
lo
g2
	F
C	
to
	d
ay
	0
		
lo
g2
	F
C	
to
	d
ay
	0
		
day	2	
day	4	
day	6	
day	8	
day10	
day	12	
Chapter	2	
	 27	
suggesting	 that	 the	 neuronal	 lineage	 network	 becomes	 activated	 early	 and	consistently	increases	over	time.			Two	other	clusters,	Cluster	3	and	Cluster	5,	also	displayed	enrichment	for	distinct	biological	 processes,	 including	 cell	 cycle	 progress	 and	 morphogenesis	 of	 a	branching	 structure,	 respectively.	 The	 proteins	 in	 Cluster	 3	 are	 downregulated	already	from	day	0	onwards	and	decrease	sharply	between	day	8	and	day	10	(Fig.	2.4),	reflecting	on	the	decrease	of	the	high	proliferation	rates	in	ESCs	towards	the	post-mitotic	 state	 of	 the	 TNs.	 The	 proteins	 in	 Cluster	 5	 increase	 during	differentiation	 and	 the	 development	 of	 branching	 structures	 is	 necessary	 for	neuronal	 development	 and	 maturation.	 	 This	 result	 showcases	 the	 clear	 link	between	 co-expression	 and	 co-functionality	 in	 the	 context	 of	 neuronal	differentiation.	
	
Figure	2.6	Gene	ontology	enrichment	of	differentially	expressed	proteins.	All	protein	clusters	from	Fig.	2.4	were	tested	for	enrichment	of	Biological	Process	GO	terms	 compared	 to	 unregulated	 proteins.	 Cluster	 1	 is	 highly	 enriched	 for	neurological	and	neural	differentiation	processes.	Fischer's	exact	test,	p.adj<0.05.		Having	 identified	 a	 group	 of	 proteins	 involved	 in	 neuronal	 differentiation	which	are	both	co-expressed	and	highly	functionally	related,	we	proceeded	to	investigate	
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whether	 they	 are	 also	 co-regulated,	 i.e.	 if	 they	 are	 regulated	 by	 the	 same	transcription	factors	(TFs).	Using	a	method	originally	developed	for	transcriptomic	datasets,	 we	 performed	 an	 analysis	 based	 on	 transcription	 factor	 	 motif	recognition,	called	iRegulon,	which	predicts	whether	a	group	of	genes	is	regulated	by	 the	 same	 transcription	 factors	 (Fig.	 2.7)(Janky	 et	 al.	 2014).	 Interestingly,	 our	results	 indicate	 that	 the	 great	 majority	 (70%)	 of	 all	 proteins	 in	 Cluster	 1	 are	predicted	to	be	regulated	by	the	same	7	transcription	factor	families.	From	all	TFs	belonging	to	these	families,	27	passed	our	filter	for	direct	motif	similarity	(Suppl.	table	1)	and	one	of	the	top	ones	was	the	core	pluripotency	factor	Sox2	(Fig	2.7B).	This	result	suggests	that	the	proteins	in	Cluster	1	not	only	share	the	same	dynamic	expression	pattern	and	neuron-related	 functionality,	but	are	also	 likely	regulated	by	the	same	transcription	factors,	one	of	which	is	Sox2.		
	
Figure	2.7	iRegulon	analysis	of	differentially	expressed	proteins	in	Cluster	1.	(A)	70%	of	all	tested	proteins	(in	pink;	the	rest	30%	is	in	blue)	are	predicted	to	be	regulated	by	7	TF	families	(green).	(B)	Sox2	is	among	the	top	predicted	regulators	of	 the	 Cluster	 1	 proteins.	 For	 list	 see	 Suppl.	 table	 1.	 False	 discovery	 rate<0.001,	normalized	enrichment	score	=	3.	Full	description	of	the	iRegulon	tool	in	(Janky	et	al.	2014).			
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2.5 Chromatin-associated Sox2 interaction network in ESCs 
and neurons 
	We	 found	 that	 in	 our	 differentiation	 system,	 Sox2	 is	 present	 both	 in	 ESCs	 and	terminal	 neurons	 (TNs)	 (Suppl.	 Fig.	 2)	 and	 our	 data	 suggests	 that	 it	 is	 a	 key	regulator	 of	 genes	 involved	 in	 neuronal	 differentiation	 (Fig.	 2.7).	 In	 order	 to	elucidate	the	mechanisms	which	allow	Sox2	to	fulfill	its	different	functions	in	ESCs	and	 terminal	 neurons,	 we	 performed	 an	 experiment	 to	 determine	 its	 protein	interaction	partners	in	both	cellular	states,	while	it	 is	bound	to	DNA.	For	this,	we	used	 ChIP-SICAP	 (selective	 isolation	 of	 chromatin-associated	 regions),	 a	 novel	technique	 developed	 in	 our	 lab	 	 (Rafiee	 et	 al.	 2016).	 The	 exact	 procedure	 is	described	in	the	"Materials	and	Methods"	section	of	this	thesis.	Briefly,	cells	were	crosslinked	 using	 1.5%	 formaldehyde	 under	 standard	 ChIP	 conditions	 and	 the	nuclei	 were	 extracted	 and	 lysed	 after	 which	 the	 chromatin	 was	 sheered	 to	 a	fragment	 size	 of	 ~500	 base	 pairs	 (Suppl.	 Fig.	 3).	 Sox2	 was	 first	 immuno-precipitated	 using	 a	 specific	 antibody	 and	 then	 the	 ends	 of	 the	 DNA	 fragments	were	 biotinylated	 using	 terminal	 deoxynucleotidyl	 transferase	 (TdT)	 and	 pulled	down	using	streptavidin-coated	beads	(Fig.	2.8).	This	ensures	the	specific	isolation	of	 the	 chromatin-associated	 Sox2	 interactome.	 As	 a	 negative	 control,	 the	 same	procedure	was	done	using	an	unspecific	IgG	antibody.	Finally,	the	isolated	proteins	were	subjected	to	proteolytic	digestion	and	measured	on	LC-MS/MS.		
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Figure	2.8	Schematic	illustration	of	ChIP-SICAP	for	Sox2.			In	 order	 to	 examine	 the	 enrichment	 efficiency,	we	 ranked	 all	 identified	 proteins	based	on	their	protein	iBAQ	intensity	(Fig.	2.9A),	in	each	sample	and	replicate.	In	all	 cases,	 Sox2	 was	 among	 the	 most	 highly	 enriched	 proteins,	 indicating	 a	 high	
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efficiency	 of	 the	 ChIP	 pull-down.	 There	were	 few	 proteins	with	 higher	 intensity	than	 Sox2,	most	 notably	 histones,	which	 is	 expected	 given	 their	 high	 abundance	and	the	chromatin	isolation	(Fig.	2.10A).		To	ensure	that	only	true	Sox2	interactors	and	no	ubiquitous	proteins	are	included	in	the	analysis,	the	experiment	was	performed	again	with	an	unspecific	antibody,	IgG,	 and	 only	 proteins	 which	 were	 either	 exclusively	 present	 in	 the	 Sox2	 pull-downs	or	displayed	a	minimum	of	4X	enrichment	over	the	negative	control	in	both	biological	replicates	were	included	in	the	analysis.		We	 identified	 a	 total	 of	 92	 proteins	 in	 ESCs	 and	 105	 in	 TNs	 of	 which	 57	 were	common	 between	 the	 two	 cell	 types	 (Fig.	 2.10B,C).	 Over	 95%	 of	 all	 identified	proteins	 are	 nuclear,	 showcasing	 the	 high	 specificity	 of	 the	method	 (Fig.	 2.10C).	Interestingly,	13%	of	all	Sox2	interactors	in	ESCs	and	19%	in	TNs	are	transcription	factors	 (TFs),	 and	 over	 13%	 co-transcription	 factors	 (CoTFs),	 underlining	 the	regulatory	essence	of	the	Sox2-centred	network	(Fig.	2.10C).		
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Figure	2.10	Sox2	enrichment	and	interaction	proteins	in	ESCs	and	TNs.	(A)	All	identified	proteins	are	ranked	based	on	 their	 intensity	 (X	axis,	protein	rank	with	the	most	intense	protein	being	1,	second-most	intense	2	and	so	on;	Y	axis	is	log10	of	the	protein	intensity).	Sox2	is	among	the	most	highly	enriched	proteins	in	each	sample	and	raplicate.	 (B)	Number	of	enriched	Sox2	 interactors	over	 the	negative	control	in	ESCs	and	TNs.	(C)	Overview	of	the	identified	enriched	Sox2	interactors	in	each	cell	type.	Color	code:	blue=ESCs,	green=TNs.		Going	 through	 a	detailed	 analysis	 of	 the	 Sox2	 interactome	 in	both	 cell	 types,	we	observed	a	remarkable	transition	from	plutipotency-	to	neurobiology-related	Sox2	interaction	 partners	 (Fig.	 2.10).	 As	 expected,	 one	 of	 the	 most	 highly	 enriched	interactors	present	exclusively	in	ESCs	is	Oct4.	Other	prominent	stem	cell	 factors	identified	 solely	 in	 ESCs	 include	 Sall4	 and	 Rif1	 -	 the	 former	 is	 a	 known	 Sox2	interactor,	 the	 latter	 is	 novel.	 The	 proteins	 identified	 as	 Sox2	 interactors	 in	 TNs	encompass	a	multitude	of	neuronal	genes,	including	Fabp7,	which	has	been	shown	to	 play	 an	 essential	 role	 for	 neurogenesis	 in	 vivo	 (Watanabe	 et	 al.	 2007),	 the	topoisomerase	 Top2b	 which	 plays	 a	 critical	 role	 in	 forebrain	 development	 and	
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neuronal	 migration	 (Yang	 et	 al.	 2000)(Lyu	 &	Wang	 2003)	 and	 the	 CoTF	 Ctbp2,	which	 is	 a	 coactivator	 of	 retinoic	 acid	 signaling	 (Bajpe	 et	 al.	 2013)	 and	 is	 thus	essential	 for	 neuronal	 differentiation.	 The	 majority	 of	 the	 proteins	 identified	 in	TNs	have	not	previously	been	described	as	Sox2	interactors,	possibly	owing	to	the	fact	that	virtually	all	interactome	studies	thus	far	have	been	focused	on	pluripotent	or	neural	stem	cells,	but	not	on	differentiated	neurons.		For	 all	 shared	 Sox2	 interactors	 between	 ESCs	 and	 TNs,	 we	 calculated	 an	association	rate	relative	to	Sox2	between	the	two	cell	types	in	order	to	determine	if	 the	 association	of	 the	 respective	 interactor	 is	preferential	 in	ESCs	or	TNs	 (Fig.	2.10).	Remarkably,	we	observe	a	stem	cell-	 to	neuronal-	 factor	 transition	here	as	well:	 the	known	pluripotency-related	proteins	Trim24	and	Trim28	preferentially	bind	to	Sox2	in	ESCs	and	the	neuronal	factors	Adnp	and	Myef2	increase	their	Sox2	association	rate	in	TNs.			Notably,	a	significant	part	of	the	identified	Sox2	interactors	are	proteins	involved	in	 different	 levels	 of	 epigenetic	 remodeling.	 For	 example,	 in	 ESCs	we	 report	 the	histone	deacetylase	Mta2,	as	well	as	Hells	-	a	 factor	 involved	in	DNA	methylation	during	development.	Among	the	shared	factors	between	the	two	cell	types	are	the	DNA	methyl	transferase	Dnmt1	and	the	histone	methyl	transferase	Ehmt1.	In	TNs	we	 identify	 the	 multifunctional	 chromatin	 regulator	 Hmgb1	 and	 Wiz	 -	 a	 factor	linking	 histone	 methyltransferases	 to	 Ctbp,	 the	 factor	 involved	 in	 retinoic	 acid	signaling	which	we	also	 identified	 in	TNs	(Fig.	2.10)	(Ueda	et	al.	2006).	The	high	representation	of	epigenetic	factors	(20	in	ESCs	and	19	in	TNs)	might	be	directly	related	 to	 the	 fact	 that	 the	 ESC-to-TN	 transition	 is	 associated	 with	 dramatic	chromatin	and	DNA	methylation	reorganization.				
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Figure	 2.10	 Chromatin-associated	 Sox2	 interactome	 in	 ESCs	 and	 TNs.	 We	report	 three	 groups	 of	 Sox2	 interactors:	 present	 exclusively	 in	 ESCs,	 present	 in	both	ESCs	and	TNs	and	present	 exclusively	TNs.	There	 is	 a	 clear	 transition	 from	stem	cell	to	neuronal	interactors.	This	is	also	recapitulated	in	the	Sox2	association	rate	 of	 the	 shared	 interactors	 between	 ESCs	 and	 TNs.	 The	 association	 rate	 is	defined	as	intensity	ratio	between	the	interactor	and	Sox2	in	TNs	over	ESCs.	
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Taken	together,	our	data	suggests	that	Sox2	is	involved	in	the	process	of	neuronal	differentiation	of	ESCs	and	it	relies	on	a	highly	dynamic	interaction	network	which	displays	a	remarkable	stem	cell-to-neuronal	transition	and	is	likely	responsible	for	altering	the	Sox2	target	genes	during	this	dramatic	cellular	transformation.			
2.6 Sox2 and its interactors: effects on target gene expression 
and biological processes 	To	 examine	 the	 effect	 of	 the	 associated	 binding	 of	 Sox2	 and	 its	 newly	 identified	interaction	 partners,	 we	 first	 studied	 the	 chromatin	 accessibility	 change	 in	 the	common	 binding	 sites	 across	 the	 genome	 during	 neuronal	 differentiation	 and	correlated	it	to	the	transcriptional	change	of	the	genes	in	close	proximity	to	these	binding	sites.	This	was	done	in	collaboration	with	Dr.	Bunina,	a	shared	member	of	the	 labs	of	Dr.	Noh	and	Dr.	Zaugg.	To	 this	end,	Assay	 for	Transposase-Accessible	
Chromatin	using	sequencing	(ATAC-seq)	was	performed	at	four	time	points	during	differentiation.	 ATAC-seq	 provides	 quantitative	 information	 about	 the	 genomic	regions	 which	 are	 more	 "open"	 (i.e.	 accessible)	 or	 "closed"	 (i.e.	 inaccessible)	(Buenrostro	 et	 al.	 2013).	 Using	 available	 databases	 for	 transcription	 factor	 DNA	binding	 motifs,	 ATAC-seq	 allows	 the	 estimation	 of	 transcription	 factor	 activity	increase/decrease	 between	 cellular	 states:	 if	 there	 is	 an	 overall	 enrichment	increase	 of	 the	 motifs	 that	 a	 particular	 TF	 binds	 to,	 this	 is	 an	 indication	 of	 TF	activity	increase	(for	full	method	description	see	(Buenrostro	et	al.	2013)).		For	 the	 following	 analysis,	 in	 addition	 to	 the	 chromatin-associated	 Sox2	interactome	 described	 in	 Fig	 2.10,	 we	 also	 included	 Sox2	 interactors	 which	 we	identified	in	a	ChIP-MS	experiment	(i.e.	without	additional	selection	for	chromatin-bound	proteins).	We	did	 this	 in	order	 to	 include	Sox2-centered	complexes	which	might	 bind	 on	 chromatin	 only	 transiently	 or	 very	 dynamically	 and	 therefore	 be	missed	by	the	ChIP-SICAP	approach.			We	 first	 identified	 the	 ATAC-seq	 peaks	 containing	 motifs	 for	 both	 Sox2	 and	 its	interactors.	We	then	identified	the	genes	which	are	positioned	in	the	vicinity	of	the	
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common	ATAC-seq	peaks	and	are	therefore	putative	targets	of	the	Sox2-interactor	complex.	We	then	calculated	a	ratio	between	the	ATAC-seq	peak	intensity	 in	TNs	(day	12)	over	ESCs	(day	0)	and	correlated	it	to	the	target	gene	expression	change	between	 these	 time	points	 (Fig.	 2.11).	We	observed	 a	 correlation	with	 five	 Sox2	interactors,	the	highest	of	which,	0.24,	is	between	the	Sox2-Fubp1	ATAC-seq	peak	intensity	change	and	their	target	expression	(Fig.	2.11).	Unexpectedly,	in	the	case	of	 Sox2-Oct4,	 this	 correlation	 appears	 lower,	 0.20.	 However,	 this	 is	 possibly	explained	by	the	fact	that	at	day	12,	Oct4	is	not	expressed	at	all	and	therefore	its	motifs	are	occupied	by	other	factors.			
	
Figure	2.11	Spearman	correlation	between	common	ATAC-seq	peaks	of	Sox2	
and	 its	 interactors	 and	 their	 target	 genes	 expression.	 Genes	marked	with	 *	were	 derived	 from	 our	 ChIP-MS	 dataset,	 the	 others	 from	 ChIP-SICAP.	 ATAC-seq	data	and	analysis	by	D.Bunina,	RNA-seq	data	by	M.Gehre.		We	went	on	to	investigate	the	biological	processes	in	which	the	common	targets	of	Sox2	and	its	interaction	partners	are	involved.	To	this	end,	we	first	examined	the	differential	 chromatin	 accessibility	 of	 the	 common	 motifs	 regions	 (contained	within	common	ATAC-seq	peaks)	of	Sox2	and	its	interaction	partner	between	day	12	 and	 day	 0	 (Fig.	 2.12).	We	 focused	 on	 the	 regions	with	 differential	 chromatin	accessibility	 in	 either	 TNs	 or	 ESCs	 (Fig.	 2.12A).	 We	 subjected	 the	 genes	 in	 the	vicinity	 of	 these	 regions	 (the	 putative	 target	 genes)	 to	 GO	 term	 enrichment	analysis	 and	 found	 significant	 enrichment	 for	 the	 targets	 of	 four	 of	 the	 Sox2	
Oct4	
R=0.20	
Smrc1*	
R=0.23	
Hmga1	
R=0.20	
-5	 0	 5	 10	 -5	 0	 5	 10	 -5	 0	 5	 10	 -5	 0	 5	 10	
Fubp1	
R=0.24	
-5	 0	 5	 10	
Nr2f1*	
R=0.16	
6	
3	
0	
-3	
-6	
target	gene	transcription	log2(day12/day0)		
AT
AC
se
q	
pe
ak
	lo
g2
(d
ay
12
/d
ay
0)
		
common	Sox2+interactor	
ATACseq	peak	
proximal	gene	
Chapter	2	
	 37	
interactors:	Nr2f1,	Hmga1,	Smrc1,	and	Oct4	(Fig.	2.12B).	Remarkably,	we	observe	enrichment	 for	 targets	which	 at	 the	 respective	 time	 point	 are	 silent	 (like	 neural	genes	in	ESCs,	in	proximity	to	common	Sox2	and	Oct4	binding	sites)	or	active	(like	genes	involved	in	blastocyst	formation	in	ESCs,	in	proximity	to	common	Sox2	and	Smrc1	 binding	 sites).	 This	 possibly	 relates	 to	 the	 "priming"	 effect	which	 Sox2	 is	known	 to	 have	 together	with	 other	 transcription	 factors,	which	 keep	 genes	 in	 a	silent,	but	"ready"	state	for	transcription	once	an	additional	signal	is	received	(see	"Introduction"	for	details).	Our	results	suggest	that	the	chromatin	regulator	Smrc1,	whose	 expression	 positively	 correlates	 with	 the	 accessibility	 of	 its	 common	binding	sites	with	Sox2	(Fig.	2.11),	might	cooperate	with	Sox2	in	ESCs	to	maintain	a	stem	cell	state	and	simultaneously	prime	them	for	differentiation	(see	enriched	terms	 in	 Fig.	 2.12).	 Hmga1,	 whose	 common	 binding	 sites	 with	 Sox2	 are	 more	accessible	in	neurons	than	in	ESCs,	might	act	in	a	complex	with	Sox2	as	activator	of	neurogenesis-related	processes	(Fig.	2.12).	This	is	in	line	with	our	observation	that	the	 overall	 expression	 levels	 of	 their	 common	 targets	 correlates	 with	 the	accessibility	of	their	common	binding	sites	(Fig.	2.11).	Nr2f1	might	cooperate	with	Sox2	 as	 a	 repressor	 of	 the	 mesoderm	 lineage	 and	 Oct4	 might	 block	 the	 exit	 of	pluripotency	and	entry	 into	 the	neuronal	 lineage	by	repressing	the	expression	of	neuronal	genes.	
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Figure	 2.12	 Gene	 Ontology	 enrichment	 of	 targets	 of	 Sox2-interactor	
complexes.	 (A)	 Schematic	 representation	 of	 the	 ATAC-seq	 peak	 distributions	 of	Sox2,	its	interactors	and	the	common	peaks	between	them,	between	ESCs	(day	0)	and	TNs	(day	10).	We	selected	the	top	20%	most	changing	peaks	and	performed	GO	 enrichment	 for	 their	 putative	 targets.	 (B)	 GO	 enrichment	 for	 genes	 in	 the	vicinity	 of	 the	 common	 ATAC-seq	 peaks	 of	 Sox2	 and	 its	 interactors.	 Only	 genes	which	displayed	significant	GO	enrichment	are	shown.	p.adjusted<0.05.	The	Gene	Ratio	is	a	measure	of	the	proportion	of	target	genes	belonging	to	the	respective	GO	term.	The	number	under	each	gene	name	indicates	the	number	of	common	targets	it	has	with	Sox2.	ATAC-seq	data	and	analysis	by	D.Bunina.	
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Finally,	we	mined	publically	available	ChIP-seq	datasets	and	found	data	for	a	total	of	 18	 TFs	 which	 we	 had	 identified	 as	 Sox2	 interactors.	 The	 ChIP-seq	 data	 was	obtained	 in	 ESCs.	 We	 overlayed	 the	 signals	 of	 Sox2	 and	 each	 of	 these	 TFs	 and	selected	 their	 common	 binding	 sites	 across	 the	 genome	 (Fig.	 2.13A).	 Then,	 the	closest	 target	 genes	 (up	 to	 100kb	 from	 the	 common	binding	 site)	were	 selected	and	 the	 gene	 expression	 correlation	was	 calculated	 between	 the	 Sox2-interactor	and	its	respective	target,	across	the	entire	differentiation	timeline	(Fig.	2.13B).	We	focused	 our	 analysis	 on	 interactors	 which	 are	 either	 highly	 correlated	 (pearson	correlation	 >0.5)	 or	 highly	 anti-correlated	 (pearson	 correlation	 <-0.5)	 to	 their	targets	(Fig.	2.13B).	Intriguingly,	there	are	distinct	GO	term	enrichments	for	these	two	 groups,	 belonging	 to	 the	 same	 Sox2	 interactor.	 For	 example	 Sall4,	 a	 known	pluripotency	gene,	is	anti-correlated	to	genes	involved	in	neurogenesis	and	neural	development	 and	 correlated	 to	 genes	 involved	 in	 embryonic	 development	 and	stem	cell	maintenance	(Fig.	2.13C).	One	possible	explanation	 is	 that	 in	a	complex	with	Sox2,	it	might	simultaneously	act	as	an	activator	of	some	(pluripotency)	genes	and	repressor	of	other	(neuronal)	ones.			
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Figure	 2.13	 ChIP-seq-based	 GO	 term	 enrichment	 analysis	 correlated	 and	
anti-correlated	 target	 genes	 of	 Sox2-interactor	 complexes.	 (A)	 We	 selected	common	ChIP-seq	peaks	between	Sox2	and	its	interectors	and	the	closest	genes	to	these	 peaks,	 which	 we	 refer	 to	 as	 target	 genes.	 (B)	We	 correlated	 the	 dynamic	expression	 during	 the	 course	 of	 neuronal	 differentiation	 between	 the	 Sox2	interactor	 and	 its	 targets.	We	 selected	 the	most	 highly	 correlated	 (pearson>0.5)	and	anti-correlated	 (pearson<-0.5)	 target	genes	 for	 further	analysis.	 (C)	GO	 term	enrichment	 analysis	 of	 the	 correlated	 (+)	 and	 anti-correlated	 (-)	 target	 genes.	Interactors	marked	 in	 blue	were	 only	 shown	 to	 bind	 to	 Sox2	 in	 ESCs,	 the	 black	ones	were	common	between	ESCs	and	TNs.	Analysis	by	D.	Bunina.		In	summary,	our	analysis	suggests	that	the	joint	DNA	binding	of	Sox2	and	some	of	the	 key	 interaction	 partners	 we	 identified	 has	 an	 effect	 on	 target	 gene	transcription	 (Fig.	 2.11,	 Fig	 2.13)	 and	 that	 their	 joint	 target	 genes	 are	 highly	
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involved	in	developmental	regulatory	processes	during	neural	differentiation	(Fig.	2.12,	Fig.	2.13).	Furthermore,	the	results	suggest	that	the	interaction	between	Sox2	and	 its	 partners	 can	 have	 an	 activating	 or	 repressing	 effect	 dependent	 on	 the	biological	context	(ESCs	vs	TNs)	(Fig.	2.12,	Fig.	2.13).		
2.7 Discussion  	The	 process	 of	 complete	 transition	 from	 embryonic	 stem	 cells	 to	 terminally	differentiated	 neurons	 entails	 great	 molecular,	 morphological	 and	 functional	changes	which	need	to	be	elucidated	in	order	to	bring	the	technology	to	the	clinic.	In	 this	 study,	we	presented	a	high	 throughput	analysis	of	 the	dynamic	proteome	changes	 taking	 place	 during	 this	 major	 cell	 fate	 transition.	 Our	 dataset	 greatly	exceeds	the	depth	of	any	previously	existing	proteomic	study,	thereby	serving	as	a	valuable	resource	for	future	research	and	enabling	integrative	analysis	in	a	multi-omics	context.			We	 identified	 a	 cluster	 of	 proteins	 with	 highly	 dynamic	 and	 coordinated	expression	increase	during	the	differentiation	time-course,	which	was	enriched	for	processes	 related	 to	 nervous	 system	 development	 and	 neuronal	 differentiation.	Based	 on	 predictive	 bioinformatic	 analysis,	 we	 identified	 Sox2	 as	 a	 key	 factor	involved	in	the	regulation	of	this	group	of	proteins.	This	was	not	surprising,	since	Sox2	 is	 known	 to	 be	 involved	 both	 in	 pluripotency	 maintenance	 and	 neuronal	development	(Avilion	et	al.	2003;	Ferri	et	al.	2004;	Cavallaro	et	al.	2008).			The	fact	that	Sox2	relies	on	its	protein	interaction	partners	in	order	to	change	its	target	specificity	in	different	cellular	contexts	has	prompted	various	studies	which	aimed	 to	 determine	 the	 Sox2	 protein	 interactome	 (Kondoh	 &	 Kamachi	 2010;	Zhang	 &	 Cui	 2014;	 Gao	 et	 al.	 2012;	 Huang	 &	 Wang	 2014;	 Rafiee	 et	 al.	 2016).	However,	the	majority	of	this	work	was	focused	on	ESCs,	where	Sox2	fulfills	a	very	different	 function	 compared	 to	 neurons.	 In	 fact,	 the	 comprehensive	 protein	interactome	network	of	Sox2	has	never	been	established	in	differentiated	neurons	before.	The	main	reason	is	that	while	Sox2	is	still	highly	abundant	in	neural	stem	
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cells,	where	it	maintains	their	progenitor	identity,	it	completely	disappears	in	most	mature	neurons	and	remains	present	 in	only	 few	of	them	(Cavallaro	et	al.	2008).	This	 left	 an	 important	 question	 open:	 how	 does	 the	 Sox2	 interactome	 change	between	 pluripotent	 and	 fully	 differentiated	 neuronal	 cells?	 The	 fact	 that	 in	 our	differentiation	system	Sox2	was	still	present	in	the	terminal	neurons	(Suppl.	Fig.	2)	allowed	us	to	address	this	knowledge	gap	by	generating	the	first	comparative	Sox2	interactome	 dataset	 at	 the	 beginning	 and	 end	 of	 neuronal	 differentiation.	 We	identified	a	"core"	Sox2	interactome	which	was	present	both	in	ESCs	and	TNs,	as	well	as	subsets	specific	to	either	cell	type	(Fig.	2.10).	Remarkably,	we	observe	that	the	 composition	 of	 the	 Sox2	 interactome	 undergoes	 a	 stem-cell-to-neuronal	transition,	with	key	pluripotency-related	proteins	like	Oct4,	Sall4	and	Rif1	present	only	in	ESCs	and	proteins	involved	in	neurogenesis,	like	Fabp7	and	Top2b	present	only	in	TNs	(Fig.	2.10).	Interestingly,	we	observe	similar	functional	transition	even	in	the	"core"	Sox2	interactome:	we	find	that	the	Sox2	association	rate	of	proteins	with	known	stem	cell-related	functions	is	higher	in	ESCs	(Trim24,	Trim28)	and	the	association	 rate	 of	 proteins	 involved	 in	neuronal	 differentiation	 is	 higher	 in	TNs	(Adnp)	 (Fig.	 2.10).	 It	 should	 be	 noted	 that	 many	 of	 these	 proteins	 are	multifunctional	 and	 a	 strict	 distinction	 between	 a	 "stem	 cell"	 and	 "neuronal"	proteins	 is	 not	 always	 possible.	 For	 example,	 Smarcd1,	which	we	 identified	 as	 a	Sox2	 interactor	 in	 TNs,	 is	 a	 known	 component	 of	 the	 neuron-specific	 chromatin	remodeling	 complex	 nBAF	 and	 the	 neural	 progenitor-specific	 complex	 npBAF,	which	 are	 key	 regulators	 of	 the	 epigenetic	 remodeling	 mechanism	 occurring	during	 the	 progenitor-to-neuron	 transition	 (Lessard	 et	 al.	 2007).	 However,	 the	same	protein	was	also	shown	to	play	an	important	role	in	pluripotent	cells,	were	its	knockdown	impairs	the	self-renewal	capacity	of	the	stem	cells	(Gao	et	al.	2012).	That	being	 said,	when	 taken	 together,	 the	 Sox2	 interactors	we	 identified	 in	both	cellular	states	form	a	clear	pattern	of	pluripotent-to-neuronal	functional	transition.		Our	interrogation	of	the	putative	effects	of	cooperative	binding	between	Sox2	and	a	subset	of	 its	newly	 identified	 interaction	partners	suggests	 that	 it	might	have	a	regulatory	effect	on	the	gene	expression	of	their	common	target	genes	(Fig.	2.11).	Based	on	our	data,	this	effect	can	be	either	activating	or	repressive,	dependent	on	the	 cellular	 context	 (ESCs	 or	 TNs).	 Our	 results	 indicate	 that	 the	 chromatin	
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regulator	 Smrc1	 may	 cooperate	 with	 Sox2	 in	 ESCs	 to	 maintain	 their	 stem	 cell	character	 	 while	 at	 the	 same	 time	 prime	 them	 to	 exit	 pluripotency	 (a	 major	enriched	 term	 is	 "cell	 fate	determination").	 "Priming"	here	 refers	 to	a	 repressive	binding	at	a	 target	promoter,	which	can	be	quickly	activated	upon	association	of	additional	 factors.	 The	 dual	 function	 of	 activating	 pluripotency-associated	 genes	while	at	the	same	time	repressing	genes	involved	in	lineage	commitment	has	been	described	 for	 the	 cooperative	 binding	 of	 Oct4	 and	 Sox2	 in	 pluripotent	 cells	 (see	"Introduction"	for	details).	Another	interesting	Sox2	interactor	we	identified	is	the	chromatin	 remodeling	 protein	 Hmga1.	 Based	 on	 the	 increased	 chromatin	accessibility	measured	with	our	ATAC-seq	approach,	 	Hmga1	appears	to	 increase	its	 cooperative	 DNA	 binding	 with	 Sox2	 in	 neurons	 compared	 to	 ESCs	 and	 their	common	 targets	 are	 enriched	 for	 processes	 related	 to	 neuronal	 differentiation,	such	as	regulation	of	synapse	assembly	and	morphogenesis	during	differentiation	(Fig.	2.12).	Interestingly,	in	glioblastoma	stem	cells,	Hmga1	has	been	described	as	a	regulator	of	Sox2	itself,	which	controls	its	expression	by	modifying	the	chromatin	architecture	at	the	Sox2	promoter	(Lopez-Bertoni	et	al.	2016).	Given	that	Sox2	is	also	 self-regulatory,	 it	 is	 thus	 possible	 that	 Hmga1	 and	 Sox2	 act	 as	 a	 complex	entangled	in	an	expressional	feedback	loop	involved	in	different	stem-cell	related	settings:	 regulation	 of	 stemness	 in	 glioblastoma	 and	 promotion	 of	 neuronal	differentiation	 in	CNS	development.	 Exploring	 this	 possibility	 calls	 for	 functional	experiments	 in	 vivo	 and	 in	 vitro	 which	 test	 the	 phenotypic	 manifestation	 of	 a	disrupted	binding	between	the	two	factors.			It	 should	 be	 noted	 that	 ATAC-seq-based	 analysis	 offer	 a	 proxy	 of	 possible	cooperative	 binding	 of	 different	 transcription	 factors	 which	 is	 solely	 based	 on	prior	 information	 of	 the	 genome-wide	 recognition	motifs	 of	 each	 factor	 and	 the	accessibility	 of	 the	 regions	 containing	 these	motifs.	 Stringently	 investigating	 the	cooperative	 binding	 between	 Sox2	 and	 selected	 interaction	 partners	 requires	 a	different	approach,	such	as	performing	ChIP-seq	for	each	of	them	and	comparing	their	binding	sites.	However,	this	is	only	feasible	for	selected	interaction	partners	(a	 high-throughput	 ChIP-seq	 experiment	 for	 hundreds	 of	 interaction	 partners	 is	very	time-	and	resourse-consuming).	The	ATAC-seq	based	analysis	can	serve	as	a	valuable	 foundation	 for	 selecting	 of	 the	most	 promising	 candidates.	 At	 the	 same	
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time,	 combined	with	 our	 RNA-seq	 data,	 ATAC-seq	 offers	 a	more	 comprehensive	overview	of	the	relationships	between	chromatin	accessibility	and	transcriptional	regulation	at	different	sites.		As	 a	 next	 step,	 we	 are	 currently	 working	 on	 the	 generation	 of	 a	 Sox2	 ChIP-seq	dataset	 in	 both	 ESCs	 and	 TNs.	While	 ChIP-seq	 data	 in	 pluripotent	 cells	 exists	 in	wide	 abundance,	 there	 is	 currently	 no	 publically	 available	 data	 in	 glutamatergic	neurons.	 Adding	 this	 information	 to	 our	 current	 dataset	 will	 expand	 our	understanding	 about	 the	 relationship	 between	 the	 changing	 Sox2	 interaction	partners	 and	 Sox2	 target	 genes	 during	 neuronal	 differentiation.	 Combined,	 the	ChIP-SICAP	and	ChIP-seq	datasets	 from	ESCs	and	TNs	can	also	 serve	as	valuable	resource	 for	 future	 functional	 analyses.	 For	 example,	 the	 knock-down	 effect	 of	distinct	 Sox2	 interactors	 can	 be	 interrogated	 in	 the	 context	 of	 Sox2	 target	specificity	in	neuronal	cells.	This	is	a	field	in	which	the	current	knowledge	is	very	sparse	 and	 our	 integrated	 multi-omic	 datasets	 lay	 a	 solid	 foundation	 for	 its	expansion.																
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3. Epigenetic memory and spatio-temporal 
signature during neuronal differentiation and 
induced pluripotency 
3.1 Introduction 	In	 the	 last	 decades,	 a	 vast	 body	 of	 research	 has	 supported	 the	 notion	 that	development	 is	 under	 epigenetic	 control	 (Kiefer	 2007).	 DNA	 methylation,	 the	complex	histone	modification	code	and	exchange	of	histones	are	all	key	elements	of	 the	 epigenetic	 rearrangements	 which	 drive	 cellular	 specialization	 and	determine	 cell	 identity	 (Kiefer	 2007).	 Notably,	 these	 epigenetic	 rearrangements	are	also	crucially	involved	in	the	reverse	process,	namely	cellular	reprogramming,	when	 the	 developmental	 program	 of	 the	 cells	 is	 turned	 backwards	 towards	pluripotency	 or	 totipotency	 (Apostolou	 &	 Hochedlinger	 2013).	 In	 fact,	 the	 first	reprogramming	 experiments	 using	 somatic	 cell	 nuclear	 transfer	 (SNCF)	simultaneously	 served	 as	 the	 first	 and	 ultimate	 demonstration	 that	 cellular	differentiation	is	caused	by	epigenetic	and	not	by	genetic	changes	(Briggs	&	King	1952).	 SNCF	 is	based	on	enucleating	 an	 egg	 and	 inserting	 the	nucleus	of	 a	more	differentiated	cell.	This	reprogramming	technology	was	a	milestone	in	bioresearch	and	demonstrated	that	by	resetting	the	epigenetic	landscape	of	the	chromatin,	the	cells	 can	 re-gain	 the	 necessary	 developmental	 potential	 to	 give	 rise	 to	 (cloned)	organisms.	SNCF	was	used	to	generate	the	first	mammal	from	reprogrammed	adult	cells	("Dolly	the	sheep")(Wilmut	et	al.	1997)	and	later	on	from	fully	differentiated	cells	(Hochedlinger	&	Jaenisch	2002).			Despite	the	indisputable	success	of	SNCF	technology,		the	cloned	animals	displayed	clinical	 anomalies,	 which	 have	 been	 attributed	 to	 the	 so	 called	 "epigenetic	memory"	 (Gao	 et	 al.	 2003;	 Santos	 et	 al.	 2003;	Ng	&	Gurdon	2005;	Ng	&	Gurdon	2008;	Wee	et	al.	2006).	The	concept	of	epigenetic	memory	refers	to	residual	gene	expression	 and	 chromatin	 structure	 traits	 which	 have	 been	 inherited	 from	 the	donor	cell.	Cloned	animals	have	been	shown	to	retain	histone	modification	marks	from	their	cell	of	origin	(Santos	et	al.	2003;	Wee	et	al.	2006;	Ng	&	Gurdon	2008),	as	
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well	as	gene	expression	signatures	(Gao	et	al.	2003;	Ng	&	Gurdon	2005),	indicating	that	the	reset	of	the	epigenome	back	to	a	totipotent	state	was	not	100%	complete	and	the	residual	marks	affect	the	developmental	process.				An	 entire	 new	 branch	 of	 reprogramming	 and	 epigenetic	 studies	 emerged	 when	Takahashi	and	Yamanaka	made	the	groundbreaking	discovery	that	it	is	possible	to	reverse	the	developmental	clock	and	transform	fully	differentiated	cells	back	to	a	pluripotent	state	only	by	overexpressing	four	defined	factors,	Oct4,	Sox2,	Klf4	and	c-Myc	(OKSM)	(Takahashi	&	Yamanaka	2006).	Aside	from	its	immense	promise	for	biomedical	 research	(one	can	now	create	personalized	pluripotent	cells	 from	the	patient's	own	somatic	cells	and	differentiate	them	to	almost	any	needed	cell	type),	induced	 pluripotency	 provided	 an	 invaluable	 tool	 for	 studying	 the	 molecular	mechanisms	 behind	 cell-fate	 plasticity	 and	 lineage	 commitment.	 Compared	 to	SCNT,	 generating	 induced	pluripotent	 stem	 cells	 (iPSCs)	 is	much	 less	 technically	challenging	 and,	 importantly,	 allows	 the	 performance	 of	 experiments	 which	require	 high	 cell	 numbers	 as	 starting	 material	 and	 which	 explore	 the	 dynamic	molecular	transformations	during	reprogramming.		Since	 their	 establishment	 12	 years	 ago,	 iPSC	 have	 been	 the	 foundation	 of	 a	multitude	 of	 epigenetic	 studies,	 serving	 as	 a	 unique	 tool	 to	 examine	 the	mechanisms	 behind	 cellular	 plasticity	 (Krishnakumar	 &	 Blelloch	 2013).	 The	phenomenon	of	epigenetic	memory	retention	in	particular	has	been	the	object	of	much	 investigation.	 While	 iPSCs	 generated	 from	 various	 cell	 types	 reach	 a	functional	and	epigenetic	state	highly	similar	to	embryonic	stem	cells	(ESCs),	they	also	retain	specific	epigenetic	signatures	which	are	remnants	from	the	cell	type	of	origin	 (Vaskova	et	al.	2013).	Hochedlinger's	 lab	showed	 that	early-passage	 iPSCs	generated	 from	 fibroblasts,	 hematopoietic	 and	 myogenic	 cells	 display	 distinct	epigenetic	 and	 transcriptional	 patterns,	 and	 vary	 in	 their	 in	 vitro	differentiation	potentials	 (Polo	 et	 al.	 2010).	 Importantly,	 these	 cell-of-origin	 traits	 disappeared	over	 long-time	 culture	 of	 iPSCs	 (Polo	 et	 al.	 2010).	 In	 the	 same	 year,	 Daley's	 lab	reported	 that	 the	 retention	 of	 epigenetic	memory	 can	 be	 observed	 also	 on	DNA	methylation	level	(Kim	et	al.	2010).	In	this	study,	the	authors	generated	iPSCs	from	fibroblasts	 and	 hematopoetic	 progenitors	 and	 compared	 their	 methylation	
Chapter	3	
	 47	
patterns	 to	 ESCs.	 They	 report	 that	 fibroblast-derived	 iPSCs	 contained	 3349	differentially	 methylated	 regions	 compared	 to	 ESCs,	 whereas	 only	 516	 were	differentially	methylated	 in	 iPSCs	 derived	 from	hematopoietic	 cells.	 Importantly,	cells	 involved	 in	 hematopoiesis	 and	 osteogenesis	 (i.e.	 responsible	 for	 cell	specialization)	 were	 among	 the	 most	 highly	 expressed	 differentially	 methylated	regions,	underlining	the	existence	and	importance	of	epigenetic	memory	retention	(Kim	et	al.	2010).	 In	a	study	 focused	on	chromatin	accessibility,	Benvenisty's	 lab	demonstrated	that	iPSCs	derived	from	pancreatic	islet	beta	cells	not	only	retained	an	 open	 chromatin	 state	 at	 key	 beta-cell	 genes	 (INSULIN,	PDX1,	 and	MAFA),	 but	also	preferentially	differentiated	into	insulin-producing	cells	(Bar-Nur	et	al.	2011).	Remarkably,	 this	differentiation	was	more	efficient	 compared	 to	ESCs,	which	are	considered	 the	 "gold	 standard"	 of	 pluripotency	 (Bar-Nur	 et	 al.	 2011).	 Taken	together,	 these	 studies	demonstrate	 the	 significant	 impact	 of	 epigenetic	memory	on	 the	developmental	potential,	 cellular	plasticity	 and	gene	expression	 signature	during	reprogramming.		While	iPSCs	can	and	have	been	generated	from	almost	any	cell	type,	to	date	there	has	been	no	successful	reprogramming	of	neurons	using	only	the	four	"Yamanaka	factors"	(OKSM).	Two	research	groups,	Jaenisch	and	Dyer,	reported	attempts	to	do	this	 (Kim	et	 al.	 2011;	Hiler	 et	 al.	 2016).	 Because	neurons	 are	 very	 sensitive	 and	difficult	 to	 manipulate,	 the	 authors	 of	 both	 studies	 made	 use	 of	 a	 so	 called	"reprogrammable	 mouse"	 -	 a	 genetically	 modified	 mouse	 strain	 containing	 a	genome-integrated	 doxycycline-inducible	 OKSM	 cassette,	 along	 with	 a	 reverse	tetracycline	 transactivator	 (rtTA)	 and	 an	 Oct4-GFP	 pluripotency	 reporter	(Stadtfeld	 et	 al.	 2010).	 This	 system	 allows	 the	 initiation	 of	 reprogramming	 in	primary	neurons	upon	addition	of	doxycycline	to	the	cell	culture,	thereby	omitting	the	otherwise	necessary	viral	transduction	which	is	particularly	challenging	for	the	sensitive	 postnatal	 neurons.	 In	 2011,	 Jaenisch's	 lab	 demonstrated	 that	reprogramming	 of	 post-natal	 neurons	 was	 only	 possible	 if	 in	 addition	 to	 OKSM	overexpression,	the	key	tumor-suppressor	p53	was	inactivated	(Kim	et	al.	2011).	Later	 on,	 Dyer's	 lab	 developed	 a	 protocol	 which	 omitted	 the	 necessity	 of	 p53	inactivation;	 however,	 the	 reprogramming	 of	 neurons	 required	mixed	 culture	 in	which	cells	 from	"reprogrammable	mice"	were	cultured	as	aggregates	with	wild-
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type	 cells	 (Hiler	 et	 al.	 2016).	 This	 protocol	 does	 not	 enable	 neuronal	reprogramming	using	only	OKSM	overexpression,	it	requires	the	dispersion	of	the	cellular	 aggregates	 and	growth	of	 individual	 iPSC	 clones,	 and	 it	 takes	56	days	 to	complete	(Hiler	et	al.	2016).			In	 this	 thesis,	we	 present	 a	 study	 examining	 the	 presence,	 potential	 and	 spatio-temporal	manifestation	of	epigenetic	memory	and	its	effect	on	the	proteome	in	the	context	 of	 neural	 differentiation	 and	 reprogramming.	 Although	 primary	 neurons	cannot	 be	 reprogrammed	 only	 by	 OKSM	 overexpression,	 we	 hypothesized	 that	neurons	generated	from	pluripotent	stem	cell	in	vitro	may	give	rise	to	iPSC	due	to	retention	of	epigenetic	memory.	 Indeed,	we	successfully	differentiated	 (primary)	iPSCs	 to	 a	neuronal	 culture,	which	was	 then	 reprogrammed	back	 to	 (secondary)	iPSCs.	In	order	to	interrogate	the	potential	effect	of	epigenetic	memory	on	protein	expression,	we	 then	used	mass	 spectrometry	 to	 analyze	 and	 compare	 the	 global	proteome	composition	of		primary	and	secondary	iPSCs.	As	a	final	step,	we	aimed	to	investigate	the	spatio-temporal	dynamics	of	the	developmental	switches	driving	differentiation.	 To	 this	 end,	 we	 explored	 the	 proteomic	 changes	 which	 occur	 at	different	sites	(rim	vs.	core)	of	embryoid	bodies	during	differentiation	of	iPSCs.	
3.2 Full cycle of cell-fate transitions 	The	"reprogrammable	mouse"	strain	described	in	(Stadtfeld	et	al.	2010)	and	used	in	 Jaenisch	 and	 Dyer's	 studies	 (Kim	 et	 al.	 2011;	 Hiler	 et	 al.	 2016)	 is	 not	commercially	available.	Therefore,	we	generated	it	ourselves	from	separate	strains	containing	each	of	the	desired	mutations	(for	details	see	Materials	and	Methods).	Specifically,	 we	 generated	 two	mouse	 lines,	 a	 double	mutant	R26-rtTA+/+/	Oct4-
GFP+/+	and	Col1a1-OKSM+/+.	When	mated	with	each	other,	these	mice	give	rise	to	heterozygous	 triple-mutant	 embryos.	 Cells	 extracted	 from	 these	 embryos	 can	be	subjected	 to	 reprogramming	 upon	 addition	 of	 doxycycline	 to	 the	 cell	 culture	medium.	MEFs	 from	 triple-mutant	 embryos	 at	 13.5	 dpc	 were	 reprogrammed	 to	 iPSCs	(Suppl.	Fig.5;	procedural	details	 in	"Materials	and	Methods").	Clonal	 iPS	cell	 lines	were	generated	upon	picking	distinct	iPSC	colonies	and	culturing	them	separately.	
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To	ensure	the	erasure	of	any	residual	fibroblast-specific	epigenetic	traits,	the	lines	were	 cultured	more	 than	 two	weeks	 and	 split	 several	 times	 before	 initiation	 of	neural	differentiation	(the	epigenetic	reset	of	long-time	iPSC	culturing	is	described	in	 (Polo	 et	 al.	 2010)).	 The	 pure	 iPS	 cell	 lines	 are	 referred	 to	 as	 primary	 iPSC	(p.iPSC).	They	displayed	characteristic	iPSC	morphology,	were	strongly	Oct4+,	AP+	and	expressed	other	key	pluripotency	factors,	among	which	Nanog,	Sox2,	Sall4	and	Esrrb	(Fig.	3.1A,	Fig.3.3D,	Suppl.	Fig.5).		The	 p.iPSC	 were	 differentiated	 to	 glutamatergic	 neurons	 passing	 through	 an	embryoid	body	stage,	using	Bibel's	protocol	(Fig.3.1A)(Bibel	et	al.	2007).	The	final	neuronal	 culture	 (day	 12)	 displayed	 characteristic	 neuronal	 morphology	 and	network,	 was	 100%	 Oct4–negative,	 98.2%	 of	 the	 cells	 stained	 positive	 for	 the	neuron-specific	marker	NeuO	(Suppl.	Fig.	8)	and	86%	of	the	cells	were	positive	for	the	mature	neuronal	marker	Map2	(Suppl.	Fig.6).	 In	addition,	 the	cells	expressed	the	 glutamatergic	 neuronal	 marker	 glutamine	 synthetase,	 as	 well	 as	 the	neurogenesis	 marker	 doublecortin,	 the	 synaptic	 vesicle	 glycoprotein	synaptophysin	and	the	neural	cell	adhesion	proteins	Ncam1/2	(Suppl.	Fig.7).			The	 neuronal	 culture	 was	 subjected	 to	 reprogramming	 upon	 addition	 of	doxycycline	for	14	days,	after	which	the	drug	was	withdrawn	from	the	culture	to	ensure	 the	 purely	 endogenous	 expression	 of	 OKSM.	 We	 developed	 a	reprogramming	protocol	which	takes	a	total	of	32	days	and	is	based	on	the	step-wise	removal	of	neuronal	signals	and	increase	of	pluripotency-facilitating	ones	(for	full	details,	see	"Materials	and	Methods").	To	accurately	monitor	the	progression	of	pluripotency	 loss	 and	 gain,	 the	 cells	 were	 analyzed	 via	 flow	 cytometry	 for	 the	pluripotency	 marker	 Oct4-GFP	 (Fig.	 3.1A,B).	 We	 observed	 a	 very	 clear	 shift	 of	Oct4+	to	Oct4–	majority	populations	during	differentiation	and	vice	versa	during	reprogramming.	 At	 day	 32,	 secondary	 iPSCs	 (s.iPSCs)	 had	 formed.	 The	 s.iPSCs	displayed	 characteristic	 iPSC	 morphology	 and	 strong	 expression	 of	 Oct4-GFP	(Fig.3.1B).	 In	addition,	 they	expressed	many	pluripotency-network	genes,	 among	which	 Sox2,	 Sall4,	 Stat3,	 Lin28	 as	 well	 as	 the	 stem	 cell	 marker	 alkaline	phosphatase	(Fig.	3.3B).	
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Figure	3.1	Full	cycle	of	cell-fate	transitions	–	iPSCs	differentiated	to	neurons,	
neurons	reprogrammed	back	to	 iPSC.	(A)	Primary	iPSCs	were	differentiated	to	glutamatergic	neurons	 in	12	days,	passing	 through	an	embryoid	body	stage	until	day8.	Oct4-GFP	expression	is	progressively	lost	starting	from	the	outer	rim	of	the	embryoid	body	and	continuing	towards	the	core.	Flow-cytometry	analysis	at	days	4-8	displays	a	clear	shift	from	Oct4-GFP+	to	Oct4-GFP–	majority.	(B)	Glutamatergic	neurons	 from	 (A)	 	 reprogrammed	 to	 secondary	 iPSCs	 in	 32	 days.	 Day	 12	 of	differentiation	 represents	 day	 0	 of	 reprogramming.	 Flow	 cytometry	 analysis	 at	distinct	time	points	reveals	a	shift	from	Oct4–	back	to	Oct4+	majority	of	the	cells.	
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	Taken	together,	these	results	suggest	that	the	full	cyclic	conversion	of	pluripotent	cells	to	differentiated	neuronal	culture	and	back	to	pluripotent	cells	was	successful	and	 required	only	 the	 controlled	overexpression	of	 the	 four	 "Yamanaka	 factors".	This	supports	the	hypothesis	that	in	contrast	to	primary	neurons,	which	cannot	be	reprogrammed	 in	 this	way,	 reprogramming	of	neuronal	 cultures	 generated	 from	pluripotent	cells	is	feasible,	possibly	owing	to	their	epigenetic	memory.			
3.3 The dual nature of secondary iPSC 	The	 primary	 iPSCs	 underwent	 a	 long	 process	 of	 differentiation	 to	 neurons	 and	subsequent	 reprogramming	 to	 secondary	 iPSC	 (44	 days	 in	 total;	 12	 days	 of	differentiation,	 32	 days	 of	 reprogramming).	 To	 examine	 the	 effect	 of	 these	transformations	 on	 the	 cells'	 expression	 signatures,	 we	 compared	 the	 proteome	profiles	 of	 p.iPSCs	 and	 s.iPCSs	 (Fig.	 3.2A).	 The	 full	 proteome	 of	 each	 of	 the	 two	populations	was	measured	in	replicates	on	an	OrbitrapFusion	mass	spectrometer,	coupled	to	an	LC	system.	In	the	p.iPSCs,	3242	and	3220	proteins	were	identified	in	each	replicate,	3085	(>95%)	of	which	were	common	between	them.	In	the	s.iPSCs	-	3433	 and	 3353,	 3231	 (>96%)	 common	 (Fig.	 3.2B).	 For	 both	 populations,	 the	correlation	 between	 the	 replicates	 was	 very	 high	 (R=0.96;	 Fig.	 3.2C),	 indicating	high	 reproducibility	 of	 the	 data.	 Comparing	 the	 proteins	 identified	 in	 both	replicates	 for	 the	 p.iPSC	 and	 s.iPSC	 populations,	 we	 find	 that	 they	 share	 2767	proteins	 (~90%)(Fig.	 3.2B),	 the	 expression	 change	 correlation	 between	 them	 is	very	 high	 (R=0.85;	 Fig.3.2C),	 and	 only	 6%	 of	 all	 proteins	 display	 a	 significant	difference	 in	expression	(p.adjusted<0.05,	over	2	 fold;	Fig.	3.3A).	This	underlines	that	 the	 primary	 and	 secondary	 iPS	 cell	 populations	 reproducibly	 display	 highly	similar	proteome	profiles.		
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Figure	3.2	Proteome	analysis	of	primary	and	secondary	iPSCs.	(A)	Primary	iPSCs	were	differentiated	to	neuronal	culture,	which	was	reprogrammed	to	secondary	iPSCs.	The	two	iPSC	 populations	 were	 collected	 and	 subjected	 to	 full	 proteome	 analysis	 via	 mass	spectrometry.	 (B)	Protein	 identifications	 in	both	 replicates	 and	 conditions.	High	overlap	between	 the	 replicates	 (>96%)	 and	 conditions	 (~90%).	 (C)	 Scatter	 plots	 of	 the	 log10	protein	intensities	between	the	replicates	and	iPSC	populations	reveals	high	experimental	reproducibility.	 Scatter	 plot	 of	 the	 log2	 expression	 changes	 between	 p.iPSC	 and	 s.iPSC	showcases	they	are	highly	consistent	between	the	replicates	(R=0.85)	
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			Focusing	on	the	proteins	uniquely	identified	or	significantly	enriched	in	either	the	primary	or	secondary	iPS	cell	populations,	we	found	a	clear	distinctive	trend	which	separates	 them	 in	 "more	 pluripotent"	 (p.iPSC)	 and	 "more	 neuronal"	 (s.iPSCs).	While	the	majority	of	pluripotency-network	proteins	are	shared	between	the	two	populations	(Oct4,	Sox2,	Sall4,	Rif1,	Stat3,	Lin28),	 there	are	 few	which	were	only	identified	in	the	primary	iPSCs	(Nanog,	Esrrb,	Dppa4)	(Fig.3.3B).	Several	proteins	with	key	functions	in	neurogenesis	were	exclusively	identified	in	secondary	iPSCs,	most	 notably	 the	 neural	 progenitor	 marker	 Nestin	 (Fig.	 3.3B).	 To	 gain	 a	 more	global	 overview	 of	 the	 differences	 between	 the	 two	 iPSC	 populations,	 we	performed	 GO	 term	 enrichment	 analysis	 of	 the	 proteins	 uniquely	 identified	 or	significantly	enriched	in	either	one.	Our	results	demonstrate	that	in	p.iPSCs,	there	is	 an	enrichment	 for	proteins	associated	with	 stem	cell	maintenance	and	 related	processes	(Fig.	3.3C).	For	example,	proteins	associated	with	RNA	processing	were	also	highly	enriched	in	p.iPSC,	which	is	 	expected	in	pluripotent	cells,	as	they	are	transcriptionally	hyperactive	and	contain	twice	as	much	RNA	(normalized	to	DNA	content)	compared	to	neural	progenitors	(Efroni	et	al.	2008).	In	contrast,	proteins	overexpressed	or	unique	to	s.iPSC	were	enriched	for	nervous	system	development	and	related	processes	such	as	morphogenesis	in	cell	differentiation	(Fig.	3.3D).		
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Figure	3.3	Differential	 expression	 analysis	 between	primary	 and	 secondary	 iPSCs.	(A)	Volcano	plot	of	common	proteins	between	p.iPSCs	and	s.iPSCs.	X-axis:	log2	expression	fold	 change	 between	 both	 populations.	 Y-axis:	 –log10	 of	 the	 p.adjusted	 value	 calculated	using	 the	 limma	 statistical	 test	 (for	 details	 see	 “Materials	 and	 Methods”.	 Significantly	(p.adj<0.05)	 differentially	 (>2	 fold)	 expressed	 proteins	 are	 displayed	 in	 red.	 Only	 170	(6%)	 of	 all	 proteins	 are	 differentially	 expressed.	 (B)	 Key	 pluripotency,	 neuronal	 and	epigenetic	 factors	 identified	 in	each	population.	Uniquely	 identified	proteins	 in	only	one	population	are	displayed	in	bold.	(C,D)	GO	term	enrichment	analysis	of	proteins	uniquely	
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identified	in	primary	(C)	and	secondary	(D)	iPSCs.	Only	significantly	enriched	terms	were	included	 in	 the	 analysis	 (p<0.05).	 For	 a	 detailed	 disambiguation	 of	 number	 of	proteins/term	and	term	representation,	see	Suppl.Fig.8	
			A	key	difference	between	 the	primary	and	secondary	 iPSC	was	 the	presence	and	enrichment	 of	 distinct	 epigenetic	 regulators.	 Primary	 iPSC	 displayed	 an	 overall	high	 enrichment	 of	 proteins	 related	 to	 chromatin	 remodeling	 (Fig.	 3.3C).	Specifically,	 an	 entire	 network	 of	 epigenetic	 regulators	with	 known	 functions	 in	pluripotency	 and	 development	was	 uniquely	 identified	 in	 p.iPSCs	 (Fig.	 3.3B,	 Fig.	3.4).	 An	 important	 constituent	 of	 this	 network	 are	 the	 polycomb	 repressive	complex	 2	 (PRC2)	 catalytic	 subunit	 Ezh2,	 its	 non-catalytic	 partner	 Eed,	 and	 the	PRC2	recruiter	Jarid2	(Fig.3.4).	PRCs	play	a	crucial	role	in	embryonic	development;	in	 pluripotent	 stem	 cells,	 the	 promoters	 of	 many	 genes	 involved	 in	 lineage	specialization	 are	 enriched	 for	 PRCs	 and	 contain	 bivalent	 chromatin	 marks	 (i.e.	involved	both	in	transcriptional	activation	and	repression;	H3K4me3,	H3K27me3)	(Landeira	 et	 al.	 2010).	 This	 is	 part	 of	 a	 process	 referred	 to	 as	 "transcriptional	priming",	which	ensures	that	no	unscheduled	differentiation	takes	place	and	as	the	embryo	development	progresses,	 the	 lineage-specific	gene	expression	 is	 initiated	correctly	(Landeira	et	al.	2010).	In	the	primary	iPSCs,	we	also	uniquely	identified	the	H3K9	euchromatic	methyltransferase	Ehmt1,	which	 is	known	 to	act	 together	with	 PRC2	 to	 promote	 gene-specific	 silencing	 during	 early	 pre-implantation	development	(Fig.3.4)(Maier	et	al.	2015;	Simon	&	Kingston	2013).			Another	 protein	 with	 a	 key	 epigenetic	 regulatory	 function	 which	 we	 uniquely	identified	in	primary	iPSCs	is	Chaf1a,	the	major	subunit	of	the	chromatin	assembly	factor	1	(CAF-1)	(Fig.3.3B,	Fig.3.4).	CAF-1	is	critically	involved	in	heterochromatin	organization	during	early	embryonic	development	and	 the	depletion	of	 its	major	subunit	 leads	 to	 developmental	 arrest	 at	 the	 16-cell	 stage	 and	 disrupted	heterochromatin	organization,	resembling	a	2-	to	4-cell	stage	(Houlard	et	al.	2006).	In	 embryonic	 stem	 cells,	 Chaf1a	 depletion	 also	 leads	 to	 severe	 disruption	(mislocalization,	 loss	 of	 clustering,	 de-condensation)	 of	 the	 heterochromatic	regions	(Houlard	et	al.	2006).			
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Figure	3.4	Highly	interconnected	epigenetic	network	in	p.iPSCs.	The	network	included	 a	 multitude	 of	 epigenetic	 regulators	 with	 key	 functions	 in	 pluripotent	cells.	Most	of	the	connections	in	the	network	are	based	on	experimental	data.	The	color	code	of	the	connective	edges	is	as	follows:	experimental	data	(pink),	curated	databases	(blue);	for	predicted	interactions,	based	on	gene	neighborhoods	(green);	gene	fusions	(red);	gene	co-occurance(blue);	light	green	-	textmining	(light	green);	co-expression	(black);	protein	homology	(light	blue).		The	 only	 epigenetic	 factors	 with	 established	 roles	 in	 pluripotency	 uniquely	identified	in	secondary	iPSCs	were	the	histone	methyltransferases	Setd6	and	Setd7	(Fig.	3.3B).	Interestingly,	they	have	been	shown	to	fulfill	opposing	functions	in	this	biological	context.	Setd6	is	involved	in	embryonic	stem	cell	self-renewal,	whereas	Setd7	regulates	cell	differentiation	by	 impacting	 the	silencing	of	Oct4	and	Nanog	(Binda	et	al.	2013;	Castaño	et	al.	2016).			
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Taken	together,	our	results	demonstrate	that	the	primary	and	secondary	iPSCs	are	highly	 similar	 in	morphology	 and	 expression	patterns,	 but	 primary	 iPSCs	have	 a	stronger	 epigenetic	 and	 expression	 signature	 associated	 with	 pluripotency,	whereas	secondary	iPSCs	have	retained	certain	neuron-lineage	specific	traits.	This	finding	 suggests	 that	 the	 secondary	 iPSCs	 have	 not	 completely	 erased	 the	epigenetic	traces	of	their	neuronal	past	and	that	this	effect	translates	into	a	distinct	proteomic	signature.	
3.4 Spatio-temporal proteomic switches during neuronal 
differentiation of iPSCs 	Our	findings	complement	previous	research	which	has	showcased	the	importance	of	 epigenetic	 memory	 and	 control	 during	 cell-fate	 transitions.	 To	 elucidate	 the	spatio-temporal	 component	 of	 this	 regulatory	 transition,	 we	 examined	 the	proteome	changes	occurring	during	differentiation	of	iPSCs	to	neural	progenitors,	dissecting	the	process	in	time	(analyzing	different	time	points)	and	space	(sorting	the	cells	from	the	Oct4–	rim	and	Oct4+	core	of	the	embryoid	bodies)	(Fig.3.5).	Oct4	is	considered	as	the	most	stringent	molecular	marker	for	pluripotency	and	is	often	used	to	distinguish	between	pluripotency-	and	lineage-committed	cell	populations.	In	 our	 system,	 we	 observe	 that	 during	 neuronal	 differentiation,	 the	 Oct4-GFP	expression	 gradually	 diminishes,	 starting	 from	 the	 outer	 edges	 of	 the	 embryoid	bodies	and	progressing	towards	the	core,	suggesting	that	the	differentiation	itself	follows	 the	 same	 spatial	 progression	 (Fig.	 3.5B).	 iPS	 cells	 in	 biological	 replicates	were	 differentiated	 until	 day	 8,	 which	 represents	 the	 neural	 progenitor	 stage.	Embryoid	 bodies	 were	 collected	 every	 2	 days,	 dissociated	 and	 sorted	 via	 FACS	based	on	their	Oct4-GFP	expression	(Fig.3.5).	Cells	from	each	collected	population	were	 subjected	 to	 full	 proteome	 characterization.	 To	 maximize	 the	 proteomic	identification	 rate,	 we	 also	 collected	 unsorted	 cell	 populations	 at	 each	 stage,	pooled	 them,	 isolated	 and	 fractionated	 the	 proteome	 and	 generated	 a	 library	 of	MS/MS	IDs	(details	 in	"Materials	and	Methods").	Each	of	 the	sorted	samples	was	matched	 against	 this	 library,	 thereby	 increasing	 the	overall	 identification	 rate	 to	5382	proteins.		
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Figure	3.5	Experimental	setup	for	sorting	and	mass	spectrometry	analysis	of	
embryoid	bodies.	(A)	Percentage	of	Oct4-GFP	positive	and	negative	cells	at	each	differentiation	 time	 point,	 measured	 by	 flow	 cytometry.	 (B)	 iPSCs	 (day	 0)	 were	differentiated	 to	 neural	 progenitors	 (day	 8)	 and	 sorted	 based	 on	 Oct4-GFP	expression	every	two	days.	Each	population	was	measured	via	mass	spectrometry.	A	 pooled	 sample	 from	 all	 populations	 was	 used	 to	 generate	 an	 MS/MS	 spectra	library,	 against	which	 the	 samples	were	matched.	 For	 details	 see	 "Materials	 and	Methods".		
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We	 observed	 very	 high	 correlation	 between	 the	 biological	 replicates	 in	 each	condition,	 showcasing	 the	high	reproducibility	of	 the	experiment	 (Fig.	3.6A).	Our	mass	spectrometry	data	confirms	the	marker-based	FACS	separation	in	Oct4–	and	Oct4+	 populations,	 as	 this	 transcription	 factor	 was	 only	 identified	 in	 the	 Oct4+	populations	 (Fig.	 3.6B).	 In	 line	with	 expectation,	we	 found	 that	 key	pluripotency	factors	 were	 strongly	 downregulated	 in	 the	 Oct4–	 populations	 and	 showed	moderate	or	no	downregulation	in	the	Oct4+	populations	(Fig.3.6B).	For	example,	at	 day	 8	 the	 pluripotency-associated	 protein	 Esrrb	was	 downregulated	 nearly	 5	fold	 in	 the	Oct4–	and	only	1.3	 fold	 in	 the	Oct4+	population	 (Fig.3.6B).	Like	Oct4,	Nanog	was	exclusively	identified	in	the	Oct4+	populations.		In	 contrast,	 proteins	 associated	with	 neuronal	 lineage	 conversion	were	 strongly	upregulated	in	the	Oct4–	and	downregulated	in	the	Oct4+	populations	(Fig.3.6B).	At	day	8,	the	neural	progenitor	marker	Nestin	was	upregulated	8	fold	in	the	Oct4–	population	and	downregulated	nearly	5	fold	in	the	Oct4+	population	(Fig.	3.6B).			
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Figure	 3.6	 Proteome	 analysis	 of	 sorted	 populations.	 (A)	 Scatter	 plots	 of	 the	log10	 protein	 intensities	 between	 the	 biological	 replicates	 of	 each	 population	reveals	 high	 experimental	 reproducibility	 (R≥0.9).	 (B)	 Key	 pluripotency	 factors	(left)	 and	 neuronal	 factors	 (right)	 log2	 expression	 changes	 compared	 to	 day	 0	(iPSC)	in	Oct4–	and	Oct4+	populations.		
		These	observations	confirm	the	notion	that	the	process	of	neuronal	differentiation	has	 a	 spatial	 component	 and	 progresses	 from	 the	 Oct4–	 outer	 edges	 of	 the	embryoid	 bodies	 towards	 their	 Oct4+	 core.	 To	 gain	 a	 global	 overview	 of	 the	
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dynamic	proteome	changes	occurring		in	the	Oct4+	and	Oct4–	populations	during	differentiation,	we	first	subjected	them	to	differential	expression	analysis	using	a		limma	test	 (for	details	 see	 "Materials	and	Methods").	As	expected,	we	 found	 that	compared	to	the	initial	iPSCs,	many	more	proteins	display	a	significant	expression	change	 in	 the	 Oct4–	 populations	 (1408)	 than	 in	 the	 Oct4+	 populations	 (254)	(p.adjusted<0.1;	 Fig.3.7A).	 Interestingly,	 we	 observed	 that	 while	 the	 average	magnitude	 of	 these	 expression	 changes	 increases	 over	 time	 (3.4	 fold	 at	 day	 4	versus	nearly	16	 fold	 at	day	8	 in	 the	Oct4–	populations),	 there	 is	 a	much	higher	number	of	 proteins	 changing	 in	 the	 initial	 than	 in	 the	 late	differentiation	 stages,	implying	that	many	proteins	change	only	transiently		(Fig.3.7A).	This	might	be	an	indication	that	the	initial	differentiation	signals	triggered	by	the	withdrawal	of	LIF	and	 the	 formation	 of	 3D	 cultures	 cause	 a	 multitude	 of	 weak	 and	 transient	expression	 changes,	 and	 upon	 addition	 of	 retinoic	 acid	 at	 day4,	 the	 expression	differences	 are	 channeled	 and	 amplified	 more	 specifically	 towards	 neuronal	lineage	conversion.		To	examine	 the	biological	processes	 in	which	 significantly	 changing	proteins	 are	involved,	 we	 performed	 GO	 enrichment	 analysis	 for	 each	 of	 the	 sorted	 cell	populations	 (all	 time	 points	 compared	 to	 the	 initial	 iPSC	 stage)	 (Fig.	 3.7B).	Expectedly,	 in	 the	 Oct4–	 populations,	 we	 found	 that	 terms	 related	 to	differentiation	 and	 neuronal	 development	 were	 enriched	 at	 each	 time	 point,	including	 retinoic	 acid	 metabolism,	 neuronal	 differentiation,	 head	 development	and	lipid	metabolic	processes	(Fig.3.7B).	Also	expected	was	the	downregulation	of	RNA	 processing,	 mitotic	 cell	 division	 and	 early	 embryonic	 development	 in	 the	Oct4–	populations	(Fig.3.7B).			Given	 all	 these	 results,	 it	 was	 very	 surprising	 to	 find	 that	 in	 the	 earliest	differentiation	stage	(day4),	 in	the	Oct4+	population,	key	pluripotency-associated	factors	 and	 epigenetic	 remodelers	 were	 significantly	 downregulated	(p.adjusted<0.1).	 This	 included	 the	pluripotency	 factors	Dppa4	 and	Esrrb,	which	were	downregulated	over	3	fold	as	well	as	the	epigenetic	regulators	Jarid2,	Zfp57	and	the	major	unit	of	the	CAF-1	complex,	Chaf1a,	whose	roles	in	pluripotency	hav	been	discussed	in	detail	above	(Fig.3.7B).	The	positive	c-Myc	regulator	Rnf17	was	
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also	 downregulated	 in	 this	 population,	 possibly	 reflecting	 slowed	 proliferation	rates.	Interestingly,	the	proteins	upregulated	in	the	Oct4+	populations	at	each	time	point	were	 enriched	 for	 neurogenesis-related	 processes,	 including	 ceramide	 and	sphingolipid	metabolism,	microtubule	 organisation	 and	 retinoic	 acid	metabolism	(Fig.3.7B).	Among	the	upregulated	proteins	are	Camkd2,	which	is	associated	with	neural	projection	(Uboha	et	al.	2007)	and	Myosin1b,	which	has	been	shown	to	play	a	critical	role	in	axon	formation	(Iuliano	et	al.	2018).			Taken	 together,	 our	 results	 suggest	 that	 contrary	 to	 expectation,	 the	 proteomic	and	 developmental	 switches	 involved	 in	 the	 pluripotency-to-neural	 lineage	transformation	 become	 activated	 very	 early	 during	 differentiation	 and	 do	 not	exclusively	affect	the	Oct4–	rim	of	the	embryoid	bodies,	but	also	their	core,	which	is	more	protected	from	the	cell	culture	environment	and	continues	to	express	Oct4	and	 other	 key	 pluripotency	 genes	 like	 Nanog	 and	 Sall4.	 This	 finding	 suggests	effective	 cross-communication	 between	 the	 signal-receiving	 outer	 layer	 of	 the	embryoid	 bodies	 and	 their	 isolated	 core	 and	 sheds	 a	 new	 light	 on	 the	 spatio-temporal	progression	of	pluripotency	loss	and	neuronal	differentiation.		
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Figure	 3.7	 Differential	 expression	 and	 GO	 term	 enrichment	 analysis.	 (A)	Differentially	 expressed	 proteins	 between	 each	 time	 point	 and	 day0,	 as	determined	 by	 a	 limma	 test	 (p.adjusted<0.1).	 The	 differential	 expression	 is	displayed	 in	 log2.	 Upregulated	 proteins	 in	 red,	 downregulated	 in	 blue.	 Numbers	represent	 the	 number	 of	 up-/downregulated	 proteins	 at	 each	 time	 point.	 Oct4–	populations	on	 the	 left,	Oct4+	on	 the	right.	 (B)	GO	term	enrichment	analysis	and	notable	proteins	for	each	protein	group	in	(A).		
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3.5 Discussion 	The	 presented	 study	 explores	 the	 capacities	 and	 proteomic	 manifestation	 of	epigenetic	memory	in	the	context	of	cell	differentiation	and	reprogramming.	Using	an	identical	mouse	model	like	the	one	we	generated,	previous	studies	have	shown	that	driving	primary	neurons	back	 to	a	pluripotent	state	using	exclusively	OKSM	overexpression	is	impossible	(Kim	et	al.	2011;	Hiler	et	al.	2016).	Our	data	suggests	that	 unlike	 primary	 neurons,	 a	 neuronal	 culture	 generated	 in	 vitro	 from	pluripotent	 cells	 retains	 sufficient	 epigenetic	 information	 to	 enable	 their	reprogramming	back	to	pluripotent	cells	using	only	OKSM.	It	should	be	noted	that	there	 are	 differences	 between	 these	 two	 types	 of	 neuronal	 cultures.	 Most	importantly,	 primary	 neuronal	 cultures	 are	 free	 of	 other	 cell	 types,	 whereas	 in	
vitro	neuronal	differentiation	is	never	100%	pure.	That	means	that	there	is	a	small	minority	of	cells	present	in	the	culture	which	are	not	mature	post-mitotic	neurons	(Suppl.	 Fig.6).	 It	 cannot	 be	 excluded	 that	 they	 have	 also	 contributed	 to	 the	generation	of	secondary	iPSC.	We	made	an	attempt	to	use	flow	cytometry	to	sort	viable	 bona	 fide	 neurons	 with	 the	 help	 of	 a	 fluorescent	 label	 for	 the	 neuronal	marker	 NeuO.	 However,	 the	 vast	 majority	 of	 the	 neurons	 did	 not	 survive	 the	procedure	and	from	those	who	did,	only	a	few	single	cells	managed	to	reconstruct	the	 morphological	 features	 they	 lost	 during	 the	 flow	 cytometry	 sort	 (data	 not	shown).	 Therefore	 we	 performed	 the	 experiment	 with	 a	 bulk	 neuronal	 culture,	which	we	determined	to	be	completely	 free	of	 the	pluripotency	marker	Oct4	and	was	98.2%	NeuO+	and	86%	Map2+.	Thus,	despite	the	presence	of	a	few	cells	which	are	not	strictly	mature	neurons,	our	neuronal	culture	was	of	very	high	purity	and	contained	no	visible	traces	of	pluripotent	cells.		Comparing	 the	 primary	 iPSC	 populations	 to	 the	 secondary	 neuron-derived	 iPSC,	we	 found	 that	 while	 they	 are	 extremely	 similar	 in	 terms	 of	 both	morphological	characteristics	 and	 proteome	 expression	 profiles,	 each	 population	 had	 a	 distinct	signature.	 Primary	 iPSCs	 expressed	 more	 pluripotency-associated	 proteins	compared	 to	 secondary	 iPSCs,	 as	 well	 as	 an	 entire	 network	 of	 epigenetic	remodelers	with	key	 functions	 in	pluripotent	cells.	Secondary	 iPSCs	on	 the	other	hand	 retained	 expression	 of	 several	 key	 neural-lineage	 specific	 proteins.	 We	
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attribute	 this	 "proteomic	 memory"	 effect	 to	 the	 phenomenon	 of	 epigenetic	memory.	 After	 generating	 the	 initial	 iPSCs	 from	 embryonic	 fibroblasts,	 we	 kept	them	in	culture	for	more	than	two	weeks	before	initiating	neuronal	differentiation.	The	motivation	was	specifically	to	erase	any	residual	fibroblast-specific	epigenetic	signatures,	which	 is	an	effect	 that	 long-time	culture	 is	known	to	elicit	(Polo	et	al.	2010).	In	contrast,	secondary	iPSCs	were	collected	for	mass	spectrometry	analysis	as	soon	as	they	had	formed.	We	expect	that	if	subjected	to	long-time	culture,	these	differences	will	diminish	over	 time,	which	 is	 something	we	plan	 to	 test	 in	 future	experiments.		Studying	 the	 proteome	 changes	 which	 occur	 during	 neuronal	 differentiation	 of	iPSCs	 by	 separating	 the	Oct4–	 rims	 from	 the	Oct4+	 core	 of	 the	 embryoid	 bodies	opened	 a	 new	perspective	 into	 the	 spatial	 component	 of	 the	molecular	 switches	controlling	 the	 in	 vitro	 differentiation	 process.	 Several	 findings	 supported	 the	assumption	 that	 differentiation	 starts	 at	 the	 embryoid	 body	 rim	 and	 progresses	towards	the	core,	which	retains	pluripotent	features	for	many	days	after	initiation	of	differentiation.	First	and	foremost,	the	core	continues	to	express	Oct4,	as	well	as	other	 pluripotency	 proteins	 like	Nanog,	 Sall4	 and	 Esrrb.	 In	 the	 Oct4–	 rim,	 these	factors	 are	 either	 completely	 absent	 or	 strongly	 downregulated.	 In	 contrast,	neuronal	proteins	such	as	Nestin	and	Dpysl	are	strongly	upregulated	in	the	Oct4–	rim.	Additionally,	compared	to	the	initial	iPSC	stage,	many	more	proteins	change	in	expression	in	the	Oct4–	rim	than	in	the	Oct4+	core.	Finally,	it	should	be	noted	that	in	 the	 cell	 culture	 system	 we	 use,	 the	 differentiation-promoting	 signals	 are	delivered	 in	 the	 external	 fluid	 rather	 than	 in	 the	 internal	 structure	 (which	 is	 a	major	 difference	 to	 in	vivo	 embryonic	 development).	 The	 limitations	 in	 diffusive	transport	 are	 increased	 by	 the	 fact	 that	 embryoid	 bodies	 tend	 to	 form	 shells	 of	collagen	(Sachlos	&	Auguste	2008).	Based	on	all	 these	observations,	we	assumed	that	the	inside	of	the	embryoid	bodies	will	retain	a	pluripotency-like	state	up	until	the	moment	when	Oct4	expression	is	completely	absent.	We	were	surprised	to	find	that	 instead,	 key	 pluripotency-related	 factors	 and	 epigenetic	 regulators	 become	significantly	 downregulated	 in	 the	 Oct4+	 cells	 immediately	 upon	 initiation	 of	differentiation	and	this	effect	becomes	more	pronounced	over	time	(Fig.3.7).	This	suggests	 that	 even	 though	 only	 the	 outside	 of	 the	 embryoid	 body	 is	 exposed	 to	
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differentiation-promoting	 signals	 from	 the	 cell	 culture	 environment,	 the	 cross-communication	 within	 the	 3D	 aggregates	 is	 very	 fast	 and	 efficiently	 transmits	signals	which	promote	the	exit	from	the	pluripotent	state.	Moreover,	these	signals	preferentially	elicit	a	neuronal-lineage	entry,	as	in	the	Oct4+	embryoid	body	core	we	 primarily	 observe	 significant	 upregulation	 of	 proteins	 involved	 in	 nervous	system	development	like	Myosin1b	and	Camkd2,	as	well	as	enrichment	of	related	processes	 such	 as	 retinoic	 acid	 metabolism,	 retinol	 transport,	 ceramide	 and	sphyngolipid	metabolism.	 Our	 findings	 shed	 a	 new	 light	 on	 the	 spatio-temporal	resolution	 of	 neuronal	 differentiation	 and	 showcase	 the	 speed	 and	 efficiency	 of	differentiation-promoting	 signal	 transmission	 within	 the	 three-dimentional	embryoid	body	structures.																							
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4. Targeted isolation of proteins 
associated with the c-Myc- promoter  
4.1 Introduction 	Understanding	 the	 molecular	 mechanisms	 driving	 differentiation	 and	reprogramming	is	to	a	large	extent	dependent	on	interrogating	the	transcriptional	regulatory	 networks	 in	 pluripotent	 cells.	 The	 field	 relies	 on	 various	 approaches	which	 aim	 to	 identify	 novel	 regulators	 within	 this	 transcriptional	 network.	 For	example,	 loss-of-function	 screens	 based	 on	RNA	 interference	 (RNAi)	 have	 led	 to	the	 discovery	 of	 important	 pluripotency	 factors	 such	 as	 Esrrb,	 Tbx3	 and	 Tcl1	(Ivanova	 et	 al.	 2006).	 Protein-DNA	 interaction	 studies	 have	 also	 greatly	contributed	 to	 our	 understanding	 of	 transcriptional	 regulation	 in	 pluripotency.	The	 most	 prominent	 technique	 to	 study	 this	 is	 chromatin	 immunoprecipitation	combined	 with	 sequencing	 (ChIP-seq).	 In	 ChIP-seq,	 a	 protein	 is	 immuno-precipitated	 from	 sheared	 chromatin	 using	 a	 high-quality	 antibody	 and	subsequently	the	co-isolated	fragments	of	DNA	are	used	to	determine	the	genome-wide	binding	sites	of	 the	protein	of	 interest.	This	method	was	used	to	determine	the	binding	sites	of	the	core	pluripotency	factors	Oct4,	Sox2	and	Nanog	(and	later	many	others)	in	embryonic	stem	cells	(ESCs)	and	led	to	the	fundamental	discovery	that	they	bind	cooperatively	at	numerous	active	and	silent	target	sites	(Loh	et	al.	2006;	 Boyer	 et	 al.	 2005).	 These	 studies	 shaped	 the	 current	 understanding	 that	Oct4,	Sox2	and	Nanog	establish	and	maintain	a	pluripotent	state	by	simultaneously	activating	 pluripotency-associated	 genes	 (including	 their	 own	 and	 each	 other's	expression)	and	repressing	lineage-specific	ones	(Yeo	&	Ng	2013).			Given	 that	 genomic	 regulation	 is	 to	 a	 large	 extent	 controlled	 by	 association	 of	specific	 proteins	 to	 DNA,	 it	 is	 not	 surprising	 that	 ChIP-seq	 has	 become	 the	 core	method	in	studying	transcriptional	regulation	in	pluripotent	cells.	It	addresses	the	fundamental	 question	 which	 genes	 are	 regulated	 by	 a	 particular	 protein	 of	interest.	However,	the	vast	majority	of	transcriptional	regulators	do	not	act	alone,	but	 as	 protein	 complexes,	 meaning	 that	 a	 lot	 of	 regulatory	 interactions	 remain	
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undescribed.	 In	 order	 to	 construct	 a	 truly	 comprehensive	 transcriptional	regulatory	 network,	 one	 needs	 to	 interrogate	 the	 DNA-protein	 interactions	 not	only	 from	 the	 protein	 perspective	 (which	 genomic	 sites	 are	 bound	 by	 a	 given	protein),	but	also	from	the	DNA	perspective	(which	proteins	are	bound	on	a	given	genomic	site).		The	targeted	isolation	of	specific	genomic	segments	and	subsequent	identification	of	 the	 proteins	 associated	 with	 them	 has	 been	 the	 subject	 of	 a	 large	 body	 of	research	 (Wierer	 &	 Mann	 2016).	 Notably,	 Kingston's	 lab	 developed	 a	 strategy	which	 they	 named	 "proteomics	 of	 isolated	 chromatin	 segments"	 (PICh),	 which	relies	 on	 DNA	 probes	 to	 retrieve	 specific	 genomic	 loci	 and	 identify	 the	 proteins	associated	 with	 them	 via	 mass	 spectrometry	 (Déjardin	 &	 Kingston	 2009).	 The	authors	were	successful	in	characterizing	the	telomere-bound	proteome,	owing	to	the	 large	abundance	of	these	genomic	segments.	However,	 they	report	that	using	conventional	DNA	capture	via	gene-specific	probes	commonly	used	for	fluorescent	
in	 situ	 hybridization	 resulted	 in	 low	 yields	 and	 contamination	 with	 unspecific	proteins	(Déjardin	&	Kingston	2009).	Their	strategy	can	therefore	not	be	applied	for	the	characterization	of	the	proteome	associated	with	a	singular	locus,	such	as	a	gene	promoter.		Another	study	presented	the	tagged	transcription	activator-like	-	protein	A	fusion	protein	 (TAL-prA),	 designed	 to	 recognize	 a	 specific	 promoter	 in	 yeast,	 thus	enabling	the	usage	of	ChIP	to	obtain	the	specific	promoter	site	along	with	the	other	proteins	 bound	 to	 it	 (Byrum	 et	 al.	 2013).	While	 this	 technique	was	 successfully	applied	to	isolate	the	particular	promoter	of	interest,	it	suffers	from	the	fact	that	it	relies	 on	 the	 generation	 and	 promoter-association	 of	 an	 artificial	 protein,	which	possibly	disrupts	the	natural	proteome	composition	at	the	site.		Finally,	 the	 widespread	 expansion	 of	 technologies	 based	 on	 clustered	 regularly	interspased	 short	 palindromic	 repeats	 (CRISPR)	 has	 also	made	 its	 way	 into	 the	proteomics	 field	 by	 using	 the	 capacity	 of	 guide	 RNA	 (gRNA)	 to	 target	 specific	genomic	 loci	 and	 using	 it	 as	 a	 basis	 to	 identify	 the	 proteome	 associated	with	 it	(Fujita	&	Fujii	2013;	Waldrip	et	al.	2014;	Liu	et	al.	2017).	Tackett	and	Fujii's	 labs	
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used	 affinity	 tag	 coupled	 to	 an	 inactive	 form	 of	 the	 endonuclease	 Cas9	 to	immunoprecipitate	 the	 genomic	 region	 of	 interest	 and	 subsequently	 identify	 the	proteins	which	were	co-purified	 (Fujita	&	Fujii	2013;	Waldrip	et	al.	2014).	Their	studies	identified	histones	and	some	transcriptional	regulators	as	bound	to	the	site	of	interest,	some	of	which	the	authors	could	validate	via	ChIP-seq,	demonstrating	the	capacity	of	the	method	to	identify	novel	proteins	binding	to	a	site	of	 interest.	Xu's	 lab	 used	 in	 vivo	biotyinilation	 of	 dactivated	 Cas9	 to	 capture	 the	 chromatin-regulating	 proteome	 and	 long-range	 DNA	 interactions	 at	 targeted	 cis-regulatory	elements	 (Liu	 et	 al.	 2017).	 Although	 these	 CRISPR-based	 methods	 successfully	identified	 proteins	 associated	 at	 targeted	 loci,	 they	 have	 several	 important	disadvantages.	First,	they	require	transfections,	which	can	elicit	immunogenic	and	cytotoxic	reactions	and	are	not	always	possible	(or	desirable)	in	certain	cell	types.	Second,	 they	 require	 the	 locus-binding	 of	 a	 (fusion)	 protein,	 thereby	 possibly	disrupting	 the	 natural	 stochiometry	 and	 composition	 of	 the	 locus-associated	protein	 complexes.	 Third,	 they	 suffer	 from	 the	 general	 concerns	 regarding	 off-target	effects	in	the	CRISPR-Cas9	system	(O’Geen	et	al.	2015).		Recently,	our	lab	began	developing	a	technique	which	would	enable	the	unbiased	proteome	 characterization	 of	 any	 genomic	 locus.	 The	 technique,	which	 is	 still	 in	development,	was	named	"targeted	isolation	of	genomic	regions"	(TIGR)	and	aims	to	 circumvent	all	 above-mentioned	 limitations	of	 the	existing	methods	and	 fulfill	the	following	criteria:	
• not	rely	on	exogenous	protein	expression;	
• not	 involve	 any	 artificial	 interaction	 which	 could	 disrupt	 the	 natural	composition	of	DNA-associated	protein	complexes;	
• allow	the	targeted	isolation	of	singular	loci,	such	as	gene	promoters.		TIGR	is	based	on	the	use	of	biotynilated	DNA	probes		(~50bp)	which	are	specific	to	the	target	region	of	interest	(Fig	4.1).	The	DNA	and	protein	content	of	the	cells	is	crosslinked	using	standard	ChIP	conditions,	the	DNA	is	sheared	to	a	fragment	size	of	 500-1000	 bp	 and	 semi-denatured	 to	 allow	 the	 binding	 of	 the	 probes.	Streptavidin	beads	are	used	to	"fish	out"	 the	biotninylated	probes	along	with	the	genomic	fragment	to	which	they	bind	and	all	proteins	associated	with	it	(Fig	4.1A).	
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A	 scrambled	 probe,	 not	 complementary	 to	 any	 genomic	 region,	 is	 used	 as	 a	negative	 control.	 To	 ensure	 the	 specificity	 and	 enrichment	 of	 the	 targeted	 locus,	the	purified	DNA	fragments	are	tested	against	a	whole-genome	input	via	qPCR	and	subjected	 to	 next	 generation	 sequencing	 (NGS).	 To	 test	 the	 reproducibility,	 the	experiment	is	performed	with	two	probes	binding	in	close	proximity	of	each	other,	which	 should	 therefore	 pull	 out	 the	 same	 fragments	 of	 sheared	DNA,	 serving	 as	stringent	 replicates.	 Finally,	 the	 co-isolated	 proteins	 are	 measured	 via	 mass	spectrometry	(Fig	4.1A).		In	this	 thesis,	we	aimed	to	 isolate	the	promoter	region	of	c-Myc	 from	pluripotent	cells	and	identify	the	proteins	bound	to	it	(Fig.	4.1B).	C-Myc	plays	a	crucial	role	in	development,	 stem	cell	 self-renewal	and	differentiation	(Meyer	&	Penn	2008),	as	well	as	pluripotency	establishment	and	maintenance	(Chappell	&	Dalton	2013).	In	fact,	 c-Myc	 is	 one	 of	 the	 four	 "Yamanaka	 factors"	 originally	 used	 to	 induce	pluripotency	in	somatic	cells	(Takahashi	&	Yamanaka	2006).	Approximately	30%	of	all	active	genes	in	embryonic	stem	cells		are	bound	by	both	c-Myc	and	the	core	pluripotency	factors	Oct4,	Sox2,	and	Nanog	(Rahl	et	al.	2010)	and	it	is	believed	that	they	work	 in	 a	 coordiated	manner	whereby	 a	 complex	 of	Oct4,	 Sox2	 and	Nanog	recruits	 RNA	 Pol	 II	 to	 selected	 genes	 and	 c-Myc	 controls	 gene	 expression	 by	releasing	 a	 transcriptional	 pause	 (Young	 2011).	 Additionally,	 c-Myc	 is	 a	transcription	 factor	critically	 involved	 in	proliferation,	growth	and	apoptosis	and	its	 overexpression	 is	 a	 key	 event	 in	 tumor	 formation	 (Levens	2008).	 It	 has	been	shown	 to	 be	 the	most	 important	 contrubuting	 factor	 for	 tumor	 development	 in	iPSC-derived	mice	 (Nakagawa	 et	 al.	 2008).	 It	 is	 thus	 clear	 that	 c-Myc	 sits	 at	 the	crossroad	of	pluripotency	and	cancer,	entangled	in	a	complex	regulatory	network	involved	 in	 the	 regulation	 of	 thousands	 of	 genes	 (Chappell	 &	 Dalton	 2013).	Elucidating	the	mechanisms	behind	its	transcriptional	regulation	would	provide	an	invaluble	 insight	 into	 these	 processes	 and	 characterizing	 the	 proteome	composition	on	its	promoter	constitutes	an	essential	step	in	this	direction.	To	this	end,	 we	 performed	 TIGR	 targeting	 the	 region	 upstream	 from	 the	 transcription	start	 site	 (TSS)	 of	 the	 c-Myc	 promoter	 in	mouse	 embryonic	 stem	 cells	 (mESCs),	using	 two	 biotinylated	 probes:	 one	 is	 complementary	 to	 the	 region	 369	 bp	
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upstream	of	the	TSS	and	the	other	424	bp	(Fig	4.1B).	Hereafter	the	probes	will	be	referred	to	as	Myc-369	and	Myc-424.				
	
Figure	4.1	TIGR	principle	and	probe	design.	(A)	Summarized	TIGR	protocol	(full	details	 in	 "Materials	 and	 Methods").	 (B)	 Two	 probes	 binding	 to	 the	 promoter	region	of	c-Myc	were	designed.	They	have	a	 length	of	50	bases	and	bind	369	and	242	bases	upstream	from	the	TSS.	Thus,	they	are	designed	to	pull	down	the	same	DNA	fragments.		
4.2 Enrichment and specificity of c-Myc promoter isolation 	In	 order	 to	 estimate	 the	 enrichment	 of	 the	 targeted	 region,	we	 performed	 qPCR	comparing	 the	 c-Myc	 promoter	 enrichment	 to	 the	 negative	 control	 (TIGR	performed	with	a	 scrambled	probe)	and	 the	whole	genome	 input	 (Fig.	4.2).	As	a	negative	control,	we	tested	for	the	enrichment	of	two	other	gene	promoters,	Oct4	
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and	 Nanog,	 as	 well	 as	 a	 non-coding	 region	 on	 chromosome	 2.	 Our	 results	demonstrate	 that	 the	 targeted	 region	 was	 highly	 enriched	 compared	 to	 the	scrambled	 control	 -	 over	 1500	 and	 3000	 fold	 with	 each	 probe	 (Fig.	 4.2A).	 The		targeted	region	was	enriched	with	high	efficiency	(7%	and	15%,	compared	to	the	whole-genome	 input	 sample)	 (Fig.	 4.2B).	 In	 both	 cases,	 the	 enrichment	 was	significantly	 higher	 using	 the	 Myc-424	 probe.	 None	 of	 the	 other	 regions	 we	included	in	the	qPCR	experiments	as	negative	controls	displayed	any	enrichment	(Fig.	4.2A,B)		
	
Figure	4.2	Estimation	c-Myc	promoter	region	enrichment	via	qPCR.	(A)	Using	the	Myc-369	probe,	the	targeted	region	was	enriched	>1500	fold	compared	to	the	scrambled	control;	with	the	Myc-424	probe	over	3000	fold.	There	is	no	unspecific	enrichment	 on	 any	 of	 the	 other	 sites	 we	 included	 as	 negative	 control.	 (B)	Compared	to	the	whole	genome	input	sample,	the	c-Myc	promoter	was	recovered	with	an	efficiency	of	7%	and	15%	using	each	of	the	probes.			After	 having	 ensured	 the	 enrichment	 of	 the	 c-Myc	 promoter,	 we	 proceeded	 to	examine	the	specificity	of	the	genomic	isolation.	The	only	comprehensive	approach	to	 do	 this	 is	 using	 next	 generation	 sequencing	 (NGS)	 and	 testing	 whether	 the	targeted	 locus	 is	 the	 only	 highly	 enriched	 region	 across	 the	 entire	 genome.	 As	before,	we	performed	 the	 experiment	using	 the	Myc-396	and	Myc-424	probes,	 a	scrambled	 probe	 as	 a	 negative	 control	 and	 whole-genome	 sample	 as	 input	 to	compare	to.	Indeed,	our	results	show	a	clear	enrichment	on	the	promoter	region	of	
c-Myc,	which	is	not	present	in	the	negative	control	(Fig.	4.3A).	Aside	from	the	c-Myc	promoter,	there	were	several	other	regions	that	displayed	slight	enrichment	over	the	negative	control.	However,	upon	comparing	them	to	the	target	region	we	find	that	 they	 are	 all	 significantly	 lower	 (Fig.	 4.3B),	 indicating	 that	 the	 targeted	isolation	 of	 the	 c-Myc	 promoter	was	 highly	 specific.	 As	 expected,	 the	 number	 of	
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mapped	 reads	was	 overall	 very	 low,	 possibly	 owing	 to	 the	miniscule	 amount	 of	DNA	resulting	from	a	narrowly	targeted	genomic	isolation	(Suppl.	Fig.	4).		
	
Figure	 4.3	 Specificity	 of	 targeted	 c-Myc	 promoter	 isolation	 using	 next	
generation	 sequencing.	 (A)	We	 report	 highly	 specific	 enrichment	 on	 the	 c-Myc	promoter	 compared	 to	 the	 negative	 scrambled	 control.	 The	 displayed	 peaks	 are	the	most	highly	enriched	ones	across	the	genome.	(B)	All	genomic	regions,	which	displayed	 any	 enrichment	 over	 the	 scrambled	 control,	 were	 compared	 to	 the	targeted	region.	The	y-axis	represents	the	fold-enrichment	compared	to	c-Myc.	All	regions	 are	 designated	 with	 their	 chromosomal	 position.	 C-Myc	 displays	significantly	higher	enrichment	than	all	subsequent	regions.				
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4.3 Analysis of the proteome associated with the c-Myc 
promoter 	ESCs	 in	 native	 ground	 state	 of	 pluripotency	 were	 cultured	 serum-free	 under	 2i	conditions	and	labeled	via	"stable	isotope	labeling	with	amino	acids	in	cell	culture"	(SILAC).	The	 cells	 treated	with	 the	negative	 scrambled	 control,	 the	Myc-369	and	Myc-424	probes	were	labeled	as	"light",	"medium"	and	"heavy",	respectively	(Fig.	4.4).	 24	million	 cells	 from	 each	 condition	were	 collected,	 subjected	 to	 TIGR	 and	mixed	in	a	ratio	1:1:1.	Subsequently	the	samples	were	run	on	a	mass	spectrometer,	using	LC-MS/MS	(Fig.	4.4).	
	
Figure	4.4	Schematic	outline	of	the	proteomic	experimental	setup.	24	million	cells	 cultured	 in	 light,	medium	 and	 heavy	 SILAC	medium	were	 crosslinked	with	formaldehyde	 and	 subjected	 to	 TIGR	 with	 a	 scrambled,	 Myc-369	 and	 Myc-424	probes,	respectively.	Subsequently	the	isolated	proteins	were	pooled	together	and	measured	via	LC-MS/MS.	The	SILAC	 labeling	enables	 the	distinction	between	 the	origins	and	quantities	of	each	identified	protein.		A	total	of	338	proteins	were	isolated	using	Myc-424	and	254	proteins	using	Myc-369	(Fig.	4.5A).	We	calculated	the	ratios	of	the	protein	intensities	with	each	probe	
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compared	 to	 the	 negative	 control	 and	 find	 that	 they	 display	 a	 high	 correlation	(R=0.72;	Fig.	4.5B).			
	
Figure	4.5	Proteome	analysis	of	TIGR	results	for	c-Myc.	(A)	With	the	Myc-424	probe,	we	 fetched	 a	 total	 of	 338	proteins.	With	Myc-369,	 254,	 all	 of	which	were	also	identified	with	Myc-424.	(B)	A	scatter	plot	of	the	log2	ratios	over	the	negative	scrambled	 control	 for	 each	 of	 the	 probes.	 The	 results	 display	 a	 high	 correlation	(R=0.72),	but	an	overall	lower	intensity	in	the	Myc-369	pull-down.		There	is	a	large	overlap	between	the	proteins	isolated	with	each	probe;	in	fact,	all	proteins	 isolated	 using	 Myc-369	 were	 also	 identified	 in	 the	 Myc-424	 sample,	indicating	 high	 reproducibility.	 This	 was	 further	 confirmed	 by	 the	 highly	correlated	enrichment	rates	compared	to	the	negative	control.	It	should	be	noted	that	there	is	a	significant	difference	in	the	overall	intensities	between	the	proteins	isolated	 with	 each	 probe	 -	 Myc-369	was	 significantly	 less	 efficient	 compared	 to	Myc-424,	which	is	in	line	with	our	enrichment	comparison	between	the	probes	on	DNA	 level	 (Fig.	 4.2A,B).	 This	made	 it	 difficult	 to	 select	 highly	 enriched	 proteins	compared	 to	 the	negative	 control	 from	both	 replicates.	To	ensure	 the	 stringency	and	specificity	of	all	further	analysis,	we	therefore	focused	only	on	proteins,	which	were	exclusively	present	in	the	Myc-pull-downs,	but	not	present	in	the	scrambled	control.			This	 proteomic	 subset	 encompasses	 a	 total	 of	 90	 proteins.	 It	 includes	 the	transcription	factor	Ybx1,	which	is	a	known	component	of	a	complex	promoting	c-Myc	 stability	 and	 the	 co-transcription	 factor	Ewing	 sarcoma	breakpoint	 region	1	
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(Ewsr1)	 which,	 as	 a	 fusion	 protein	 with	 FLI,	 is	 a	 regulator	 targeting	 c-Myc	(Kowalewski	et	al.	2011).			In	 order	 to	 examine	more	 globally	 the	 biological	 processes	 in	 which	 the	 c-Myc-associated	 proteins	 are	 involved,	 we	 subjected	 them	 to	 GO	 term	 enrichment	analysis,	 using	 the	 whole	 genome	 as	 a	 background	 and	 stringent	 statistical	selection	 for	enrichment	significance	(p<0.05)	(Fig.	4.6).	 In	 line	with	expectation,	we	 find	 that	 among	 the	 most	 highly	 enriched	 terms	 are	 processes	 related	 to	proliferation	and	cell	cycle	progression,	in	which	c-Myc	is	critically	involved.	Other	enriched	 terms	 include	 biogenesis	 or	 ribonucleoprotein	 complexes	 and	 RNA	localization	(Fig.	4.6).			
	
Figure	4.6	GO	term	enrichment	analysis	of	proteins	associated	with	the	c-Myc	
promoter.	 Only	 proteins	 exclusively	 identified	 with	 either	 of	 the	 Myc-specific	probes,	 but	 not	 with	 the	 negative	 control,	 were	 included.	 Only	 significantly	enriched	pathways	were	included	(p<0.05),	minimum	3	genes	per	term.	We	report	high	enrichment	for	processes	related	to	cell	cycle	transition	and	proliferation.			In	order	to	examine	the	connectivity	between	the	proteins	specifically	associated	with	 the	 c-Myc	 promoter,	we	 subjected	 them	 to	 network	 analysis	 (Fig.	 4.7).	 The	connectivity	was	 estimated	based	on	1)	known	 interactions	 from	experimental	data	 and	 manually	 curated	 databases;	 2)	 predicted	 interactions	 from	 gene	neighborhood,	 fusion	 and	 co-occurrence;	 3)	 text-mining,	 co-expression	 and	protein	homology.	We	 find	 that	 that	 91%	of	 the	proteins	 isolated	with	TIGR	 are	highly	 interconnected	 and	 the	 majority	 of	 these	 connections	 are	 based	 on	experimental	 data	 (Fig.	 4.7).	 We	 further	 find	 that	 38	 proteins	 are	 known	 to	 be	
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involved	 in	 gene	 expression	 (highlighted	 in	 red),	 as	 would	 be	 expected	 for	promoter-associated	proteins.		
	
Figure	4.7	Network	analysis	of	proteins	associated	with	the	c-Myc	promoter.	Over	90%	of	the	isolated	proteins	are	highly	interconnected	and	the	information	is	primarily	 based	 on	 experimental	 data	 (pink	 edges)	 or	 curated	 databases	 (blue	edges)	which	represent	 the	highest	confidence	 levels	of	 interactome	studies.	The	rest	 of	 the	 color	 code	 refers	 to	 predicted	 interactions,	 green	 -	 based	 on	 gene	neighborhoods;	 red	 -	 gene	 fusions;	 blue	 -	 gene	 co-occurance;	 light	 green	 -	textmining;	black	-	co-expression;	light	blue	-	protein	homology.		Taken	 together,	 our	 data	 shows	 that	 the	 proteins	 we	 identify	 are	 enriched	 in	processes	in	which	c-Myc	is	a	key	factor	and	they	are	highly	interconnected,	which	are	indications	supporting	the	hypothesis	that	they	are	specifically	associated	with	the	c-Myc	promoter	and	thus	involved	with	its	regulation.	This	is	further	confirmed	by	the	presence	of	known	c-Myc	regulators	like	Ybx1	and	Ewsr1.	At	the	same	time,	the	data	contains	many	interesting	novel	candidates	such	as	the	Chromatin	Target	of	Prmt1	(Chtop),	which	is	critically	involved	in	the	tumorigenicity	of	glioblastoma	cells	 (Takai	 et	 al.	 2014).	Chtop	 is	 also	predicted	 to	play	an	 important	 role	 in	 the	ligand-dependent	 activation	 of	 estrogen	 receptor	 target	 genes	 (UniprotKB,	 by	
Chapter	4	
	78	
similarity).	 This	 makes	 it	 a	 particularly	 interesting	 candidate	 for	 further	exploration,	 since	 c-Myc	 is	 a	 known	 and	 important	 target	 of	 estrogen	 and	regulation	 of	 c-Myc	 expression	 is	 a	 key	 step	 in	 estrogen-induced	proliferation	 of	breast	cancer	(Dubik	et	al.	1987;	Dubik	&	Shiu	1988).	
	
4.4 In-vitro versus in-silico proteomic composition on the c-
Myc promoter 	To	make	a	more	general	comparison	between	our	results	and	data	from	previous	experiments,	we	used	the	in	silico	ChIP	predictive	analysis	tool,	which	is	a	part	of	the	 ChIP-Atlas	 project	 (Oki	 &	 Ohta	 2015).	 The	 ChIP-Atlas	 uses	 virtually	 all	publically	available	ChIP-seq	data	from	over	69	000	experiments	and	offers	series	of	 tools	 for	 integrative	 analysis.	 The	 in	 silico	ChIP	 tool	 uses	 this	 comprehensive	database	to	predict	proteins	bound	to	given	genomic	loci.		The	analysis	 resulted	 in	 a	 total	 of	273	proteins	predicted	 to	 localize	on	c-Myc	 in	pluripotent	 stem	 cells	 (Suppl.	 table	 2).	 From	 those,	 10	 were	 present	 in	 our	extended	 dataset,	 which	 includes	 all	 identified	 proteins	 with	 higher	 expression	compared	to	the	negative	control,	in	at	least	one	replicate.			These	overlapping	proteins	 are	primarily	 factors	 critically	 involved	 in	 epigenetic	regulation,	 such	 as	 Smarca5,	 which	 is	 involved	 in	 nucleosome	 remodeling;	 the	histone	deacetylase	Hdac1;	the	nucleosome	assembly	protein	Nap1l1;	and	Ruvbl2,	which	is	part	of	a	histone	acetyl-transferase	complex.	Other	overlapping	proteins	include	 the	 pro-apoptotic	 transcription	 factor	 Parp1,	 the	 core	 promoter	 binding	transcription	factor	Nono	and	Trim28,	which	is	required	to	maintain	a	repressive	state	on	various	genes	in	pluripotent	cells.			While	some	of	the	proteins	we	identified	as	associated	to	the	c-Myc	promoter	have	been	 previously	 described	 as	 such,	 the	 majority	 are	 novel,	 underlining	 the	promising	potential	of	TIGR	to	identify	new	gene	regulators.		
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4.5 Discussion  	In	 the	 current	 study,	we	 aimed	 to	 specifically	 isolate	 the	 promoter	 of	 c-Myc	and	identify	the	proteins	associated	with	it	in	the	biological	setting	of	embryonic	stem	cells,	 thereby	 expanding	 the	 Myc-centred	 gene	 regulatory	 network	 involved	 in	pluripotency	maintenance.	We	showed	that	by	using	a	novel	technique	developed	in	our	lab,	we	were	able	to	efficiently	(Fig.	4.2)	and	specifically	(Fig.	4.3)	isolate	the	
c-Myc	promoter	region	along	with	over	250	proteins	associated	with	it	(Fig.	4.5A),	many	 of	 which	 specifically	 (i.e.	 not	 identified	 in	 the	 negative	 control).	 These	proteins	displayed	enrichment	for	processes	related	to	the	biological	activity	of	c-Myc,	 such	 as	 proliferation	 and	 cell-cycle	 transition	 (Fig.	 4.6)	 and	 were	 highly	interconnected	 in	a	common	protein-association	network	(Fig.	4.7).	Among	them	were	known	c-Myc	regulators	such	as	Ybx1	and	Ewsr1,	as	well	as	proteins	shown	to	 bind	 to	 c-Myc	 in	 previous	ChIP-seq	 experiments,	 such	 as	 Smarca5	 and	Hdac1.	Importantly,	 our	 dataset	 contained	 interesting	 novel	 candidates	 such	 as	 the	Chromatin	Target	of	Prmt1,	Chtop.	Their	association	with	the	c-Myc	promoter	will	be	subjected	 to	validation	by	ChIP-PCR	and	 their	potential	 functional	effect	on	c-
Myc	expression	tested	by	knockdown	experiments.		In	our	experimental	setup,	we	chose	 to	use	 two	different	probes	 to	 isolate	 the	c-
Myc	promoter	as	they	represent	very	stringent	replicates.	Indeed,	the	overlap	and	correlation	between	the	proteins	isolated	with	each	probe	was	very	high,	pointing	to	 high	 reproducibility	 (Fig.	 4.5).	 However,	 there	 was	 a	 two	 fold	 difference	 in	target	 region	 enrichment	 efficiency	 between	 the	 two	 probes	 (Fig.	 4.2),	 which	ultimately	 translated	 to	 a	 difference	 in	 number	 and	 enrichment	 of	 proteins	 (Fig.	4.5).	 	By	only	focusing	on	proteins	isolated	with	both	probes,	we	would	therefore	exclude	many	interesting	candidates	which	are	not	present	in	the	negative	control	(proteins	co-isolated	with	a	scrambled	probe).	We	therefore	included	them	in	our	analysis.	 Based	 on	 the	 observation	 we	 made	 that	 higher	 genomic	 enrichment	efficiency	 ultimately	 results	 in	 more	 proteins	 identified	 (Fig.	 4.2,	 Fig.	 4.5),	 for	future	 experiments	 we	 consider	 testing	 the	 probe	 efficiency	 first	 and	 then	proceeding	 using	 only	 technical	 replicates	 of	 the	 most	 efficient	 probe.	 Another	
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option	 would	 be	 to	 scale	 the	 amount	 of	 input	 material	 proportionally	 to	 the	efficiency	of	the	probe.		Taken	together,	our	data	suggests	that	we	successfully	isolated	the	promoter	of	c-
Myc		and	identified	a	multitude	of	novel	proteins	associated	with	it,	many	of	which	with	 potential	 regulatory	 function.	 Our	 data	 serves	 as	 a	 valuable	 basis	 for	 the	expansion	of	the	pluripotency-associated	transcriptional	regulatory	network.																							
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5. Concluding remarks 
	The	expansion	of	biological	knowledge	and	understanding	 is	crucially	dependent	on	 technological	 advances	 which	 allow	 us	 to	 see	 the	 invisible.	 Present-day	bioscience	 heavily	 relies	 on	 progress	 in	 engineering,	 physics,	 chemistry	 and	informatics	and	these	 integrated	efforts	have	drastically	 increased	the	speed	and	efficiency	 with	 which	 biological	 information	 is	 acquired.	 The	 proteomics	 field	belongs	 to	 the	most	prominent	examples	of	 this.	Recent	advances	 in	biochemical	assays,	 mass	 spectrometry	 engineering	 and	 bioinformatic	 analytical	 tools	 have	enabled	 the	 characterization	 of	 the	 global	 proteome	 composition,	 as	 well	 as	specific	 sub-proteomes	 in	 various	 biological	 contexts.	 This	 major	 progress	 has	tremendous	impact	on	bioresearch,	as	proteins	are	the	main	functional	entities	in	a	cell	 and	 the	 characterization	 of	 their	 complex	 interplay	 is	 paramount	 to	understanding	how	biological	processes	work.		The	presented	thesis	aimed	to	expand	the	current	understanding	of	the	regulatory	networks	 involved	 in	 differentiation	 and	 reprogramming	 by	 exploiting	 these	technological	advances.	Indeed,	we	used	a	multitude	of	techniques,	many	of	which	innovative,	to	unravel	different	layers	of	proteomic	information	in	this	context.	On	a	global	scale,	 this	 included	an	 interrogation	of	 the	 full	proteome	changes	during	neuronal	 differentiation	 and	 reprogramming.	 We	 further	 narrowed	 down	 the	profiling	by	 investigating	 the	 spatio-temporal	 expression	patterns	of	distinct	 cell	populations	 during	 differentiation.	 Finally,	we	 focused	 on	 highly	 specific	 protein	interaction	networks	which	were	 either	 associated	with	 a	 targeted	 transcription	factor	 (Sox2)	 or	 genomic	 locus	 (c-Myc).	 This	 multi-level	 interrogation	 of	 the	dynamic	 proteome	 architecture	 revealed	 several	 novel	 findings,	 including	 the	interplay	between	the	dynamically	changing	Sox2	interactome,	the	subsequent	re-definition	of	its	targets	and	the	effect	on	neuronal	protein	expression.	The	dynamic	Sox2	 interactome	 reflects	 its	 dual	 functionality	 in	 pluripotency	maintenance	 and	neuronal	 differentiation,	 as	 it	 undergoes	 the	 same	 compositional	 transition.	We	also	 demonstrated	 that,	 strikingly,	 within	 the	 three	 dimentional	 embryoid	 body	structures,	 the	 epigenetic	 and	 developmental	 proteome	 switches	 towards	
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differentiation	become	initiated	immediately	and	within	an	enclosed	group	of	cells	which	 express	 many	 pluripotency	 markers.	 Finally,	 by	 successfully	 isolating	 a	single	genomic	locus,	we	discovered	a	highly	interconnected	and	specific	group	of	proteins	 associated	 with	 the	 promoter	 of	 c-Myc,	 many	 of	 which	 novel.	 Taken	together,	these	and	other	findings	expand	the	current	understanding	of	the	highly	dynamic	 and	 interconnected	 molecular	 mechanisms	 behind	 cell-fate	 transitions	and	open	up	new		questions	and	follow-up	perspectives.		One	example	of	an	interesting	future	prospect	would	be	the	application	of	TIGR	in	a	 different	 biological	 setting,	 particularly	 cancerous	 tissues.	 Given	 that	 the	(mis)regulation	of	this	proto-oncogene	is	commonly	involved	in	the	emergence	of	different	tumors,	investigating	the	proteins	associated	with	the	c-Myc	promoter	in	this	 setting	 could	 potentially	 provide	 valuable	 insight	 regarding	 the	 regulatory	mechanisms	behind	its	tumorigenicity.	Such	insight	would	also	benefit	 the	use	of		iPSC-based	therapies	in	the	clinic,	as	currently	the	most	serious	impediment	is	that	c-Myc	overexpression	in	iPSC-derived	cells	leads	to	tumor	formation.		Another	interesting	field	of	exploration	would	be	the	signaling	transmission	within	three-dimentional	embryoid	bodies.	Since	their	core	is	largely	protected	from	the	cell	culture	environment	both	by	their	position	and	by	an	external	collagen	shell,	it	is	 likely	 that	 the	quick	proteomic	 rearrangements	we	 find	 in	 their	 core	might	be	caused	by	secretion	of	epigenetic	and	develomental	cues	from	the	cell	coat	on	the	outer	 rim	 of	 the	 embryoid	 body.	 Exploring	 this	 could	 provide	 valuable	 insight	regarding	 the	 similarities	 and	 differences	 in	 signal	 trasduction	 between	 early	embryos	and	the	embryoid	bodies	designed	to	model	them.		In	sum,	by	expanding	our	knowledge	on	the	regulatory	networks	within	different	stem	 cell	 systems,	 this	 thesis	 underlines	 the	 significance	 of	 proteomics-based	studies	 in	 developmental	 biology	 and	 lays	 a	 solid	 foundation	 for	 further	exploration.			
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6. Materials and Methods 
	
6.1 Establishment of 'reprogrammable' mouse line 	'Reprogrammable'	 mouse	 embryos	 were	 obtained,	 containing	 three	 key	components:	 (1)	 a	 reprogramming	 cassette	 with	 the	 four	 "Yamanaka"	 genes	
Pou5f1,	Klf4,	Sox2,	and	Myc,	(OKSM	cassette)	under	the	control	of	the	bi-directional	tet-responsive	 element	 (tetO)	with	CMV	minimal	 enhancer-less	promoter;	 (2)	 an	expression	of	reverse	tetracycline-controlled	transactivator	protein	(rtTA);	and	(3)	IRES-EGFP	 fusion	 cassette	 downstream	 of	 the	 stop	 codon	 of	 the	 Oct4	 (Pou5f1)	gene.	To	this	end,	male	mice	homozygous	for	each	of	the	three	mutations	were	first	obtained	from	The	Jackson	Laboratory:		-	Col1a1-OKSM,	http://jaxmice.jax.org/strain/011001.html;		-	Rosa26-rtTA,	http://jaxmice.jax.org/strain/006965.html;	-	Oct4-eGFP,	http://jaxmice.jax.org/strain/008214.html.			The	mutant	males	were	mated	with	wildtype	(WT)	females.	The	resulting	embryos	were	subjected	to	rederivation	by	embryo	transfer.	After	birth,	the		heterozygous	population	was	left	to	reach	reproductive	maturity	(min	7	weeks	for	the	males	and	12	 weeks	 for	 the	 females)	 and	 mated	 to	 homozygousity.	 Subsequently,	 double-homozygous	 (hom/hom)	 mutants	 for	 Rosa26-rtTA	 and	 Oct4-eGFP	 were	established	and	mated	with	hom	Col1a1-OKSM	mice.		The	 resulting	 embryos	 were	 het/het/het	 for	 all	 three	 mutations.	 Any	 cell	 type	obtained	 from	 them	 could	 be	 subjected	 to	 reprogramming	 upon	 addition	 of	doxycycline	to	the	cell	culture	media.		
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6.2 Cell culture  
 
6.2.1 Generation of STEMCCA-MEFs 	Due	 to	 the	 presence	 of	 a	 stem	 cell	 cassette	 in	 the	 'reprogrammable'	 mice,	 the	mouse	 embryonic	 fibroblasts	 obtained	 from	 them	 are	 here	 referred	 to	 as	STEMCCA-MEFs.			Pregnant	 female	mice	were	sacrificed	at	13.5	dpc	after	 timed	mating.	The	uterus	was	placed	in	a	petri	dish	and	each	embryo	was	separated	from	the	placenta	and	the	embryo	sac.	The	embryos	were	dissected,	whereby	 the	head,	 internal	organs	and	 gonads	 were	 removed	 and	 the	 remaining	 tissue	 was	 washed	with	 PBS	 and		minced	manually	in	1	ml	of	0.05%	Trypsin-EDTA	(Thermo	Fisher,	25300054)	in	a	laminar	 cell	 culture	 hood.	 After	 incubation	 5	 minutes	 at	 37°	 C,	 the	 trypsin	 was	inactivated	using	1	volume	of	MEF	medium	(DMEM	high	glucose	(Thermo	Fisher,	11965-092)	 with	 10%	 fetal	 serum	 albumin	 (Thermo	 Fisher,	 10270-106),	GlutaMAX	 (1:100,	 Thermo	 Fisher,	 35050-061),	 penicillin-streptomycin	 (1:100,	Thermo	 Fisher,	 15140-122),	 nonessential	 amino	 acids	 (1:100,	 Thermo	 Fisher,	11140-050),	2-mercaptoethanol	(10	µM,	Sigma,	M7522).	Cells	were	centrifuged	at	300	g,	5	minutes,	taken	up	in	fresh	media	and	plated	in	T25	filtered	flasks	(Thermo	Fisher,	156367)	coated	 in	0.2%	gelatine	 (Sigma)	at	a	density	 corresponding	 to	1	embryo	 per	 flask.	 Flasks	were	 stored	 under	 low-oxygen	 (5%)	 conditions	 for	 24	hours,	after	which	they	had	reached	>95%	confluency.	Cells	were	frozen	with	10%	DMSO	(Sigma)	in	liquid	nitrogen	until	further	use.	Upon	usage,	cells	were	routinely	tested	 for	mycoplasma	 infection	with	 e-MycoTM	 plus	 Mycoplasma	 PCR	 Detection	Kit	(Intron	Biotechnology).		
6.2.2 Culture of ESCs and iPSCs 
	
Self-generated iPSCs and 46C mESCs were grown feeder-free on 0.2% gelatinized 
plates in media with the following components: DMEM	high	glucose	(Thermo	Fisher,	11965-092),	 15%	 fetal	 serum	 albumin	 (Thermo	 Fisher,	 10270-106),	 GlutaMAX	(1:100, Thermo	 Fisher,	 35050-061),	 penicillin-streptomycin	 (1:100, Thermo	
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Fisher,	15140-122),	nonessential	amino	acids	(1:100,	Thermo	Fisher, 11140-050),	2-mercaptoethanol	 (10	 µM,	 Sigma,	M7522)	 and	 20	 ng/ml	 (iPSCs)	 or	 200	 ng/ml	(46C	cells)	LIF	(EMBL	protein	expression	facility).			Cells	 grown	 under	 2i	 conditions	 were	 cultured	 in	 DMEM/F12 medium (Pierce, 
88215; product discontinued), nonessential	 amino	 acids	 (1:100,	 Thermo	 Fisher, 
11140-050),	penicillin-streptomycin	(1:100, Thermo	Fisher,	15140-122),	GlutaMAX	(1:100, Thermo	 Fisher,	 35050-061),	 2-mercaptoethanol	 (10	 µM,	 Sigma,	M7522),	20	ng/ml	LIF	(EMBL	protein	expression	facility),	0.5mg/ml	of	BSA	(Sigma,	A3059),	1μM	 of	 PD0325901	 (Reagents	 Direct,	 39-C68),	 3μM	 of	 CHIR99021	 (Reagents	Direct,	 27-H76),	 100 mg/ml Proline (Sigma, P5607). For light SILAC labeling, 100 
mg/ml of Lysine (L8662) and 100 mg/ml of Arginine (Sigma, A6969) were used; for 
medium SILAC – 100 mg/ml of L-Lysine-2HCl, 4,4,5,5-D4 (Silantes, 211104113) and 
100 mg/ml of Arginine 13C6 (Silantes 201204102); for heavy SILAC, 100 mg/ml of 
13C6,15N2-L-Lysine HCl (Silantes, 211604102) and 100 mg/ml of 13C6,15N4-L-
Arginine HCl (Silantes, 201604102). 
 Cells	 were	 routinely	 tested	 for	 mycoplasma	 infection	 with	 e-MycoTM	 plus	Mycoplasma	PCR	Detection	Kit	(Intron	Biotechnology).	
 
Fixation:	 added to the 2iL-medium. For cell fixation, the cells were harvested by 
Stempro Accutase (Life technologies, A11105-01), and spun 5min at 200g to remove 
the medium. Then the cell pellet was resuspended in 1.5% formaldehyde (Pierce, 
28906) in PBS. After 15 min incubation at room temperature with occasional rotations, 
125mM Glycine (Merck, 56-40-6) was added to the solution to quench cross-linking. 
Then the cells were washed twice with PBS, counted and aliquoted, and stored at -80◦C 
as dry cell pellets. 	
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6.2.3 Cellular reprogramming and establishment of STEMCCA-iPS cell 
lines 	MEFs	were	thawed	upon	placing	in	37°C	water	bath	for	5	minutes	and	taken	up	in	9	 ml	 MEF	 medium	 (composition	 see	 above),	 centrifuged	 at	 1200	 rpm	 for	 4	minutes,	 taken	 up	 in	 fresh	 MEF	 medium	 and	 expanded	 in	 T25	 flasks	 (Thermo	Fisher,	 156367)	 in	 low	 oxygen	 conditions	 (5%	 O2)	 for	 24	 hours	 until	 full	confluency.		The	 cells	were	 split	 in	 gelatinized	 (0.2%)	15	 cm	 cell	 culture	plates	 	 in	 ES	media	containing	 2	 µg/ml	 doxycycline	 and	 the	 AGi	 (ascorbic	 acid	 (Sigma,)	 and	 GSK3b	inhibitor	 CHIR99021	 (Reagents	 Direct,	 27-H76)	 small	molecules	 combination	 as	described	by	 (Bar-Nur	et	al.	2014).	The	medium	was	changed	every	day	and	 the	cells	 were	 kept	 on	 doxycycline	 for	 8	 days	 and	 cultured	 for	 additional	 4	 days	without	 doxycycline	 to	 ensure	 that	 the	 endogenous	 pluripotency	 network	 had	been	 initiated.	The	cells	were	 routinely	monitored	 for	 their	Oct4-GFP	expression	under	 a	 fluorescent	microscope.	 At	 day	 12,	 typical	 iPSCs	with	 clear,	 shiny	 edges	and	pronounced	GFP	expression	had	formed.	A	subset	of	the	colonies	were	tested	and	 were	 positive	 for	 Alkaline	 Phosphatase	 (AP	 staining	 Kit,	 Vector	 Labs,	 SK-5100).			To	generate	clean,	iPS-only	lines,	50	colonies	were	cut	out	surgically	under	a	light	microscope	(using	a	scalpel	and	a	syringe	needle),	collected	 in	a	well	of	a	round-bottom	96	well	plate	(Thermo	Fisher)	containing	10	µl	trypsin	and	dissociated	for	20	 minutes	 at	 room	 temperature.	 The	 dissociated	 cells	 from	 each	 colony	 were	subsequently	plated	in	one	well	from	a	gelatinized	(0.2%)	96	well	plate.	Over	the	following	days,	 the	cells	were	monitored	 for	 colony	 formation	and	only	 the	ones	which	managed	to	re-build	distinct,	GFP-positive	iPS	colonies	were	expanded	and	kept	as	iPS	cell	lines.				
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6.2.4 Neuronal differentiation of pluripotent stem cells 	The	 differentiation	 protocol	 was	 performed	 as	 described	 in	 (Bibel	 et	 al.	 2007),	with	 few	 modifications.	 Briefly,	 self-generated	 iPSCs	 and	 129X1/SvJ ESCs	 were	thawed	on	feeder-MEFs	(for	129	cells)	or	on	gelatinized	plates	(for	iPSCs)	and	kept	on	 for	 two	 passages	 in	 ES	 medium	 (see	 composition	 above)	 with	 15%	 ES	 Cell	Qualified	 EmbryoMax®	 FBS	 (Millipore,	 ES-009-B)	 and	 20	 ng/ml	 LIF	 (EMBL	protein	 expression	 facility).	 The	 129	 cells	 were	 then	 plated	 for	 2	 passages	 on	gelatinized	 plates.	 Differentiation	 starts	 upon	 transfer	 of	 4e6	 cells/10	 cm	 non-adhesive	 plates	 (Sigma,	 P9366	 Sigma)	 and	 removal	 of	 LIF	 from	 the	 medium,	leading	to	the	formation	of	embryoid	bodies.	The		medium	was	changed	every	two	days.	On	days	four	and	six,	retinoic	acid	(Sigma,	R2625)	at	a	final	concentration	of	5	µM	was	added	 to	 the	medium.	On	day	8,	 the	emryoid	bodies	were	dissociated,	brought	 in	 single-cell	 suspension,	 plated	 on	 PORN/laminin-coated	 plates	 and	switched	 to	N2	medium	 containing	DMEM	high	 glucose	 (Thermo	 Fisher,	 11965-092),	1xN2	supplement	(Thermo	Fisher,	17502048),	1x	B27	supplement	(Thermo	Fisher,	 17504044)	 and	 penicillin-streptomycin	 (1:100, Thermo	 Fisher,	 15140-122),	following	the	exact	protocol	as	described	by	Bibel	(Bibel	et	al.	2007).	At	day	10	the	cells	had	formed	dense	neuronal	networks	and	represented	a	differentiated	neuron	state.		Cells	were	 collected,	 centrifuged	at	2000	 rpm	 for	5	minutes	 and	 the	 cell	 pelletts	were	frozen	at	-80°C	for	all	proteomic/biochemical	experiments.		
6.2.5 Reprogramming of neuronal cultures 	The	STEMCCA-iPSCs	were	 subjected	 to	neuronal	differentiation	described	above.	The	 differentiated	 neurons	 (day	 10)	 were	 kept	 in	 N2	 medium	 culture	 for	additional	two	days	(day	12).	To	ensure	that	there	were	no	pluripotent	cells	left	in	the	 neuronal	 culture,	 the	 cells	 were	 observed	 under	 fluorescent	 microscope	(Evos).	No	Oct4-GFP-positive	cells	were	observed.			
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At	 day	 12,	 the	 reprogramming	 was	 initiated	 upon	 addition	 of	 2	 µg/ml	 of	doxycycline	 to	 the	 cell	 culture	 and	 simultaneous	 switch	 to	 ES	 media	 (see	composition	 above).	 The	 entire	 reprogramming	 of	 the	 neuronal	 culture	 took	 32	days	after	this	initiation	step.	Doxycycline	was	added	to	the	cells	for	a	total	of	14	days.	 The	 cells	 were	 kept	 in	 their	 PORN/laminin	 coated	 plates	 for	 4	 days	 after	initiation	 of	 reprogramming.	 At	 day	 4,	 the	 cells	 were	 split	 1:3	 and	 plated	 on	gelatin-coated	plates.	The	media	was	changed	without	splitting	on	days	2,	6,	8,	11	and	25;	they	were	split	on	days	4,	9,	12,	14,	16,	19,	23,	27.	To	estimate	the	progress	of	reprogramming,	the	cells	were	analyzed	on	a	cell	sorter	(MoFlo)	on	days	7,	12	and	21.	On	day	32,	Oct4-GFP-positive	colonies	with	characteristic	iPSC	morphology	and	size	had	formed.		
6.3 Proteome sample preparation 
 
6.3.1 SP3 sample preparation 	The	 following	 procedure	 termed	 "Single-Pot	 Solid-Phase-enhanced	 Sample	Preparation"	(SP3)	was	adapted	from	(Hughes	et	al.	2014).	It	was	applied	for	the	whole	 proteome	 samples	 from	 chapter	 2	 and	 the	 Oct4-GFP	 sorted	 populations	from	chapter	3.	Cell	 pellets	 of	 1e6	 cells	 from	 each	 condition	 and	 replicate	were	 reconstituted	 in	100	 µl	 of	 lysis	 buffer	 (50mM	 Ambic,	 1%	 SDS,	 1X	 Protease	 Inhibitor	 Cocktail	(Roche;	05892791001),	10mM	TCEP	and	40mM	CAA)	and	sonicated	for	12	cycles	(30/30	seconds	on/off)	on	a	Bioruptor	Pico	(Diagenode).	They	were	heated	up	at	95°C	for	5	min	and	cooled	down	for	5	min	at	room	temperature.		A	50/50%	mixture	of	 Sera-Mag	Speed	Beads	A	 and	B	 (Fisher	 Scientific;	 CAT	No.	24152105050250,	CAT	No.	44152105050250)	was	rinsed	in	water	on	a	magnetic	stand	2	times	and	taken	up	water,	in	their	original	volume.	4µl	of	the	bead	mixture	was	 added	 to	 the	 samples	 and	 immediately	 afterwards,	 104	 µl	 of	 acetonitrile	(ACN)	were	 added.	The	 samples	were	 left	 for	10	minutes	 	 at	 room	 temperature,	after	which	they	were	placed	on	a	magnetic	rack	and	left	for	another	2	minutes	to	allow	the	magnetic	beads	to	settle.	The	supernatant	was	removed,	the	beads	were	washed	on	the	rack	2	times	with	1	ml	70%	ethanol	and	once	with	1	ml	ACN.	The	
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supernatant	was	removed,	the	beads	were	air-dried	for	1	minute	and	taken	up	in	20	µl	TEAB	with	pH	8.5.	For	the	whole	proteome	samples	in	chapter	2,	2	µg	of	the	proteolytic	enzyme	LysC	were	added	to	the	samples;	for	the	sorted	populations	in	chapter	 3,	 we	 used	 Trypsin,	 the	 amount	 was	 adapted	 to	 the	 measured	 sample	amount	as	 follows	 	 sample:trypsin	=	1:50.	The	samples	were	 left	 for	16	hours	at	37°C.	The	 following	 day,	 samples	 in	 chapter	 2	 were	 subjected	 to	 TMT	 labeling	 (see	method	 below).	 The	 other	 samples	 were	 subjected	 to	 SP3	 peptide	 clean-up	 as	follows:	2	µl	from	the	prepared	seramagnetic	bead	mixture	(see	above)	was	added	to	each	sample	and	vortexed.	ACN	was	added	to	a	final	concentration	of	95%	and	the	sample	incubated	for	18	minutes	at	room	temperature.	The	samples	were	spun	briefly	with	a	 tabletop	centrifuge	and	 the	 tubes	were	placed	on	a	magnetic	 rack.	The	 supernatant	 was	 removed,	 the	 beads	 were	 washed	with	 200	 µl	 100%	 ACN	once.	The	beads	were	air-dried	for	1	minute.	10	µl	of	0.1%	formic	acid	was	added	to	the	dried	beads,	the	tubes	were	vortexed	and	placed	in	a	sonication	water	bath	for	5	minutes.	The	tubes	were	placed	on	a	magnetic	rack,	the	liquid	was	removed	and	 placed	 in	 fresh	 tubes.	 These	 	 samples	were	 then	 run	 on	 an	Orbitrap	 Fusion	mass	spectrometer	(see	settings	below)	without	further	clean-up.	
6.3.2 In-solution sample preparation 	1.5e6	cells	 from	each	condition	were	lysed	in	300	µl	 lysis	buffer	containing	0.1%	Rapigest	 (Waters),	 50	 mM	 Ammonium	 Bicarbonate	 pH	 8.0,	 10	 mM	 Tris(2-carboxyethyl)phosphine	 hydrochloride	 (TCEP)	 (Sigma-Aldrich,	 C4706)	 	 and	 40	mM	CAA.	The	lysate	was	sonicated	with	a	Benson	probe	sonicator	for	60	seconds	at	 10	 seconds	 on,	 2	 seconds	 off	 cycle	 and	 20%	 output	 on	 ice	 and	 afterwards	subjected	 to	 proteolytic	 digestion	 with	 1:50	 trypsin	 (Promega)	 for	 16	 hours	 at	37°C.	The	samples	were	then	acidified	to	1%	end	concentration	of	trifluoroacetic	acid	 (TFA)	 (Sigma-Aldrich,	 76-05-1),	 incubated	 for	30	minutes	 at	37°C	 and	 spun	down	at	15000g	for	10	minutes.	The	supernatant	was	then	subjected	to	clean-up	and	 mass	 spectrometry	 measurement	 as	 described	 in	 "HPLC	 fractionation	 and	mass	spectrometry	analysis"	(without	fractionation	and	label-free).		
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6.3.3 TMT peptide labeling 	In	order	to	enable	the	multiplexed	mass	spectrometry	analysis	of	the	samples,	they	were	subjected	to	 isobaric	chemical	 labeling	using	the	so	called	tandem	mass	tag	(TMT,	 Thermo	 Fisher,	 90061).	 The	 TMT	 reagents	 are	 used	 for	 labeling	 of	 the	peptides	and	consist	of	a	reactive	group	(which	covalently	binds	to	the	peptide	N-termini	 or	 lysine	 residues),	 a	 spacer	 arm	 and	 a	 reporter	 group.	 During	 mass	spectrometry	 analysis,	 the	 tag	 fragments	 break	 off	 and	 produce	 unique	 reporter	ions,	 thus	 enabling	 the	 relative	 protein	 quantification	 between	 the	 different	samples.	We	 used	 TMT	 6-plex	 labeling	 (in	which	 the	 reporter	mass	 varies	 from	126	to	131	Da)	to	label	the	samples	of	each	stage	of	differentiation	(day	0,	2,	4,	6,	8	and	10).			After	 the	 proteolytic	 digest,	 the	 beads	 were	 put	 on	 a	 magnetic	 rack	 and	 the	supernatant	 was	 transferred	 to	 new	 tubes.	 20	 µg	 (in	 1	 µl)	 of	 TMT	 reagent	 was	added	to	each	sample	and	left	for	30	min	at	room	temperature.	After	that	the	same	amount	was	added	again	and	left	for	30	min	at	room	temperature.	1	µl	of	quench	mix	(50mM	ammonium	bicarbonate	and	10mM	Lysine)	was	added	to	each	simple	and	incubated	for	5	minutes.	2	µl	of	bead	mix	(see	preparation	above)	was	added	to	each	sample	and	ACN	was	added	up	to	a	final	percentage	of	95%	and	incubated	for	 10	 minutes.	 The	 beads	 were	 put	 on	 a	 magnetic	 rack	 for	 2	 minutes,	 the	supernatant	 was	 removed	 and	 the	 beads	 were	 washed	 with	 100%	 ACN.	 The	supernatant	was	removed	and	the	beads	were	reconstituted	in	4%	DMSO	in	water	and	placed	on	magnetic	rack.	Finally	the	supernatant	was	taken	in	fresh	tubes	and	formic	acid	was	added	to	a	final	percentage	of	0.1%.			The	 labeling	 efficiency	 was	 first	 controlled	 by	 measuring	 10%	 of	 each	 sample	separately	 on	 an	Orbitrap	Fusion	mass	 spectrometer	 (exact	 settings	below).	The	multiplexed	 samples	 were	 then	 mixed	 in	 a	 ratio	 1:1	 (based	 on	 the	 overall	abundance	estimation	from	the	label	check	run),	subjected	to	fractionation	via	high	pH	 high-performance	 liquid	 chromatography	 (HPLC)	 and	 mass	 spectrometry	measurement	 (full	 description	 and	 settings	 in	 "HPLC	 fractionation	 and	 mass	spectrometry	analysis").	
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6.3.4 MS/MS library preparation 	This	 method	 was	 used	 for	 preparation	 and	 analysis	 of	 the	 Oct4-GFP	 sorted	populations	described	in	Chapter	3.	1e6	non-sorted	cells	from	each	time	point	and	condition	 were	 combined	 and	 subjected	 to	 in-solution	 digestion	 as	 described	above.	 The	 peptide	 concentration	 was	 measured	 using	 Pierce™	 Quantitative	Colorimetric	 Peptide	 Assay	 (Thermo	 Fisher)	 and	 50	 µg	were	 subjected	 to	 HPLC	fractionation	into	60	fractions,	which	were	pooled	into	12,	as	described	below.	The	equivalent	of	1.5	µg	from	each	fraction	was	measured	on	an	OrbitrapFusion	mass	spectrometer	using	 the	 settings	described	below	and	a	2	hours	LC	gradient.	The	same	 gradient	 and	 LC-MS/MS	 settings	were	 used	 for	measurment	 of	 the	 sorted	populations,	which	were	prepared	using	the	SP3	protocol	as	described	above.	The	library	 and	 sorted	 population	 samples	 were	 measured	 in	 technical	 replicates,	which	were	combined	upon	raw	data	analysis	with	MaxQant	software.	The	"match	between	 runs"	 function	 in	MQ	was	 applied	 to	match	 IDs	 from	 the	 library	 to	 the	sorted	populations.	
6.4 HPLC fractionation and mass spectrometry analysis 
 The	 combined	 samples	 were	 fractionated	 with	 1200	 Infinity	 HPLC	 system	(Agilent),	 using	 a	 Gemini	 C18	 column	 (Phenomenex).	 A	 60	minute	 gradient	was	used,	which	progresses	linearly	from	0	to	35%	ACN	in	20	mM	ammonium	formate,	pH10.	The	flow	rate	was	set	at	100µl/minute.	Peptide	elution	was	detected	via	UV	detector	 at	 254	 nm.	 33	 fractions	 were	 collected	 and	 pooled	 into	 11	 fractions	(combination	strategy:	fraction	1,	12	and	23;	2,	13	and	24	etc.).		Each	 fraction	 was	 then	 measured	 on	 an	 Orbitrap-Fusion Quadrupole-Linear-Ion 
Trap-Orbitrap hybrid mass spectrometer (Thermo Fisher)	coupled	to	EASY-nLC	system	(Thermo	Fisher).	The	samples	were	loaded	onto	a 100 µm x 2 cm Acclaim Pepmap 
RSLC trap column (5µm particles, 100Å pores, C18) in 100% solvent A (0.1% formic 
acid in water, ULCMS Grade, Biosolve) and eluted onto a 75 µm x 50 cm (2µm 
particles, 100Å pores, C18) Acclaim Pepmap RSLC analytical column by a gradient 
from 3% solvent B (0.1% formic acid in 80% acetonitrile and 19.9% water, ULCMS 
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Grade, Biosolve) to 50% solvent B in 86 minutes at a flow rate of 300 nl/min. Eluting 
ions were analyzed by electrospray using a 10 µm Picotip coated fused silica emitter 
(New Objective) and a Nanospray-Flex ion source (Thermo) connected to an Orbitrap-
Fusion Quadrupole-Linear-Ion Trap-Orbitrap hybrid mass spectrometer (Thermo 
Fisher). The Orbitrap was operated in positive mode generating profile spectra at a 
resolution of 60.000 FWHM, AGC target was 1x106, maximum injection time 50 ms. 
The mass spectrometer was set to data-dependent mode of acquisition (top speed) and 
the most intense ions (threshold 5x103) were selected for HCD-fragmentation using 
nitrogen as a collision gas (33% HCD collision energy) by the Quadrupole (1.6 m/z 
window) and resulting fragments were analyzed by the Linear-Ion-Trap set to rapid 
scan rate, first mass 120 m/z, an AGC Target of 1x104, a maximum injection time of 50 
ms and data type to centroid. Selected ions were excluded for reselection 60 (146 min 
gradient) seconds with a window of 20 ppm. 
6.4 FACS 
 Cell	sorts	were	performed	either	on	a	Becton	Dickinson	FACSMelody	or	a	Beckman	Coulter	MoFlo	XDP	cell	sorter.	Both	instruments	were	set	to	20psi	sheath	pressure	with	a	100um	nozzle	running	Becton	Dickinson	FACSFlow	as	sheath	carrier.	GFP	was	excited	with	488nm	(20mW	or	400mW	respectively)	and	emission	was	picked	up	 with	 a	 530/30	 bandpass	 filter;	 DAPI	 live	 dead	 staining	 was	 done	 on	 both	systems	with	all	samples	to	exclude	dead	or	compromised	cells	(405nm	excitation,	450/50nm	 bandpass	 filter	 -	 25mW	 or	 240mW	 respectively).	 PMT	 performance	and	setup	was	checked	either	with	BD	CST	beads	or	Spherotech	Rainbow	beads	on	the	MoFlo	systems.	Purity	of	the	cells	was	frequently	assessed	post	sort.	Sorts	were	performed	under	chilled	sample	conditions	at	4°C.	
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6.5 ChIP-SICAP 
 Cells	were	cross-linked	using	1.5%	formaldehyde	for	15	minutes	and	the	reaction	was	stopped	using	125mM	Glycine.	24e6	fixed	cells	were	used	for	each	condition	and	 replicate.	 Each	 pellet	 was	 resuspended	 in	 5ml	 lysis	 buffer	 1	 (HEPES-KOH	pH7.5	50mM,	NaCl	140mM,	EDTA	1mM,	Glycerol	10%,	NP-40	0.5%,	Triton	X100	0.25%)	and	rotated	on	a	wheel	for	10	minutes	at	4°C.	The	lysate	was	centrifuged	at	1350rpm	for	5min	at	4°C	and	the	pellet	resuspended	with	5	ml	lysis	buffer	2	(Tris	HCl	pH	8	10mM,	NaCl	200mM,	EDTA	1mM,	EGTA	0.5mM)	and	rotated	on	a	wheel	at	 room	temperature	 for	10	minutes.	The	 lysate	was	centrifuged	at	1350rpm	 for	5min	at	4°C	and	the	pellet	resuspended	with	1.5	ml	 lysis	buffer	3	(Tris	HCl	pH	8	10mM,	 NaCl	 100mM	 EDTA	 1mM,	 EGTA	 0.5mM,	 Na-deoxycholate	 0.1%,	 Na-lauroylsarcosine	0.5%).	The	chromatin	was	 then	sonicated	 in	a	 cooled	Bioruptor	Pico	 (Diagenode)	 for	 7	 and	 11	 cycles	 for	 ESCs	 and	 TNs,	 respecitively,	 on	 30s	ON/30s	OFF	cycles.	An	aliquot	of	 the	cross-linked	material	was	de-crosslinked	at	95°C	 for	 1	 hour	 and	 tested	 on	 an	 1.5%	 agarose	 gel	 (fragment	 size	 300-500	 bp).	Triton	was	added	to	the	chromatin	samples	(1%	final	concentration),	which	were	then	 spun	 in	 a	 cooled	 centrifuge	 at	 12700rpm,	 4°C	 for	 10	minutes.	 The	 protein	amount	 in	each	sample	was	quantified	using	a	Pierce	BCA	assay	according	to	the	manufacturer's	protocol	(Thermo	Fisher).	12.5µg	to	20µg	of	Sox2	antibody	(R&D	Systems,	AF2018)	was	added	to	each	sample	and	the	same	amount	of	IgG	antibody	(Santacruz)	 was	 added	 to	 the	 samples	 which	 served	 as	 negative	 control.	 The	samples	were	rotated	for	18	hours	at	4°C.	100µl/sample	Protein	G	magnetic	beads	(Invitrogen)	were	washed	twice	using	0.5%	BSA	(Sigma)	in	1x	PBS	and	left	in	the	same	solution	on	a	wheel	overnight	at	4°C.		The	following	day,	the	beads	were	washed	twice	with	PBS,	added	to	the	chromatin	samples	and	 rotated	on	a	wheel	 for	3	hours	at	4°C.	The	 following	washing	 steps	were	 performed	 by	 resuspending	 the	 beads	 by	 flapping	 the	 tube	 several	 times,	quickly	spinning	them	down	and	and	putting	them	back	on	the	magnet.	The	beads	were	washed	 once	 using	washing	 buffer	 A	 (SDS	 0.1%,	 Triton	 0.5%,	 EDTA	 2mM,	NaCl	 150mM,	 Tris	 HCl	 pH	 7.6	 20mM),	 once	 with	 washing	 buffer	 B	 (SDS	 0.1%,	Triton	 0.5%,	 EDTA	 2mM,	 NaCl	 300mM,	 Tris	 HCl	 pH	 7.6	 20mM)	 and	 once	 with	
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100mM	Tris-HCl	pH	7.6.		The	beads	were	then	resuspended	in	100	µl	1x	TdT	buffer	(Thermo	Fisher)	 and	kept	 5	minutes	 at	 room	 temperature,	 occasionally	 swirling	the	beads.	The	tubes	were	then	placed	on	a	magnetic	stand,	the	liquid	removed	and	the	beads	resuspended	with	fresh	88	µl	TdT	buffer	(Thermo	Fisher).	10	µl	biotin-14-dCTP	(Thermo	Fisher)	and	2	µl	TdT	enzyme	(Thermo	Fisher)	were	added	and	incubated	for	30	minutes	at	37°C	on	a	thermomixer	(Eppendorf),	agitating	at	500	rpm.	After	 that,	 the	beads	were	washed	4	 times	with	1	ml	 ice	cold	 IP	buffer	(see	composition	 above)	 at	 room	 temperature	 and	 resuspended	 in	 100	 µl	mixture	 of	7.5%	SDS	and	200mM	DTT	in	water.	The	beads	were	then	incubated	30	minutes	at	37°C	on	 a	 thermomixer	 (Eppendorf),	 agitating	 at	 750	 rpm.	The	 supernatant	was	collected	and	the	beads	were	discarded.	0.7	ml	IP	buffer	(see	composition	above)	and	50	µl	protease-resistent	streptavidin	beads	(New	England	Biololabs;	patent	for	protease-resistence	filed	by	our	lab;	appl.	Nr.	CA2998549A1)	were	added	to	each	sample	and	rotated	at	4°C	overnight.		The	suspended	beads	were	put	on	a	magnetic	stand,	the	liquid	removed.	The	beads	were	then	washed	3	times	with	SDS	wash	buffer	(10	mM	Tris-Cl	pH	8,	1	mM	EDTA,	1%	SDS,	200	mM	NaCl),	1	time	with	10%	isopropanol	and	4	times	with	20%	ACN.	The	beads	were	 resuspended	 in	80	µl	ACN	and	 transferred	 to	0.2	ml	PCR	 tubes,	which	were	placed	on	magnetic	rack.	The	supernatant	was	removed	and	the	beads	resuspended	 in	 14	 µl	 digestion	 buffer	 (0.1%	 SDS	 in	 50	 mM	 Ammonium	Bicarbonate).	 1	 µl	 of	 100	mM	DTT	was	 added	 to	 the	 samples,	 which	were	 then	incubated	 at	 95°C	 for	 20	 minutes	 to	 detach	 the	 proteins	 from	 the	 streptavidin	beads.	The	tubes	were	cooled	down	to	room	temperature,	1	µl	of	200	mM	IAA	was	added	to	the	samples	and	incubated	30	minutes	at	room	temperature.	The	reaction	was	quenched	upon	addition	of	1	µl	of	100	mM	DTT.	The	tubes	were	placed	on	a	magnetic	 stand	 and	 the	 liquid	 transferred	 to	 fresh	 tubes	 (the	 beads	 were	discarded).	300	ng	Trypsin	(Promega)	was	added	to	each	sample	and	incubated	at	37°C	 overnight.	 The	 following	 day,	 they	 were	 subjected	 to	 SP3	 clean-up	 as	desicribed	above.				
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 6.6 TIGR 	For	this	experiment,	we	used	the	following	probes	(biotynilated)	and	primers:		
Probes:	 	Myc-369	 [BtnTg]TGACGCGGTCCAGGGTACATGGCGTATTGTGTGGAGCGAGGCAGCTGTT		Myc-424	 [BtnTg]TCTAAATTCTGTTTTCCCCAGCCTTAGAGAGACGCCTGGCCGCCCGGGACG	Scrambled	 [BtnTg]AGGTGCAGCCGTGGTTAAAAGATGAATAAAGTGAAATGAGGTAAAGCCTCTT	
Primers:	 	cMyc-F	 AACTCATTCGTTCGTCCTTC	cMyc-R	 ACAGTAATAGCGCAGCATGAA	Chr2-F					 TCTGAGCACCTCATCTCATTG	Chr2-R					 TTTGAAAGGACTTGCCCAGAA	Oct4-F	 AGAAATAATTGGCACACGAACA	Oct4-R	 TCACCGGACACCTCACAAAC	Nanog-F				 	GAAAGCCGTGTATAAACAGAGAC	Nanog-R					 CTTTACCTCATTTCACTTTATTCATC		We	used	fixed,	SILAC-labeled	cells	(see	preparation	details	in	"Cell	culture"	above).	The	Myc-424	probe	was	applied	to	"heavy"	labeled	cells,	Myc-369	to	"medium"	and	the	unspecific	 "Scrambled"	 probe	 to	 "light".	 For	 enrichment	 tests	with	 qPCR,	we	used	4e6	cells/condition,	 for	next	generation	sequencing	and	mass	spectrometry,	24e6	cells/condition.			The	cells	were	taken	up	and	vortexed	in	200	µl	IP	buffer	(50mM	Tris-Cl,	pH	7.5;	5	mM	EDTA,	1%	TritonX-100)	with	1x	protease	inhibitor	(Roche).	5	µl	RNaseA	(10	mg/ml,	 Fermentas)	 was	 added	 and	 incubated	 at	 37°C	 for	 20	 minutes	 in	 a	thermomixer	(Eppendorf),	agitating	at	750	rpm.	0.5	ml	DNAzol	(Life	Technologies)	was	added	to	each	sample,	followed	by	vortexing	and	centrifugation	at	5000	g	for	2	minutes.	The	supernatant	was	removed	and	the	pellet	was	resuspended	in	500	µl	DNAzol,	followed	by	vortexing	and	centrifugation	as	above.	The	pellets	were	taken	up	 in	300	µl	of	25mM	NaOH	and	 incubated	at	37°C	 for	30	minutes.	The	samples	were	sonicated	using	Bioruptor	Pico	(Diagenode)	for	12	cycles	(30	seconds	on,	30	seconds	off;	high	intensity	mode).	1µl	of	the	biotynilated	probes	(1	pmol/µl)	were	added	to	the	respective	cell	lysate	and	the	samples	were	placed	in	30	kD	Amnicon	
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ultrafiltration	columns	(Millipore).	The	columns	were	spun	5	minutes	at	12000g,	4°C.	 300	 µl	 of	 BW	 buffer	 (Tris-HCl	 10mM	 pH=7.5,	 EDTA	 1mM,	 NaCl	 1M)	 were	added	to	each	sample.	The	tubes	were	centrifuged	10	minutes	at	12000g,	4°C.	The	liquid	in	the	column	was	reduced	to	approximately	100	µl,	which	were	transferred	to	 2	ml	 eppendorf	 tubes	 with	 BW	 buffer	 with	 additional	 0.1%	 TritonX100.	 The	samples	were	heated	up	at	65°C	at	700	rpm	agitation.	600	µl	of	BW	buffer	and	50	µl	 protease-resistent	 streptavidin	 beads	 (New	 England	 Biolabs;	 patent	 for	protease-resistence	filed	by	our	lab;	appl.	Nr.	CA2998549A1)	were	added	to	each	sample	and	the	tubes	were	rotated	at	room	temperature	for	1	hour.	Subsequently,	the	beads	were	washed	2X	with	SDS-WB	1	 (Tris-HCl	10mM	pH=7.5,	EDTA	1mM,	NaCl	350	mM,	SDS	0.5%),	1X	with	SDS-WB	2	(Tris-HCl	10mM	pH=7.5,	EDTA	1mM,	NaCl	200	mM,	SDS	1%),	2X	with	20%	isopropanol	in	500mM	NaCl),	5X	with	60%	ACN	in	100mM	NaCl.		From	 this	 step	 onwards,	 the	 protocol	 "splits"	 dependent	 on	 the	 application.	 The	samples	 were	 either	 used	 for	 DNA	 enrichment	 tests	 (via	 qPCR)	 and	 next	generation	sequencing,	or	for	proteome	analysis	using	mass	spectrometry.		For	DNA	analysis:	The	 beads	were	 resuspended	 in	 220	 µl	 TE	 buffer	 (10mM	Tris,	 1mM	EDTA)	 and	incubated	overnight	at	65°C.	Proteinase	K	(2	µl	)	were	added	to	each	sample	and	put	 at	 55°C	 thermomixer	 (Eppendorf)	 at	 700	 rpm	 for	 30	 min.	 The	 tubes	 were	placed	on	a	magnetic	stand	for	2	minutes	and	the	liquid	transferred	to	fresh	tubes.	The	 samples	 were	 then	 subjected	 to	 phenol/chlorophorm	 isoamylalcohol	 DNA	purification	and	precipitated	using	glycogen	and	100%	ethanol.	The	purified	DNA	was	 taken	 up	 in	 30	 µl	 elution	 buffer	 from	 Qiagen	 PCR	 purification	 kit.	 For	enrichment	analysis	using	qPCR,	TaKaRa	SYBR	green	mastermix	and	an	ABI7500	real-time	PCR	system	(Applied	Biosciences)	were	used.	Thermal	conditions	were	set	to	95°C	for	10	minutes,	followed	by	40	cycles	of	95°C	for	15	seconds,	60°C	for	30	 seconds,	 72°C	 for	 30	 seconds.	 For	 next-generation	 sequencing,	 a	 library	was	prepared	starting	with	DNA	end	repairing	by	Klenow	T4	DNA	polymerase	and	T4	polynucleotide	kinase,	 followed	by	A-tailing	and	 ligation	with	NEBNext	Multiplex	Oligos	 for	 Illumina	 (Index	 primers	 set	 1).	 The	 libraries	 were	 amplified	 by	 PCR	under	the	following	thermal	conditions:	98°C	for	30	seconds,	16	cycles	of	98°C	for	10	seconds,	65°C	for	30	seconds,	72°C	for	30	seconds	and	extension	for	5	minutes.	
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The	products	were	subjected	to	size	selection	with	Ampure	XP	beads	(0.6X-1.5X-0.98X)	 and	 eluted	 in	 15	 µl	 elution	 buffer	 (Qiagen).	 The	 concentration	 was	measured	 with	 Qubit	 and	 the	 fragment	 size	 via	 Bioanalyzer.	 Finally	 the	 pooled	libraries	were	sequenced	using	Illumina	MiSeq	set	at	4	million	reads.	For	protein	analysis:	The	beads	were	resuspended	in	220	µl	of	0.1%	Rapigest	(Waters).	10	µl	of	10	mM	DTT	were	added	to	each	sample	and	they	were	heated	at	95°C	for	20	minutes.	10	µl	of	200	mM	IAA	were	added	to	each	sample	and	incubated	at	room	temperature	without	light	for	30	minutes.	The	reaction	was	quenched	upon	addition	of	5	µl	100	mM	DTT.	The	 tubes	were	placed	on	magnetic	 rack	and	 the	 liquid	placed	 in	 fresh	tubes.	 The	 protein	 samples	 were	 finally	 digested	 overnight	 at	 37°C	 by	 100	 ng	mixture	 of	 Trypsin	 and	 LysC	 (Promega).	 The	 peptides	 were	 subjected	 to	 SP3	peptide	 clean-up	 as	 described	 above	 and	 measured	 on	 a	 Orbitrap	 Velos	 Pro	(Thermo	 Fisher),	 connected	 to	 nanoAcquity	 UPLC	 via	 a	 nanoelectrospray	 ion	source	(Waters).	
6.7 Immunofluorescence staining and microscopy 
 The	following	antibodies	and	stains	were	used	for	immunofluorescence	in	chapter	3:		 - Anti-Map2	(Abcam,	ab5392)	- Goat	 Anti-Chicken	 IgY	 H&L	 (Alexa	 Fluor®	 647)	 preadsorbed	 (Abcam,	ab150175)	- NeuroFluorTM	 NeuO	 (Stem	 Cell	 Technologies);	 membrane-permeable	fluorescent	probe	for	the	detection	of	live	neurons	- DAPI	(Thermo	Fisher)		For	 detection	 of	Map2,	 neurons	 at	 day	 12	 of	 differentiation	were	 fixed	with	 2%	paraformaldehyde	in	PBS,	permeabelized,	and	blocked	with	1%	BSA.	Primary	Anti-Map2	antibody	diluted	1:500	in	1%	BSA	was	applied	overnight.	Cells	were	washed	in	PBS	and	secondary	goat	anti-chicken	antibody	(1:1000)	in	1%	BSA	was	applied.	DAPI	stain	(1:500)	was	added	30	min	before	microscopy.		Live	neurons	were	stained	with	NeuO	following	the	manufactuer's	protocol.			
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6.8 Bioinformatic analysis  
6.8.1 MS spectra analysis 	MS	 spectra	were	analyzed	using	 the	quantitative	proteomics	 software	MaxQuant	(open	 source	 software	 by	 Jürgen	 Cox	 and	 Matthias	 Mann	 (Cox	 &	 Mann	 2008)),	using	 the	 standard	 pre-set	 settings	 with	 the	 following	 alterations:	 label-free	quantification	(LFQ)	for	p.iPSC	vs.	s.iPSC	and	GFP-sorted	populations	analysis	from	chapter	3	and	SILAC-based	relative	quantification	for	TIGR	spectra	from	chapter	4.	Spectra	 from	 the	ChIP-SICAP	experiment	 in	 chapter	2	were	analyzed	using	 iBAQ	intensity	values.	For	the	library	MS/MS	matching	from	chapter	3,	"match	between	runs"	was	applied.	The	TMT-based	experiment	in	chapter	2	was	analyzed	using	or	Proteome	Discoverer	1.4	(Thermo	Fisher).	Proteins	were	identified	using	MASCOT	search	 engine	 (Matrix	 Science)	 and	 the	 latest	 Mus	 Musculus	 database	 from	Uniprot.			
6.8.2 Statistical and GO term enrichment analysis 	The	 statistical	 analysis	 was	 performed	 using	 the	 open-source	 computational	platform	 for	 analysis	 of	 Omics	 data	 Perseus	 (Tyanova	 et	 al.	 2016)	 and	 the	 open	source	 software	 environment	 for	 statistical	 computing	 R	 (https://www.r-project.org/).	 Contaminants,	 proteins	 only	 identified	 by	 a	 modification	 site	 and	proteins	 derived	 from	 the	 reverse	 part	 of	 the	 decoy	 database	were	 filtered	 out.	Differential	 expression	 analysis	 was	 performed	 using	 the	 "linear	 models	 for	microarray	 data"	 (limma)	R	 package	 (Ritchie	 et	 al.	 2015),	which	 is	 a	 part	 of	 the	Bioconductor	project	 (Huber	 et	 al.	 2015).	The	dynamic	 expression	 clusters	were	generated	 using	 the	 R-based	 Graphical	 Proteomics	 Data	 Explorer	 (GProX)	 using	standard	settings	as	described	 in	 the	 figure	 legend.	GO	term	enrichment	analysis	was	 either	 performed	 in	 GproX	 (for	 the	 protein	 clusters	 in	 chapter	 2)	 or	 in	Cytoscape	with	 the	ClueGo	application	 (all	 other	 chapters).	GO	 term	annotations	were	 downloaded	 from	 Perseus.	 Only	 significantly	 enriched	 terms	 were	considered	(p<0.05),	GO	levels	set	between	3	and	8.			
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7. List of Abbreviations 
	
BP	 	 	 Biological	Process	
CC	 	 	 Cellular	Compartment	
ChIP	 	 	 Chromatin	Immuno-Precipitation		
ChIP-MS		 	 Chromatin	Immuno-Precipitation	followed	by	Mass			 	 	 Spectrometry		
ChIP-SICAP	 	 Chromatin	Immuno-Precipitation	with	selective	isolation	of		 	 	 chromatin-associated	proteins		
ESCs	 	 	 Embryonic	Stem	Cells		
FBS		 	 	 Fetal	Bovine	Serum	
GO	 	 	 Gene	Ontology	
ICM	 	 	 Inner	Cell	Mass	
iPSCs		 	 	 induced	Pluripotent	Stem	Cells		
LC-MSMS	 	 Liquid	chromatography	coupled	to	MSMS.	Peptide	mixtures		 	 	 are	separated	based	on	their	biochemical	properties	usually		 	 	 hydrophobicity),	thereby	increasing	the	number	of	entified		 	 	 and	quantified	peptides	and	the	proteome	sampling	depth.	
LFQ	 	 	 Label-Free	Quantification.	A	proteomic	quantification			 	 	 strategy	which	relies	on	bioinformatic	tools	post-MS			 	 	 measurement.	
M2-rtTA		 	 reverse	tetracycline-dependent	transactivator		
MEFs		 	 	 Mouse	Embryonic	Fibroblasts	
MF	 	 	 Molecular	Function	
MS	 	 	 Mass	Spectrometry	
MSMS		 	 Tandem	Mass	Spectrometry.	A	method	by	which	precursor		 	 	 peptides	are	measured	once	to	determine	their	overall		
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	 	 	 mass	and	then	fragmented	again	to	generate	fragment			 	 	 spectrum	used	for	their	exact	identification		
OKSM		 	 Oct4,	Klf4,	Sox2	and	c-Myc		
Rosa26-rtTA		 allele	Gt(ROSA)26Sor	(Rosa26)	locus8		
RT-PCR	 	 Reverse	Transcriptase	Polymerase	Chain	Reaction	
SCNT		 	 	 Somatic-Cell	Nuclear	Transfer		
SILAC	 	 	 Stable	Isotope	Labeling	with	Amino	acids	in	Cell	culture	
SP3	 	 	 Single-Pot	Solid-Phase-enhanced	Sample	Preparation.	A			 	 	 method	for	proteomic	sample	preparation	for	ultrasensitive		 	 	 analysis.	Particularly	advantageous	for	limited	input			 	 	 material.		
SPS	 	 	 Synchronus	Precursor	Selection.		
STEMCCA	 	 Stem	Cell	Casette		(Col1A-tetO-OKSM,	usually	with	R26-		 	 	 rtTA)	
TdT	 	 	 Terminal	deoxynucleotidyl	Transferase		
TF	 	 	 Transcription	Factor	
tetO		 tetracycline	operon,	requires	doxycycline-activated	rtTA	to	allow	gene	expression	
TIGR	 	 	 Targeted	Isolation	of	Genomic	Regions		
TMT	 	 	 Tandem	Mass	Tag.	Isobaric	peptide-labeling	strategy	which		 	 	 allows	multiplexing	(simultaneous	analysis)	of	up	to	11			 	 	 samples.						
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8. Supplementary information 
	
		 		
Supplementary	Figure	1	Assessment	of	purity	of	neuronal	population	a)	Light	microscopy	 image	of	neuronal	culture	at	day	10.	Neuronal	network	with	secondary	connective	structures	clearly	visible.	Scale	bar	50	µm.	b)	Assessment	of	neuronal	 culture	with	 NeuO	 (green),	 a	 viable	marker	 for	mature	 neurons.	 Dead	cells	are	stained	with	DAPI	 (blue).	95%	of	 cells	are	NeuO-positive,	based	on	100	frame	count.	Scale	bar	100	µm.				
	
Supplementary	 Figure	 2	 Sox	 2	 protein	 expression	 during	 neuronal	differentiation.	 (A)	Western	 blot	 at	 day	 0	 (ES)	 and	 day	 10	 (TN).	 (B)	 Mass-Spec	results	for	Sox2	througlhout	differentiation.	Sox2	strongly	decreases	but	is	present	until	the	terminal	differentiation	stage.								
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Supplementary	 Figure	 3	 Sonicated	 chromatin	 of	 ESCs	 and	 TNs,	 in	biological	replicates.					
	
Supplementary	 Figure	 4	 Mapped	 reads	 of	 sequenced	 samples.	 The	 color	scheme	corresponds	to	the	number	of	reads	before	(dark	blue)	and	after	applying	different	 filters.	 Overall	 low	 number	 of	 reads	 from	 TIGR	 pull-downs	 with	 both	probes,	 varying	between	1e5	 for	Myc-369	probe	 and	3.5e5	 for	Myc-424	 and	 the	scrambled	negative	control.										
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Figure 4 TIGR results for c-Myc (A) Binding location of two biotynilated probes, Myc-369 and Myc-424 (B) Variability in enrichment 
in equal experimental conditions as measured by qPCR (C) Mapped reads of sequenced samples. Very low number of mapped reads for 
Myc-369 and Myc-424 pull-downs (D) Sequencing results on a genomic track. Both probes were successfully used to selectively pull 
down the promoter region of c-Myc (E) Comparison of enrichment of top 10 unspecific reads compared to the target c-Myc.  
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Supplementary	figure	5	Generation	of	primary	iPSC	lines	from	MEFs.	We	used	a	 "fast-track"	 protocol	 described	 in	 (Bar-Nur	 et	 al.	 2014).	 iPSC	 colonies	 with	characteristic	morphology,	 strong	Oct4-GFP	expression	and	positive	 for	 the	stem	cell	 marker	 alkaline	 phosphatase	 were	 generated	 after	 12	 days.	 Single	 colonies	were	picked	and	cultured	separately	for	two	weeks,	thereby	firming	pure	iPS	cell	lines	with	characteristic	morphology	and	pluripotency	marker	expression.				
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Supplementary	Figure	6	Neuronal	cultures	generated	from	p.iPSCs.	Left:	Light	microscopy	images	at	day	12		of	differentiation.	Clearly	visible	neuronal	networks,	with	a	few	non-neuronal	cells.	Right:	Fluorescent	microscopy	of	neuronal	cultures.	Upper:	 cells	 were	 stained	 with	 an	 antibody	 against	 the	 neuronal	 marker	 Map2	(mCherry,	red)	and	the	cellnuclei	with	DAPI	(blue).	Map2+	and	Map2-	cells	were	counted,	 the	 cultures	were	 predominantly	 neuronal	 (86%).	 Lower:	No	Oct4-GFP	expression	visible.	Scale:	upper	left,	upper	and	lower	right,	200	µm;	lower	left,	100	µm.		
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Supplementary	 figure	 7	 Expression	 of	 neuron-	 and	 neurogenesis-specific	
proteins	in	the	iPSC-generated	neuronal	cultures	(at	day	12).				
	
Supplementary	 Figure	 8	 FACS	 analysis	 of	 iPSCs-generated	 neuronal	 culture	 at	day	12,	 stained	with	neuron-specific	 life	stain	NeuO.	Cells	were	excited	with	488	nm	(NeuO)	and	405	nm	(DAPI).	98.2%	of	all	live	cells	were	NeuO+,	1.8%	NeuO–.						
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and	 secondary	 (first	 list)	 iPSCs.	 The	 number	 beside	 each	 column	 represents	 the	number	of	proteins	identified	in	this	term.	The	column	represents	the	percentage	of	all	proteins	in	a	GO	term	covered	in	our	dataset.	Only	significantly	enriched	GO	terms	were	included	(p<0.05).	Whole	genome	background.								
Motif	similarity=Direct,	NES>3.0,	all	for	which	there	is	a	TF	assigned	to	
motif	
Sox2	
Sox3	
Sox4	
Sox6	
Sox8	
Sox9	
Sox10	
Sox14	
Sox21	
Sry	
Sf1	
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Supplementary	table	1	Transcription	factors	from	iRegulon	analysis	significantly	predicted	to	regulate	the	expression	of	proteins	in	Cluster	1.				
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Chd2	 Sox2	 Smad3	 Isl1	 Stat5a	 Men1	 Kmt2b	 Pbx1	 Cdk8	 Nr0b1	 Nfyc	
Kdm1a	 Tcf3	 Myod1	 Mbd3	 Ncor1	 Kmt2a	 Cbx2	 Aebp2	 Dgcr8	 Dpf2	 E4f1	
Rest	 Tal1	 Smad2	 Kdm5b	 Ncor2	 Med23	 Onecut1	 Vsx2	 Drosha	 Klf5	 Dppa2	
Rcor2	 Setdb1	 Rfx1	 Klf4	 Daxx	 Parp1	 Smarcc1	 Hcfc1	 Phc1	 Hira	 Suv39h1	
Ehmt2	 Mtf2	 E2f4	 Meis1	 Sumo2	 Pcgf2	 Baz1a	 Zfp384	 Cbx8	 Kdm6b	 Suv39h2	
Sin3a	 Jarid2	 Tet1	 Sox3	 Hoxb4	 Ncoa3	 Phf5a	 Mafk	 Arid3a	 Crebbp	 Gad1	
Cdyl	 Kdm5a	 Yy1	 Sox11	 Baz2a	 Kat8	 Phrf1	 Zc3h11a	 Dicer1	 Thap11	 Pwp1	
Brf2	 GFP	 Mapk8	 Cbx7	 Ctcfl	 Zfp57	 Ruvbl1	 Gata4	 Mettl3	 Mcrs1	 Etv2	
Gtf3c2	 Nelfa	 Nfya	 Cebpb	 Rcor1	 Kmt2d	 Ruvbl2	 Phf19	 Smarcad1	 Msl2	 Cdk7	
Trim24	 Supt5	 Atf7ip	 Gata2	 Cbx1	 Kdm6a	 Sap18	 Gli1	 Tbx3	 Kansl3	 Zic2	
BrdU	 Ctr9	 Hdac1	 Lmo2	 Ell	 Tead4	 Smarca5	 Gli2	 Zfp322a	 Sp1	 Nkx2-2	
Smarca4	 Kdm2a	 Hdac2	 Fli1	 Cbfa2t2	 Zic3	 Srsf1	 Pcgf6	 Cbx5	 Ep400	 Nkx6-1	
Nap1l1	 Rara	 Chd4	 Gata1	 Prdm14	 Kdm2b	 Srsf2	 Usp7	 T	 Usp16	 Hnrnpl	
Kat5	 Spi1	 Dpy30	 Gfi1	 Neurod2	 Ell3	 Ssrp1	 Aff3	 Btaf1	 Tcf12	 Pknox1	
Pou5f1	 Atrx	 5-hmC	 Gfi1b	 Biotin	 Epop	 Baz1b	 Sall4	 Ino80	 Dnajc2	 Hand1	
Nanog	 Tbp	 Ctcf	 Elk4	 5-mC	 Elob	 Gtf3c1	 Leo1	 Dr1	 Utf1	 Rad23b	
Epitope	
tags	 Chd7	 Runx1	
Ncapd
3	 Dnmt3b	 Zmynd8	 Neurog2	 Cdc73	 Rbpj	 Tfap2c	 Jun	
Otx2	 Ep300	 Ell2	 Ncapg	 Taf1	 Rybp	 Lhx3	 Ldb1	 Ascl1	 Cdx2	 Fgfr1	
Brd4	 Smc1a	 Olig2	 Rad21	 Nrf1	 Zfp281	 Ebf2	 Phf20	 Esrrg	 Msl1	 Nr4a1	
Dnmt1	 Smc3	 Ncaph2	 Cdk9	 Zfp42	 Gmnn	 Onecut2	 Kdm4c	 Stat1	 Nsl1	 Zfp217	
Tet3	 Med12	 Rxra	 Pou3f1	 Nono	 Zic1	 Tfe3	 Myc	 Zbtb2	 Tgif1	 Tgif2	
Phf13	 Med1	 Rarg	 Pou3f2	 Paf1	 Ogt	 Fam60a	 Sox17	 Eed	 Tdg	 Sirt6	
Ezh2	 Nipbl	 Trim28	 Trp53	 Stag2	 Tet2	 Kdm4a	 Mbd2	 Smad4	 Taf9b	 Brd2	
Rnf2	 Rbbp5	 Taf3	 Smad1	 Stag1	 Zfp143	 Foxa2	 Cbx3	 Max	 Esrrb	
	
Suz12	 Wdr5	 Raf1	 Gtf2b	 Bmi1	 Morc3	 Foxa1	 Med26	 Supt6	 Nfyb	
	Supplementary	 table	 2	 Full	 list	 of	 all	 proteins	 predicted	 to	 interact	with	 c-
Myc	in	mouse	pluripotent	stem	cells.	Analysis	done	with	the	in	silico	ChIP	tool	in	the	ChIP	Atlas.	Threshold	of	significance	100,	antigen	type	"transcription	factors",	cell	type	"pluripotent	stem	cell".											
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